<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">84338</article-id><article-id pub-id-type="doi">10.7554/eLife.84338</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.84338.3</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>FUS regulates RAN translation through modulating the G-quadruplex structure of GGGGCC repeat RNA in <italic>C9orf72</italic>-linked ALS/FTD</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-297469"><name><surname>Fujino</surname><given-names>Yuzo</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1773-8998</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-297475"><name><surname>Ueyama</surname><given-names>Morio</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund27"/><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund11"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-235113"><name><surname>Ishiguro</surname><given-names>Taro</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-235114"><name><surname>Ozawa</surname><given-names>Daisaku</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-297476"><name><surname>Ito</surname><given-names>Hayato</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1437-5853</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-106684"><name><surname>Sugiki</surname><given-names>Toshihiko</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1716-1241</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-235125"><name><surname>Murata</surname><given-names>Asako</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-43080"><name><surname>Ishiguro</surname><given-names>Akira</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-5906"><name><surname>Gendron</surname><given-names>Tania</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-235115"><name><surname>Mori</surname><given-names>Kohji</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2629-0723</contrib-id><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="other" rid="fund28"/><xref ref-type="other" rid="fund29"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund10"/><xref ref-type="other" rid="fund13"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-235116"><name><surname>Tokuda</surname><given-names>Eiichi</given-names></name><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-297477"><name><surname>Taminato</surname><given-names>Tomoya</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-235126"><name><surname>Konno</surname><given-names>Takuya</given-names></name><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-235127"><name><surname>Koyama</surname><given-names>Akihide</given-names></name><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-235128"><name><surname>Kawabe</surname><given-names>Yuya</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5438-4797</contrib-id><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-235129"><name><surname>Takeuchi</surname><given-names>Toshihide</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff14">14</xref><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-235130"><name><surname>Furukawa</surname><given-names>Yoshiaki</given-names></name><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-66310"><name><surname>Fujiwara</surname><given-names>Toshimichi</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7739-3525</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con18"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-235131"><name><surname>Ikeda</surname><given-names>Manabu</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="con19"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-297479"><name><surname>Mizuno</surname><given-names>Toshiki</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con20"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-2029"><name><surname>Mochizuki</surname><given-names>Hideki</given-names></name><xref ref-type="aff" rid="aff15">15</xref><xref ref-type="fn" rid="con21"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-235132"><name><surname>Mizusawa</surname><given-names>Hidehiro</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con22"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-235133"><name><surname>Wada</surname><given-names>Keiji</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con23"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-235134"><name><surname>Ishikawa</surname><given-names>Kinya</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con24"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-235135"><name><surname>Onodera</surname><given-names>Osamu</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3354-5472</contrib-id><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="fn" rid="con25"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-235136"><name><surname>Nakatani</surname><given-names>Kazuhiko</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="con26"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-5832"><name><surname>Petrucelli</surname><given-names>Leonard</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="con27"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-206775"><name><surname>Taguchi</surname><given-names>Hideki</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6612-9339</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff16">16</xref><xref ref-type="fn" rid="con28"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-234382"><name><surname>Nagai</surname><given-names>Yoshitaka</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1037-3129</contrib-id><email>yoshi.nagai@med.kindai.ac.jp</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff15">15</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund12"/><xref ref-type="other" rid="fund14"/><xref ref-type="other" rid="fund26"/><xref ref-type="other" rid="fund15"/><xref ref-type="other" rid="fund16"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund17"/><xref ref-type="other" rid="fund18"/><xref ref-type="other" rid="fund19"/><xref ref-type="other" rid="fund20"/><xref ref-type="other" rid="fund21"/><xref ref-type="other" rid="fund22"/><xref ref-type="other" rid="fund23"/><xref ref-type="other" rid="fund24"/><xref ref-type="other" rid="fund25"/><xref ref-type="fn" rid="con29"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05kt9ap64</institution-id><institution>Department of Neurology, Kindai University Faculty of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Osaka-Sayama</named-content></addr-line><country>Japan</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/028vxwa22</institution-id><institution>Department of Neurology, Kyoto Prefectural University of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Kyoto</named-content></addr-line><country>Japan</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/035t8zc32</institution-id><institution>Department of Neurotherapeutics, Osaka University Graduate School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Suita</named-content></addr-line><country>Japan</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0254bmq54</institution-id><institution>Department of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry</institution></institution-wrap><addr-line><named-content content-type="city">Tokyo</named-content></addr-line><country>Japan</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/051k3eh31</institution-id><institution>Department of Neurology and Neurological Science, Tokyo Medical and Dental University</institution></institution-wrap><addr-line><named-content content-type="city">Tokyo</named-content></addr-line><country>Japan</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0112mx960</institution-id><institution>School of Life Science and Technology, Tokyo Institute of Technology</institution></institution-wrap><addr-line><named-content content-type="city">Yokohama</named-content></addr-line><country>Japan</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/035t8zc32</institution-id><institution>Laboratory of Molecular Biophysics, Institute for Protein Research, Osaka University</institution></institution-wrap><addr-line><named-content content-type="city">Osaka</named-content></addr-line><country>Japan</country></aff><aff id="aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/035t8zc32</institution-id><institution>Department of Regulatory Bioorganic Chemistry, The Institute of Scientific and28 Industrial Research, Osaka University</institution></institution-wrap><addr-line><named-content content-type="city">Osaka</named-content></addr-line><country>Japan</country></aff><aff id="aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00bx6dj65</institution-id><institution>Research Center for Micro-nano Technology, Hosei University</institution></institution-wrap><addr-line><named-content content-type="city">Tokyo</named-content></addr-line><country>Japan</country></aff><aff id="aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03zzw1w08</institution-id><institution>Department of Neuroscience, Mayo Clinic</institution></institution-wrap><addr-line><named-content content-type="city">Jacksonville</named-content></addr-line><country>United States</country></aff><aff id="aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/035t8zc32</institution-id><institution>Department of Psychiatry, Osaka University Graduate School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Osaka</named-content></addr-line><country>Japan</country></aff><aff id="aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02kn6nx58</institution-id><institution>Department of Chemistry, Keio University</institution></institution-wrap><addr-line><named-content content-type="city">Kanagawa</named-content></addr-line><country>Japan</country></aff><aff id="aff13"><label>13</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04ww21r56</institution-id><institution>Department of Neurology, Clinical Neuroscience Branch, Brain Research Institute, Niigata University</institution></institution-wrap><addr-line><named-content content-type="city">Niigata</named-content></addr-line><country>Japan</country></aff><aff id="aff14"><label>14</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05kt9ap64</institution-id><institution>Life Science Research Institute, Kindai University</institution></institution-wrap><addr-line><named-content content-type="city">Osaka</named-content></addr-line><country>Japan</country></aff><aff id="aff15"><label>15</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/035t8zc32</institution-id><institution>Department of Neurology, Osaka University Graduate School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Osaka</named-content></addr-line><country>Japan</country></aff><aff id="aff16"><label>16</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0112mx960</institution-id><institution>Cell Biology Center, Institute of Innovative Research, Tokyo Institute of Technology</institution></institution-wrap><addr-line><named-content content-type="city">Kanagawa</named-content></addr-line><country>Japan</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Eisen</surname><given-names>Michael B</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01an7q238</institution-id><institution>University of California, Berkeley</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Eisen</surname><given-names>Michael B</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01an7q238</institution-id><institution>University of California, Berkeley</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>18</day><month>07</month><year>2023</year></pub-date><volume>12</volume><elocation-id>RP84338</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2022-11-01"><day>01</day><month>11</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2022-11-01"><day>01</day><month>11</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.11.01.514717"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2023-02-13"><day>13</day><month>02</month><year>2023</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.84338.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2023-06-20"><day>20</day><month>06</month><year>2023</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.84338.2"/></event></pub-history><permissions><copyright-statement>© 2023, Fujino et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Fujino et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-84338-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-84338-figures-v1.pdf"/><abstract><p>Abnormal expansions of GGGGCC repeat sequence in the noncoding region of the <italic>C9orf72</italic> gene is the most common cause of familial amyotrophic lateral sclerosis and frontotemporal dementia (C9-ALS/FTD). The expanded repeat sequence is translated into dipeptide repeat proteins (DPRs) by noncanonical repeat-associated non-AUG (RAN) translation. Since DPRs play central roles in the pathogenesis of C9-ALS/FTD, we here investigate the regulatory mechanisms of RAN translation, focusing on the effects of RNA-binding proteins (RBPs) targeting GGGGCC repeat RNAs. Using C9-ALS/FTD model flies, we demonstrated that the ALS/FTD-linked RBP FUS suppresses RAN translation and neurodegeneration in an RNA-binding activity-dependent manner. Moreover, we found that FUS directly binds to and modulates the G-quadruplex structure of GGGGCC repeat RNA as an RNA chaperone, resulting in the suppression of RAN translation in vitro. These results reveal a previously unrecognized regulatory mechanism of RAN translation by G-quadruplex-targeting RBPs, providing therapeutic insights for C9-ALS/FTD and other repeat expansion diseases.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>ALS</kwd><kwd>C9orf72</kwd><kwd>FUS</kwd><kwd>RAN translation</kwd><kwd>repeat expansion disease</kwd><kwd>RNA chaperone</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>D. melanogaster</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001700</institution-id><institution>Ministry of Education, Culture, Sports, Science and Technology</institution></institution-wrap></funding-source><award-id>Scientific Research on Innovative Areas (Brain Protein Aging and Dementia Control) 17H05699</award-id><principal-award-recipient><name><surname>Furukawa</surname><given-names>Yoshiaki</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001700</institution-id><institution>Ministry of Education, Culture, Sports, Science and Technology</institution></institution-wrap></funding-source><award-id>Scientific Research on Innovative Areas (Brain Protein Aging and Dementia Control) 17H05705</award-id><principal-award-recipient><name><surname>Furukawa</surname><given-names>Yoshiaki</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001700</institution-id><institution>Ministry of Education, Culture, Sports, Science and Technology</institution></institution-wrap></funding-source><award-id>Transformative Research Areas (A) (Multifaceted Proteins) 20H05927</award-id><principal-award-recipient><name><surname>Nagai</surname><given-names>Yoshitaka</given-names></name><name><surname>Mori</surname><given-names>Kohji</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001700</institution-id><institution>Ministry of Education, Culture, Sports, Science and Technology</institution></institution-wrap></funding-source><award-id>Strategic Research Program for Brain Sciences 11013026</award-id><principal-award-recipient><name><surname>Nagai</surname><given-names>Yoshitaka</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>Scientific Research (B) 21H02840</award-id><principal-award-recipient><name><surname>Nagai</surname><given-names>Yoshitaka</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>Scientific Research (B) 20H03602</award-id><principal-award-recipient><name><surname>Mori</surname><given-names>Kohji</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>Scientific Research (C) 15K09331</award-id><principal-award-recipient><name><surname>Ueyama</surname><given-names>Morio</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>Scientific Research (C) 19K07823</award-id><principal-award-recipient><name><surname>Ueyama</surname><given-names>Morio</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>Scientific Research (C) 17K07291</award-id><principal-award-recipient><name><surname>Ishiguro</surname><given-names>Akira</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>Young Scientists (A) 17H05091</award-id><principal-award-recipient><name><surname>Mori</surname><given-names>Kohji</given-names></name></principal-award-recipient></award-group><award-group id="fund11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>Young Scientists (B) 25860733</award-id><principal-award-recipient><name><surname>Ueyama</surname><given-names>Morio</given-names></name></principal-award-recipient></award-group><award-group id="fund12"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>Challenging Exploratory Research 24659438</award-id><principal-award-recipient><name><surname>Nagai</surname><given-names>Yoshitaka</given-names></name></principal-award-recipient></award-group><award-group id="fund13"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>Challenging Exploratory Research 18K19515</award-id><principal-award-recipient><name><surname>Mori</surname><given-names>Kohji</given-names></name></principal-award-recipient></award-group><award-group id="fund14"><funding-source><institution-wrap><institution>Ministry of Health, Labor and Welfare, Japan</institution></institution-wrap></funding-source><award-id>Health Labor Sciences Research Grant for Research on Development of New Drugs H24-Soyaku-Sogo-002</award-id><principal-award-recipient><name><surname>Nagai</surname><given-names>Yoshitaka</given-names></name></principal-award-recipient></award-group><award-group id="fund15"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009619</institution-id><institution>Japan Agency for Medical Research and Development</institution></institution-wrap></funding-source><award-id>Strategic Research Program for Brain Sciences JP15dm0107026</award-id><principal-award-recipient><name><surname>Nagai</surname><given-names>Yoshitaka</given-names></name></principal-award-recipient></award-group><award-group id="fund16"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009619</institution-id><institution>Japan Agency for Medical Research and Development</institution></institution-wrap></funding-source><award-id>Strategic Research Program for Brain Sciences JP20dm0107061</award-id><principal-award-recipient><name><surname>Nagai</surname><given-names>Yoshitaka</given-names></name></principal-award-recipient></award-group><award-group id="fund17"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009619</institution-id><institution>Japan Agency for Medical Research and Development</institution></institution-wrap></funding-source><award-id>Practical Research Projects for Rare/Intractable Diseases JP16ek0109018</award-id><principal-award-recipient><name><surname>Nagai</surname><given-names>Yoshitaka</given-names></name></principal-award-recipient></award-group><award-group id="fund18"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009619</institution-id><institution>Japan Agency for Medical Research and Development</institution></institution-wrap></funding-source><award-id>Practical Research Projects for Rare/Intractable Diseases JP19ek0109222</award-id><principal-award-recipient><name><surname>Nagai</surname><given-names>Yoshitaka</given-names></name></principal-award-recipient></award-group><award-group id="fund19"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009619</institution-id><institution>Japan Agency for Medical Research and Development</institution></institution-wrap></funding-source><award-id>Practical Research Projects for Rare/Intractable Diseases JP20ek0109316</award-id><principal-award-recipient><name><surname>Nagai</surname><given-names>Yoshitaka</given-names></name></principal-award-recipient></award-group><award-group id="fund20"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009619</institution-id><institution>Japan Agency for Medical Research and Development</institution></institution-wrap></funding-source><award-id>Platform Project for Supporting Drug Discovery and Life Science Research JP19am0101072</award-id><principal-award-recipient><name><surname>Nagai</surname><given-names>Yoshitaka</given-names></name></principal-award-recipient></award-group><award-group id="fund21"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100009438</institution-id><institution>National Center of Neurology and Psychiatry</institution></institution-wrap></funding-source><award-id>Intramural Research Grants for Neurological and Psychiatric Disorders 27-7</award-id><principal-award-recipient><name><surname>Nagai</surname><given-names>Yoshitaka</given-names></name></principal-award-recipient></award-group><award-group id="fund22"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100009438</institution-id><institution>National Center of Neurology and Psychiatry</institution></institution-wrap></funding-source><award-id>Intramural Research Grants for Neurological and Psychiatric Disorders 27-9</award-id><principal-award-recipient><name><surname>Nagai</surname><given-names>Yoshitaka</given-names></name></principal-award-recipient></award-group><award-group id="fund23"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100009438</institution-id><institution>National Center of Neurology and Psychiatry</institution></institution-wrap></funding-source><award-id>Intramural Research Grants for Neurological and Psychiatric Disorders 30-3</award-id><principal-award-recipient><name><surname>Nagai</surname><given-names>Yoshitaka</given-names></name></principal-award-recipient></award-group><award-group id="fund24"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100009438</institution-id><institution>National Center of Neurology and Psychiatry</institution></institution-wrap></funding-source><award-id>Intramural Research Grants for Neurological and Psychiatric Disorders 30-9</award-id><principal-award-recipient><name><surname>Nagai</surname><given-names>Yoshitaka</given-names></name></principal-award-recipient></award-group><award-group id="fund25"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100009438</institution-id><institution>National Center of Neurology and Psychiatry</institution></institution-wrap></funding-source><award-id>Intramural Research Grants for Neurological and Psychiatric Disorders 3-9</award-id><principal-award-recipient><name><surname>Nagai</surname><given-names>Yoshitaka</given-names></name></principal-award-recipient></award-group><award-group id="fund26"><funding-source><institution-wrap><institution>Japan Amyotrophic Lateral Sclerosis Association</institution></institution-wrap></funding-source><award-id>IBC Grant H28</award-id><principal-award-recipient><name><surname>Nagai</surname><given-names>Yoshitaka</given-names></name></principal-award-recipient></award-group><award-group id="fund27"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007449</institution-id><institution>Takeda Science Foundation</institution></institution-wrap></funding-source><award-id>2017</award-id><principal-award-recipient><name><surname>Ueyama</surname><given-names>Morio</given-names></name></principal-award-recipient></award-group><award-group id="fund28"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007449</institution-id><institution>Takeda Science Foundation</institution></institution-wrap></funding-source><award-id>2016</award-id><principal-award-recipient><name><surname>Mori</surname><given-names>Kohji</given-names></name></principal-award-recipient></award-group><award-group id="fund29"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100008667</institution-id><institution>SENSHIN Medical Research Foundation</institution></institution-wrap></funding-source><award-id>2018</award-id><principal-award-recipient><name><surname>Mori</surname><given-names>Kohji</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Alteration of the G-quadruplex structure formed by GGGGCC repeat RNA through the direct interaction with RNA-binding proteins can suppress pathogenic repeat-associated non-AUG translation, leading to therapeutic effects on neurodegeneration in <italic>C9orf72</italic>-linked amyotrophic lateral sclerosis and frontotemporal dementia.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are incurable neurodegenerative diseases with overlapping genetic and neuropathological features. Abnormal expansions of the GGGGCC (G<sub>4</sub>C<sub>2</sub>) repeat sequence in the noncoding region of the <italic>C9orf72</italic> gene have been found to be the most common genetic mutation responsible for ALS/FTD (<xref ref-type="bibr" rid="bib11">DeJesus-Hernandez et al., 2011</xref>; <xref ref-type="bibr" rid="bib21">Gijselinck et al., 2012</xref>; <xref ref-type="bibr" rid="bib56">Renton et al., 2011</xref>). Three major pathomechanisms are thought to be involved in the pathogenesis of <italic>C9orf72</italic>-linked ALS/FTD (C9-ALS/FTD): first, expansion of the G<sub>4</sub>C<sub>2</sub> repeats results in decreased expression of the <italic>C9orf72</italic> gene, leading to its haploinsufficiency (<xref ref-type="bibr" rid="bib3">Boivin et al., 2020</xref>; <xref ref-type="bibr" rid="bib11">DeJesus-Hernandez et al., 2011</xref>; <xref ref-type="bibr" rid="bib21">Gijselinck et al., 2012</xref>; <xref ref-type="bibr" rid="bib60">Shi et al., 2018</xref>; <xref ref-type="bibr" rid="bib71">Waite et al., 2014</xref>; <xref ref-type="bibr" rid="bib79">Zhu et al., 2020</xref>). Second, the transcribed G<sub>4</sub>C<sub>2</sub> repeat-containing RNA accumulates as RNA foci in the affected tissues, sequestering various RNA-binding proteins (RBPs) and altering their function (<xref ref-type="bibr" rid="bib8">Conlon et al., 2016</xref>; <xref ref-type="bibr" rid="bib9">Cooper-Knock et al., 2014</xref>; <xref ref-type="bibr" rid="bib12">Donnelly et al., 2013</xref>; <xref ref-type="bibr" rid="bib24">Haeusler et al., 2014</xref>; <xref ref-type="bibr" rid="bib36">Lee et al., 2013</xref>; <xref ref-type="bibr" rid="bib48">Mori et al., 2013a</xref>). Third, this G<sub>4</sub>C<sub>2</sub> repeat RNA is also translated into dipeptide repeat (DPR) proteins, despite the lack of an AUG initiation codon, by noncanonical repeat-associated non-AUG (RAN) translation (<xref ref-type="bibr" rid="bib1">Ash et al., 2013</xref>; <xref ref-type="bibr" rid="bib19">Gendron et al., 2013</xref>; <xref ref-type="bibr" rid="bib49">Mori et al., 2013b</xref>; <xref ref-type="bibr" rid="bib50">Mori et al., 2013c</xref>; <xref ref-type="bibr" rid="bib80">Zu et al., 2011</xref>; <xref ref-type="bibr" rid="bib81">Zu et al., 2013</xref>). Since RAN translation occurs in all reading frames and the expanded G<sub>4</sub>C<sub>2</sub> repeat sequence is bidirectionally transcribed, five distinct DPRs, that is, poly(glycine-arginine) [poly(GR)], poly(glycine-alanine) [poly(GA)], poly(glycine-proline) [poly(GP)], poly(proline-arginine) [poly(PR)], and poly(proline-alanine) [poly(PA)], are produced and observed in patients’ brains (<xref ref-type="bibr" rid="bib1">Ash et al., 2013</xref>; <xref ref-type="bibr" rid="bib19">Gendron et al., 2013</xref>; <xref ref-type="bibr" rid="bib49">Mori et al., 2013b</xref>; <xref ref-type="bibr" rid="bib50">Mori et al., 2013c</xref>; <xref ref-type="bibr" rid="bib81">Zu et al., 2013</xref>) and cerebrospinal fluid (<xref ref-type="bibr" rid="bib20">Gendron et al., 2017</xref>; <xref ref-type="bibr" rid="bib32">Krishnan et al., 2022</xref>; <xref ref-type="bibr" rid="bib38">Lehmer et al., 2017</xref>; <xref ref-type="bibr" rid="bib64">Su et al., 2014</xref>).</p><p>DPRs have been shown to exert toxic effects in multiple C9-ALS/FTD models, such as cultured cells, flies, and mice (<xref ref-type="bibr" rid="bib7">Choi et al., 2019</xref>; <xref ref-type="bibr" rid="bib29">Jovičić et al., 2015</xref>; <xref ref-type="bibr" rid="bib45">May et al., 2014</xref>; <xref ref-type="bibr" rid="bib47">Mizielinska et al., 2014</xref>; <xref ref-type="bibr" rid="bib57">Rudich et al., 2017</xref>; <xref ref-type="bibr" rid="bib74">Wen et al., 2014</xref>; <xref ref-type="bibr" rid="bib77">Zhang et al., 2016</xref>; <xref ref-type="bibr" rid="bib78">Zhang et al., 2018</xref>). Importantly, the toxicity of DPRs was confirmed in DPR-only flies, which express DPRs translated from non-G<sub>4</sub>C<sub>2</sub> repeat RNAs with alternative codons and show neurodegeneration, whereas RNA-only flies expressing G<sub>4</sub>C<sub>2</sub> repeat RNAs with stop codon interruptions, which eliminate DPRs production, did not show any obvious degenerative phenotypes (<xref ref-type="bibr" rid="bib47">Mizielinska et al., 2014</xref>). In addition, increased DPR production, but not RNA foci, was reported to correlate with G<sub>4</sub>C<sub>2</sub> repeat-induced toxicity in a C9-ALS/FTD <italic>Drosophila</italic> model (<xref ref-type="bibr" rid="bib68">Tran et al., 2015</xref>). Taken together, these studies have strongly suggested that DPRs play a central role in the pathogenesis of C9-ALS/FTD. Indeed, DPRs have been reported to disrupt various biological pathways, such as nucleocytoplasmic transport (<xref ref-type="bibr" rid="bib27">Hutten et al., 2020</xref>; <xref ref-type="bibr" rid="bib29">Jovičić et al., 2015</xref>; <xref ref-type="bibr" rid="bib77">Zhang et al., 2016</xref>) and membraneless organelle dynamics (<xref ref-type="bibr" rid="bib34">Kwon et al., 2014</xref>; <xref ref-type="bibr" rid="bib37">Lee et al., 2016</xref>; <xref ref-type="bibr" rid="bib40">Lin et al., 2016</xref>). Therefore, elucidating the regulatory mechanism of RAN translation is a significant challenge toward developing potential therapies for C9-ALS/FTD.</p><p>Since the discovery of RAN translation in 2011 (<xref ref-type="bibr" rid="bib80">Zu et al., 2011</xref>), many studies to date have focused on its molecular mechanisms, that is, whether it has functional overlap with canonical AUG-dependent translation. Previous studies on C9-ALS/FTD using monocistronic reporters containing a G<sub>4</sub>C<sub>2</sub> repeat sequence revealed cap-dependent translation initiation from the upstream near-cognate CUG initiation codon, requiring the cap-binding eukaryotic translation factor 4F complex (<xref ref-type="bibr" rid="bib23">Green et al., 2017</xref>; <xref ref-type="bibr" rid="bib65">Tabet et al., 2018</xref>). On the other hand, studies using bicistronic reporters with a G<sub>4</sub>C<sub>2</sub> repeat sequence in the second cistron also produced DPRs by RAN translation in all reading frames, suggesting cap-independent translation initiation within the G<sub>4</sub>C<sub>2</sub> repeat sequence (<xref ref-type="bibr" rid="bib5">Cheng et al., 2018</xref>; <xref ref-type="bibr" rid="bib63">Sonobe et al., 2018</xref>). This is reminiscent of internal ribosomal entry site translation initiation, which is another type of noncanonical cap-independent translation in which specific factors are directly recruited to the highly structured mRNA for initiation (<xref ref-type="bibr" rid="bib33">Kwan and Thompson, 2019</xref>). While such initiation mechanisms of RAN translation have been explored to date, specific roles of the repeat sequence on RAN translation remain enigmatic. Considering a repeat length dependency of RAN translation (<xref ref-type="bibr" rid="bib50">Mori et al., 2013c</xref>; <xref ref-type="bibr" rid="bib80">Zu et al., 2011</xref>; <xref ref-type="bibr" rid="bib81">Zu et al., 2013</xref>), the repeat sequence itself would also be essential for the initiation or elongation steps of RAN translation. Based on our previous findings of the protective role of TDP-43 on UGGAA repeat-induced toxicity in spinocerebellar ataxia type 31 (SCA31) models (<xref ref-type="bibr" rid="bib28">Ishiguro et al., 2017</xref>), we hypothesized that RBPs specifically binding to repeat sequences of template RNA play a role in RAN translation.</p><p>Using <italic>Drosophila</italic> models of C9-ALS/FTD, we here demonstrate the regulatory roles of the ALS/FTD-linked RBP FUS on RAN translation from G<sub>4</sub>C<sub>2</sub> repeat RNA, which lead to the significant modulation of neurodegeneration. We found that FUS suppresses RNA foci formation and DPR production, resulting in the suppression of repeat-induced degeneration. This suppressive effect on degeneration was abolished by mutations in the RNA-recognition motif (RRM) of FUS. In contrast, knockdown of endogenous <italic>caz</italic>, a <italic>Drosophila</italic> homologue of <italic>FUS</italic>, enhanced DPR aggregation and RNA foci formation, resulting in the enhancement of repeat-induced degeneration. Moreover, FUS was found to directly bind to G<sub>4</sub>C<sub>2</sub> repeat RNA and modify its G-quadruplex structure as an RNA chaperone, resulting in the suppression of RAN translation in vitro. In addition, other G-quadruplex-targeting RBPs also suppressed RAN translation and G<sub>4</sub>C<sub>2</sub> repeat-induced toxicity in our C9-ALS/FTD flies. These results strongly indicate that FUS regulates RAN translation and suppresses DPR toxicity through modulating the G-quadruplex structure of G<sub>4</sub>C<sub>2</sub> repeat RNA. Our findings shed light on the regulatory mechanisms of RAN translation by G-quadruplex-targeting RBPs and propose novel therapeutic strategies for repeat expansion diseases by regulating RAN translation.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Screening for RBPs that suppress G<sub>4</sub>C<sub>2</sub> repeat-induced toxicity in C9-ALS/FTD flies</title><p>We established <italic>Drosophila</italic> models of C9-ALS/FTD that express pathogenic length 42 or 89 G<sub>4</sub>C<sub>2</sub> repeats [(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>42</sub>, or (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> flies, respectively] and confirmed that expanded G<sub>4</sub>C<sub>2</sub> repeat sequences induce eye degeneration and motor dysfunction accompanied with the formation of RNA foci and the production of three types of DPRs (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>), consistent with previous studies (<xref ref-type="bibr" rid="bib15">Freibaum et al., 2015</xref>; <xref ref-type="bibr" rid="bib22">Goodman et al., 2019</xref>; <xref ref-type="bibr" rid="bib47">Mizielinska et al., 2014</xref>; <xref ref-type="bibr" rid="bib75">Xu et al., 2013</xref>). We also established <italic>Drosophila</italic> expressing normal length 9 G<sub>4</sub>C<sub>2</sub> repeats as a control [(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>9</sub> flies] and found that they did not show eye degeneration, motor dysfunction, RNA foci formation, or DPR aggregation (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). We selected 18 RBPs that have been reported to bind to G<sub>4</sub>C<sub>2</sub> repeat RNA (<xref ref-type="bibr" rid="bib48">Mori et al., 2013a</xref>), as well as TDP-43, an ALS/FTD-linked RBP that does not bind to G<sub>4</sub>C<sub>2</sub> repeat RNA (<xref ref-type="bibr" rid="bib75">Xu et al., 2013</xref>; <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>), and examined their roles in neurodegeneration in our C9-ALS/FTD fly models. We found that coexpression of <italic>FUS</italic>, <italic>IGF2BP1</italic>, or <italic>hnRNPA2B1</italic> strongly suppressed the eye degeneration in both flies expressing (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>42 or 89</sub>, which show decreased eye size and loss of pigmentation (<xref ref-type="fig" rid="fig1">Figure 1A–D</xref> and <xref ref-type="supplementary-material" rid="fig1sdata2">Figure 1—source data 2</xref>). Coexpression of five RBPs, namely, <italic>hnRNPR</italic>, <italic>SAFB2</italic>, <italic>SF3B3</italic>, <italic>hnRNPA1</italic>, and <italic>hnRNPL,</italic> also partially suppressed the eye degeneration, whereas coexpression of the other six RBPs had no effect, and two RBPs enhanced the phenotypes (<xref ref-type="fig" rid="fig1">Figure 1A–D</xref> and <xref ref-type="supplementary-material" rid="fig1sdata2">Figure 1—source data 2</xref>). In addition, coexpression of <italic>TDP-43</italic> had no effect on the eye degeneration in (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>42</sub> flies and resulted in lethality in (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> flies, likely due to the toxicity of <italic>TDP-43</italic> expression itself (<xref ref-type="fig" rid="fig1">Figure 1A and D</xref> and <xref ref-type="supplementary-material" rid="fig1sdata2">Figure 1—source data 2</xref>). The variation in the effects of these G<sub>4</sub>C<sub>2</sub> repeat-binding RBPs on G<sub>4</sub>C<sub>2</sub> repeat-induced toxicity may be due to their different binding affinities to G<sub>4</sub>C<sub>2</sub> repeat RNA and the different toxicity of overexpressed RBPs themselves. We then analyzed the expression levels of G<sub>4</sub>C<sub>2</sub> repeat RNA in flies coexpressing (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> and three RBPs that strongly suppressed eye degeneration. We found that coexpression of <italic>IGF2BP1</italic> or <italic>hnRNPA2B1</italic> significantly decreased G<sub>4</sub>C<sub>2</sub> repeat RNA levels, whereas they were not altered upon coexpression of <italic>FUS</italic> (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). Although the suppressive effects of IGF2BP1 and hnRNPA2B1 could simply be explained by the decreased levels of G<sub>4</sub>C<sub>2</sub> repeat RNA, the molecular mechanisms by which FUS suppresses G<sub>4</sub>C<sub>2</sub> repeat-induced toxicity remain to be clarified. The suppressive effects of FUS on G<sub>4</sub>C<sub>2</sub> repeat-induced toxicity were confirmed using multiple FUS fly lines, showing the significant suppression of decreased eye size and loss of pigmentation in (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>42 or 89</sub> flies coexpressing <italic>FUS</italic> (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). Therefore, we decided to further focus on FUS, which is another ALS/FTD-linked RBP, and investigated its mechanism of the suppression of G<sub>4</sub>C<sub>2</sub> repeat-induced toxicity.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Screening for RNA-binding proteins (RBPs) that suppress G<sub>4</sub>C<sub>2</sub> repeat-induced toxicity in C9-ALS/FTD flies.</title><p>(<bold>A</bold>) Light microscopic images of the eyes in flies expressing both (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>42 or 89</sub> and the indicated RBPs using the <italic>GMR-Gal4</italic> driver. Coexpression of <italic>FUS</italic>, <italic>IGF2BP1</italic>, or <italic>hnRNPA2B</italic> suppressed eye degeneration in both (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>42</sub> and (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> flies, indicated by ‘Suppression (strong).’ Coexpression of <italic>hnRNPR</italic>, <italic>SAFB2</italic>, <italic>SF3B3</italic>, <italic>hnRNPA1</italic>, or <italic>hnRNPL</italic> suppressed eye degeneration in either (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>42</sub> or (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> flies, indicated by ‘Suppression (weak)’ (see also <xref ref-type="supplementary-material" rid="fig1sdata2">Figure 1—source data 2</xref>). Scale bar: 100 μm. (<bold>B</bold>) Quantification of eye size in (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> flies coexpressing the indicated RBPs (n = 5). (<bold>C</bold>, <bold>D</bold>) Quantification of eye pigmentation in (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> flies (<bold>C</bold>) or (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>42</sub> flies (<bold>D</bold>) coexpressing the indicated RBPs (n = 5). (<bold>E</bold>) Expression levels of (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> RNA in flies expressing both (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> and the indicated RBPs using the <italic>GMR-Gal4</italic> driver (five independent experiments, n = 25 flies per genotype). The (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub>(H) fly line expresses (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> RNA at a high level (see also <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). In (<bold>B–E</bold>), data are presented as the mean ± SEM; p&lt;0.0001, as assessed by one-way ANOVA; n.s., not significant, <sup>*</sup>p&lt;0.05, <sup>**</sup>p&lt;0.01, and <sup>***</sup>p&lt;0.001, as assessed by Tukey’s post hoc analysis. The detailed statistical information is summarized in <xref ref-type="supplementary-material" rid="fig1sdata3">Figure 1—source data 3</xref>.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>RNA-binding proteins and their cDNA accession numbers screened in the genetic analyses in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-84338-fig1-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Summary of the genetic analyses in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-84338-fig1-data2-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1sdata3"><label>Figure 1—source data 3.</label><caption><title>Statistical data related to <xref ref-type="fig" rid="fig1">Figure 1B–E</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-84338-fig1-data3-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84338-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Characterization of C9-ALS/FTD flies.</title><p>(<bold>A</bold>) (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>n</sub> constructs used in this study. These constructs do not include an ATG start codon downstream of the UAS sequence, and were expressed in a tissue-specific manner using the <italic>GAL4-UAS</italic> system. (<bold>B</bold>) Light microscopic images of the eyes in flies expressing (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>n</sub> using the <italic>GMR-Gal4</italic> driver. Scale bar: 100 μm. (<bold>C</bold>) Expression levels of (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>n</sub> RNAs in flies expressing (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>n</sub> using the <italic>GMR-Gal4</italic> driver. Strong eye degeneration with decreased eye size and loss of pigmentation was observed in (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>42 or 89</sub> flies, but not in (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>9</sub> flies. Eye degeneration was confirmed in (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>42</sub> and two (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> independent fly lines. Degree of eye degeneration in two (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> fly lines was expression-level dependent [(L) vs. (H) in (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub>] (three independent experiments, n = 15 flies per each genotype). Expression of G<sub>4</sub>C<sub>2</sub> repeat RNA of the sense transcripts but not that of the antisense transcripts was confirmed. (<bold>D</bold>) Climbing ability at 1 d of age in flies expressing (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>n</sub> using the <italic>elav-Gal4</italic> driver. Flies expressing (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub>(H) in neurons showed lethality. Decreasing climbing ability was observed in (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>42 or 89</sub> flies compared with (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>9</sub> flies (five independent experiments, n = 100 flies per each genotype). (<bold>E</bold>) Fluorescence in situ hybridization (FISH) analyses of G<sub>4</sub>C<sub>2</sub> repeat RNA in the salivary glands of fly larvae with two copies of <italic>GMR-Gal4</italic> and (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>9 or 89</sub> (red: G<sub>4</sub>C<sub>2</sub> RNA; yellow: G<sub>2</sub>C<sub>4</sub> RNA; blue [DAPI]: nuclei). RNA foci formation (arrowheads) of the sense transcripts but not that of the antisense transcripts was confirmed. RNA foci were observed in (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> flies, but not in (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>9</sub> flies. Scale bars: 100 μm (low magnification) or 20 μm (high magnification). (<bold>F</bold>) Immunohistochemical analyses of dipeptide repeat proteins (DPRs) stained with anti-DPR antibodies in the eye imaginal discs of fly larvae with two copies of <italic>GMR-Gal4</italic> and (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>9 or 89</sub> (magenta: poly(GR); orange: poly(GA); green: poly(GP); blue [DAPI]: nuclei). Expression and cytoplasmic aggregation (arrowheads) of three DPRs in (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> flies, but not in (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>9</sub> flies, were confirmed. Scale bars: 50 μm (low magnification), 10 μm (middle magnification), and 5 μm (high magnification). In (<bold>B–F</bold>), L: low-expression line; H: high-expression line. In (<bold>C, D</bold>), data are presented as the mean ± SEM; p&lt;0.0001, as assessed by one-way ANOVA; n.s., not significant, and <sup>***</sup>p&lt;0.001, as assessed by Tukey’s post hoc analysis. The detailed statistical information is summarized in <xref ref-type="supplementary-material" rid="fig1s1sdata2">Figure 1—figure supplement 1—source data 2</xref>.</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>The artificial sequence inserted in the pUAST vector for generation of (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>n</sub> flies.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-84338-fig1-figsupp1-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata2"><label>Figure 1—figure supplement 1—source data 2.</label><caption><title>Statistical data related to <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C and D</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-84338-fig1-figsupp1-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84338-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Coexpression of FUS suppresses G<sub>4</sub>C<sub>2</sub> repeat-induced toxicity in flies expressing (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub>.</title><p>(<bold>A</bold>) Light microscopic images of the eyes in flies expressing both (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>42 or 89</sub> and <italic>FUS</italic> using the <italic>GMR-Gal4</italic> driver. <italic>FUS-2</italic> and <italic>FUS-3</italic> are different strains from that in <xref ref-type="fig" rid="fig1">Figure 1</xref>. Scale bar: 100 μm. (<bold>B</bold>) Quantification of the eye size in (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> flies of the indicated genotypes (n = 10). (<bold>C</bold>, <bold>D</bold>) Quantification of eye pigmentation in (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> flies (<bold>C</bold>) or (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>42</sub> flies (<bold>D</bold>) of the indicated genotypes (n = 10). In (<bold>B–D</bold>), data are presented as the mean ± SEM; p&lt;0.0001, as assessed by one-way ANOVA; <sup>***</sup>p&lt;0.001, as assessed by Tukey’s post hoc analysis. The detailed statistical information is summarized in <xref ref-type="supplementary-material" rid="fig1s2sdata1">Figure 1—figure supplement 2—source data 1</xref>.</p><p><supplementary-material id="fig1s2sdata1"><label>Figure 1—figure supplement 2—source data 1.</label><caption><title>Statistical data related to <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B–D</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-84338-fig1-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84338-fig1-figsupp2-v1.tif"/></fig></fig-group></sec><sec id="s2-2"><title>FUS suppresses G<sub>4</sub>C<sub>2</sub> repeat-induced toxicity via its RNA-binding activity</title><p>We next investigated whether the suppressive effects of FUS on G<sub>4</sub>C<sub>2</sub> repeat-induced toxicity are mediated by its binding to G<sub>4</sub>C<sub>2</sub> repeat RNA, using flies expressing FUS with mutations in the RRM (<italic>FUS-RRMmut</italic>), which have been reported to eliminate its RNA-binding activity (<xref ref-type="bibr" rid="bib10">Daigle et al., 2013</xref>). Western blot analysis confirmed that the <italic>FUS-RRMmut</italic> fly line expresses almost an equivalent level of the FUS proteins to the <italic>FUS</italic> fly line (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). We found that coexpression of <italic>FUS-RRMmut</italic> did not restore the eye degeneration in flies expressing (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub>, suggesting that the RNA-binding activity of FUS is essential for its suppressive effects on G<sub>4</sub>C<sub>2</sub> repeat-induced toxicity (<xref ref-type="fig" rid="fig2">Figure 2A–C</xref>). We also evaluated the reduced egg-to-adult viability of (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>42</sub> flies and confirmed that this phenotype was rescued by coexpression of <italic>FUS</italic>, but not by coexpression of <italic>FUS-RRMmut</italic> (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). Expression of G<sub>4</sub>C<sub>2</sub> repeat RNA in the nervous system of flies after eclosion using the <italic>elav-GeneSwitch</italic> driver induces motor dysfunction, and coexpression of <italic>FUS</italic> significantly alleviated this motor dysfunction (<xref ref-type="fig" rid="fig2">Figure 2E</xref>), indicating that FUS suppresses the neuronal phenotypes of flies expressing G<sub>4</sub>C<sub>2</sub> repeat RNA. It is notable that the motor dysfunction caused by the expression of <italic>FUS</italic> alone was also alleviated by coexpression of (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>42</sub> (<xref ref-type="fig" rid="fig2">Figure 2E</xref>), indicating that the G<sub>4</sub>C<sub>2</sub> repeat RNA conversely suppresses FUS toxicity. This result is consistent with our previous observations in SCA31 flies that UGGAA repeat RNA reduced the aggregation and toxicity of TDP-43 (<xref ref-type="bibr" rid="bib28">Ishiguro et al., 2017</xref>). Moreover, recent studies demonstrated that RNA buffers the phase separation of TDP-43 and FUS, resulting in the suppression of their aggregation (<xref ref-type="bibr" rid="bib42">Maharana et al., 2018</xref>; <xref ref-type="bibr" rid="bib44">Mann et al., 2019</xref>). These findings hence suggest that balancing the crosstalk between repeat RNAs and RBPs neutralizes the toxicities of each other.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>FUS suppresses G<sub>4</sub>C<sub>2</sub> repeat-induced toxicity via its RNA-binding activity.</title><p>(<bold>A</bold>) Light microscopic images of the eyes in flies expressing both (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> and either <italic>FUS</italic> or <italic>FUS-RRMmut</italic> using the <italic>GMR-Gal4</italic> driver. Scale bar: 100 μm. (<bold>B</bold>) Quantification of eye size in the flies of the indicated genotypes (n = 10). (<bold>C</bold>) Quantification of eye pigmentation in the flies of the indicated genotypes (n = 10). (<bold>D</bold>) Egg-to-adult viability in flies expressing both (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>42</sub> and either <italic>FUS</italic> or <italic>FUS-RRMmut</italic> using the <italic>GMR-Gal4</italic> driver (&gt;500 flies per genotype). (<bold>E</bold>) Climbing ability in flies expressing both (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>42</sub> and <italic>FUS</italic> using the <italic>elav-GeneSwitch</italic> driver (five independent experiments, n = 100 flies per each genotype). In (<bold>B–E</bold>), data are presented as the mean ± SEM. In (<bold>B, C</bold>), p&lt;0.0001, as assessed by one-way ANOVA; n.s., not significant, and <sup>***</sup>p&lt;0.001, as assessed by Tukey’s post hoc analysis. In (<bold>D</bold>), n.s., not significant and <sup>***</sup>p&lt;0.001, as assessed by Tukey’s multiple-comparison test using wholly significant difference. In (<bold>E</bold>), n.s., not significant, <sup>*</sup>p&lt;0.05, <sup>**</sup>p&lt;0.01, and <sup>***</sup>p&lt;0.001, as assessed by two-way repeated-measures ANOVA with Tukey’s post hoc analysis. The detailed statistical information is summarized in <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Statistical data related to <xref ref-type="fig" rid="fig2">Figure 2B–E</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-84338-fig2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84338-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Western blot analysis showing expression levels of FUS and FUS-RRMmut proteins.</title><p>(<bold>A</bold>) Western blot analysis of the FUS and FUS-RRMmut proteins in the heads of adult flies expressing <italic>EGFP, FUS,</italic> or <italic>FUS-RRMmut</italic> using the <italic>GMR-Gal4</italic> driver, with an anti-FUS antibody. The arrowhead indicates bands from the FUS and FUS-RRMmut proteins, whereas the asterisk indicates bands resulting from nonspecific antibody binding. (<bold>B</bold>) Quantification of the FUS and FUS-RRMmut proteins from the western blot analysis in (<bold>A</bold>) (n = 3). In (<bold>B</bold>), data are presented as the mean ± SEM; n.s., not significant, as assessed by the unpaired <italic>t</italic>-test. The detailed statistical information is summarized in <xref ref-type="supplementary-material" rid="fig2s1sdata1">Figure 2—figure supplement 1—source data 1</xref>.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Statistical data related to <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-84338-fig2-figsupp1-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2s1sdata2"><label>Figure 2—figure supplement 1—source data 2.</label><caption><title>Source data related to <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-84338-fig2-figsupp1-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84338-fig2-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-3"><title>FUS suppresses RNA foci formation and RAN translation from G<sub>4</sub>C<sub>2</sub> repeat RNA</title><p>We next analyzed the effects of FUS expression on RNA foci and DPR production in flies expressing G<sub>4</sub>C<sub>2</sub> repeat RNA. We performed RNA fluorescence in situ hybridization (FISH) of the salivary glands of fly larvae expressing (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> and found that coexpression of <italic>FUS</italic> significantly decreased the number of nuclei containing RNA foci in (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> flies, whereas it was not altered by coexpression of <italic>FUS-RRMmut</italic> (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>). We confirmed that the expression levels of G<sub>4</sub>C<sub>2</sub> repeat RNA in (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> flies were not altered by coexpression of <italic>FUS</italic> or <italic>FUS-RRMmut</italic> (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). These results were in good agreement with our previous study on SCA31 showing the suppressive effects of FUS and other RBPs on RNA foci formation of UGGAA repeat RNA through altering RNA structures and preventing aggregation of misfolded repeat RNA as RNA chaperones (<xref ref-type="bibr" rid="bib28">Ishiguro et al., 2017</xref>), raising the possibility that FUS has RNA-chaperoning activity also for G<sub>4</sub>C<sub>2</sub> repeat RNA. Immunohistochemistry of the eye imaginal discs of fly larvae expressing (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> revealed that coexpression of <italic>FUS</italic> significantly decreased the number of DPR aggregates in (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> flies, whereas coexpression of <italic>FUS-RRMmut</italic> did not (<xref ref-type="fig" rid="fig3">Figure 3D and E</xref>). Quantitative analyses of poly(GP) by immunoassay also demonstrated that poly(GP) levels were greatly decreased in (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> flies upon coexpression of <italic>FUS</italic>, but not <italic>FUS-RRMmut</italic> (<xref ref-type="fig" rid="fig3">Figure 3F</xref>), indicating that FUS suppresses RAN translation from the G<sub>4</sub>C<sub>2</sub> repeat RNA to reduce DPR production. Considering that the 5′ upstream sequence of the G<sub>4</sub>C<sub>2</sub> repeat in the <italic>C9orf72</italic> gene is reported to affect RAN translation activity (<xref ref-type="bibr" rid="bib23">Green et al., 2017</xref>; <xref ref-type="bibr" rid="bib65">Tabet et al., 2018</xref>), we used flies expressing the G<sub>4</sub>C<sub>2</sub> repeat sequence with the upstream intronic sequence of the <italic>C9orf72</italic> gene, namely, <italic>LDS-</italic>(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>44</sub><sup>GR-GFP</sup> (<xref ref-type="bibr" rid="bib22">Goodman et al., 2019</xref>). Since this construct has a 3′-green fluorescent protein (GFP) tag in the GR reading frame downstream of the G<sub>4</sub>C<sub>2</sub> repeat sequence, the GR-GFP fusion protein is produced by RAN translation (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). We confirmed that coexpression of <italic>FUS</italic> significantly decreased the expression level of GR-GFP, whereas coexpression of <italic>FUS-RRMmut</italic> had no effect (<xref ref-type="fig" rid="fig3">Figure 3G–I</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>FUS suppresses RNA foci formation and RAN translation from G<sub>4</sub>C<sub>2</sub> repeat RNA.</title><p>(<bold>A</bold>) Fluorescence in situ hybridization (FISH) analyses of G<sub>4</sub>C<sub>2</sub> repeat RNA in the salivary glands of fly larvae expressing both (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> and either <italic>FUS</italic> or <italic>FUS-RRMmut</italic> using two copies of the <italic>GMR-Gal4</italic> driver (red: G<sub>4</sub>C<sub>2</sub> RNA; blue [DAPI]: nuclei). Arrowheads indicate RNA foci. Scale bar: 20 μm. (<bold>B</bold>) Quantification of the number of nuclei containing RNA foci from the FISH analyses in (<bold>A</bold>) (n = 10). (<bold>C</bold>) Expression levels of (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> RNA in fly larvae expressing both (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> and either <italic>FUS</italic> or <italic>FUS-RRMmut</italic> using the <italic>GMR-Gal4</italic> driver (10 independent experiments, n = 50 flies per each genotype). (<bold>D</bold>) Immunohistochemical analyses of dipeptide repeat proteins (DPRs) stained with anti-DPR antibodies in the eye imaginal discs of fly larvae expressing both (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> and either <italic>FUS</italic> or <italic>FUS-RRMmut</italic> using two copies of the <italic>GMR-Gal4</italic> driver (magenta: poly(GR); orange: poly(GA); green: poly(GP)). Arrowheads indicate cytoplasmic aggregates. Scale bars: 20 μm (low magnification) or 5 μm (high magnification). (<bold>E</bold>) Quantification of the number of DPR aggregates from the immunohistochemical analyses in (<bold>D</bold>) (n = 14 or 15 [GR], or 10 [GA or GP]). (<bold>F</bold>) Immunoassay to determine poly(GP) levels in flies expressing both (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> and either <italic>FUS</italic> or <italic>FUS-RRMmut</italic> using the <italic>GMR-Gal4</italic> driver (three independent experiments, n = 30 flies per each genotype). (<bold>G</bold>) Western blot analysis of the heads of adult flies expressing both LDS-(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>44</sub><sup>GR-GFP</sup> and any of <italic>DsRed</italic>, <italic>FUS</italic> or <italic>FUS-RRMmut</italic> using the <italic>GMR-Gal4</italic> driver, using either an anti-GFP (upper panel) or anti-GR antibody (middle panel). (<bold>H, I</bold>) Quantification of GR-GFP protein levels from the western blot analysis in (<bold>G</bold>) (nine independent experiments, n = 90 flies per each genotype). In (<bold>B</bold>, <bold>C</bold>, <bold>E</bold>, <bold>F</bold>, <bold>H</bold>, <bold>I</bold>), data are presented as the mean ± SEM. In (<bold>B</bold>, <bold>E</bold>, <bold>F</bold>), p&lt;0.0001, as assessed by one-way ANOVA; n.s., not significant, <sup>*</sup>p&lt;0.05, <sup>**</sup>p&lt;0.01, and <sup>***</sup>p&lt;0.001, as assessed by Tukey’s post hoc analysis. In (<bold>C</bold>), p=0.452, as assessed by one-way ANOVA; n.s., not significant, as assessed by Tukey’s post hoc analysis. In (<bold>H</bold>), p=0.0148, as assessed by one-way ANOVA; n.s., not significant and <sup>*</sup>p&lt;0.05, as assessed by Tukey’s post hoc analysis. In (<bold>I</bold>), p=0.0072, as assessed by one-way ANOVA; n.s., not significant and <sup>*</sup>p&lt;0.05, as assessed by Tukey’s post hoc analysis. The detailed statistical information is summarized in <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Statistical data related to <xref ref-type="fig" rid="fig3">Figure 3B, C, E, F, H and I</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-84338-fig3-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Source data related to <xref ref-type="fig" rid="fig3">Figure 3G</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-84338-fig3-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84338-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Schema of the <italic>LDS-</italic>(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>44</sub><sup>GR-GFP</sup> construct.</title><p>Schema of the <italic>LDS-</italic>(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>44</sub><sup>GR-GFP</sup> construct containing the (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>44</sub> sequence and 114 nucleotides of the 5′-flanking region of intron 1 of the human <italic>C9orf72</italic> G<sub>4</sub>C<sub>2</sub> repeat sequence. A GFP tag in the GR frame was introduced downstream of the (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>44</sub> repeat sequence.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84338-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Overexpression of <italic>FUS</italic> does not suppress eye degeneration in dipeptide repeat protein (DPR)-only flies expressing DPRs translated from non-G<sub>4</sub>C<sub>2</sub> RNAs.</title><p>Light microscopic images of the eyes in DPR-only flies coexpressing either the poly(GR) or poly(GA) protein, and either <italic>FUS</italic> or <italic>FUS-RRMmut</italic> using the <italic>GMR-Gal4</italic> driver. Overexpression of <italic>FUS</italic> did not suppress the eye degeneration in flies expressing either (GR)<sub>36</sub> or (GR)<sub>100</sub>. Overexpression of <italic>FUS</italic> also caused mild eye degeneration in flies expressing EGFP, (GA)<sub>36</sub>, or (GA)<sub>100</sub>, likely due to FUS toxicity.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84338-fig3-figsupp2-v1.tif"/></fig></fig-group><p>We further excluded the possibility that FUS directly interacts with DPRs, rather than with G<sub>4</sub>C<sub>2</sub> repeat RNA, to decrease DPR levels and exert its suppressive effects. Using DPR-only flies expressing DPRs translated from non-G<sub>4</sub>C<sub>2</sub> RNAs with alternative codons (<xref ref-type="bibr" rid="bib47">Mizielinska et al., 2014</xref>), we confirmed that FUS did not suppress the eye degeneration in DPR-only flies expressing poly(GR), but rather enhanced their phenotypes, likely due to the additive effects of FUS toxicity (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). Together with the finding that FUS decreases not only DPR expression but also RNA foci formation (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>), these results collectively indicate that FUS indeed interacts with G<sub>4</sub>C<sub>2</sub> repeat RNA and regulates RAN translation from G<sub>4</sub>C<sub>2</sub> repeat RNA in <italic>Drosophila</italic> models of C9-ALS/FTD.</p></sec><sec id="s2-4"><title>Reduction of endogenous <italic>caz</italic> expression enhances G<sub>4</sub>C<sub>2</sub> repeat-induced toxicity, RNA foci formation, and DPR aggregation</title><p>To elucidate the physiological role of FUS on RAN translation, we also investigated the role of endogenous <italic>caz</italic>, a <italic>Drosophila</italic> homologue of <italic>FUS</italic>, on G<sub>4</sub>C<sub>2</sub> repeat-induced toxicity in flies expressing G<sub>4</sub>C<sub>2</sub> repeat RNAs. Coexpression of <italic>caz</italic> as well as <italic>FUS</italic> suppressed eye degeneration in flies expressing (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>42 or 89</sub> (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). These data suggest that <italic>caz</italic> is a functional homologue of <italic>FUS</italic>. In contrast, knockdown of <italic>caz</italic> by RNA interference or its hemizygous deletion modestly but significantly enhanced the eye degeneration in (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> flies (<xref ref-type="fig" rid="fig4">Figure 4A–D</xref>), indicating that reduced <italic>caz</italic> expression enhances G<sub>4</sub>C<sub>2</sub> repeat-induced toxicity. We next analyzed the effects of <italic>caz</italic> knockdown on RNA foci formation and DPR production in flies expressing (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub>. FISH analysis of the salivary glands revealed that knockdown of <italic>caz</italic> significantly increased the number of nuclei containing RNA foci in (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> flies (<xref ref-type="fig" rid="fig4">Figure 4E and F</xref>). We also confirmed that the expression levels of G<sub>4</sub>C<sub>2</sub> repeat RNA in (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> flies were not altered by the knockdown of <italic>caz</italic> (<xref ref-type="fig" rid="fig4">Figure 4G</xref>). Immunohistochemical analysis showed that knockdown of <italic>caz</italic> significantly increased the number of DPR aggregates in (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> flies (<xref ref-type="fig" rid="fig4">Figure 4H and I</xref>). These results indicate that the reduction of <italic>caz</italic> expression enhances RNA foci formation and DPR aggregation, compatible with the results of <italic>FUS</italic> coexpression in flies expressing (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> (<xref ref-type="fig" rid="fig3">Figure 3</xref>), and that FUS functions as an endogenous regulator of RAN translation.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Reduction of endogenous <italic>caz</italic> expression enhances G<sub>4</sub>C<sub>2</sub> repeat-induced toxicity, RNA foci formation, and dipeptide repeat protein (DPR) aggregation.</title><p>(<bold>A</bold>) Light microscopic images of the eyes in flies expressing (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> using the <italic>GMR-Gal4</italic> driver, with knockdown of <italic>caz</italic>. Scale bar: 100 μm. (<bold>B</bold>) Quantification of eye size in flies of the indicated genotypes shown in (<bold>A</bold>) (n = 10). (<bold>C</bold>) Light microscopic images of the eyes in flies expressing (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> using the <italic>GMR-Gal4</italic> driver, with a hemizygous deletion of <italic>caz</italic>. Scale bar: 100 μm. (<bold>D</bold>) Quantification of eye size in the flies of the indicated genotypes shown in (<bold>C</bold>) (n = 10). (<bold>E</bold>) Fluorescence in situ hybridization (FISH) analyses of G<sub>4</sub>C<sub>2</sub> repeat RNA in the salivary glands of fly larvae expressing (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> using the <italic>GMR-Gal4</italic> driver, with knockdown of <italic>caz</italic> (red: G<sub>4</sub>C<sub>2</sub> RNA; blue [DAPI]: nuclei). Arrowheads indicate RNA foci. Scale bar: 20 μm. (<bold>F</bold>) Quantification of the number of nuclei containing RNA foci from the FISH analyses in (<bold>E</bold>) (n = 10). (<bold>G</bold>) Expression levels of (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> RNA in fly larvae expressing (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> using the <italic>GMR-Gal4</italic> driver, with knockdown of <italic>caz</italic> (four independent experiments, n = 20 flies per each genotype). (<bold>H</bold>) Immunohistochemical analyses of DPRs stained with anti-DPR antibodies in the eye imaginal discs of fly larvae expressing (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> using two copies of the <italic>GMR-Gal4</italic> driver, with the knockdown of <italic>caz</italic>. (magenta: poly(GR); orange: poly(GA); green: poly(GP)). Arrowheads indicate cytoplasmic aggregates. Scale bars: 20 μm (low magnification) or 5 μm (high magnification). (<bold>I</bold>) Quantification of the number of DPR aggregates from the immunohistochemical analyses in (<bold>H</bold>) (n = 10). In (<bold>B</bold>, <bold>D</bold>, <bold>F</bold>, <bold>G</bold>, <bold>I</bold>), data are presented as the mean ± SEM. In (<bold>B, D</bold>), p&lt;0.0001, as assessed by one-way ANOVA; <sup>***</sup>p&lt;0.001, as assessed by Tukey’s post hoc analysis. In (<bold>F</bold>, <bold>G</bold>, <bold>I</bold>), n.s., not significant, <sup>*</sup>p&lt;0.05, <sup>**</sup>p&lt; 0.01, and <sup>***</sup>p&lt;0.001, as assessed by the unpaired <italic>t</italic>-test. The detailed statistical information is summarized in <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Statistical data related to <xref ref-type="fig" rid="fig4">Figure 4B, D, F, G and I</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-84338-fig4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84338-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Endogenous <italic>caz</italic> is a functional homologue of <italic>FUS</italic> for the suppression of G<sub>4</sub>C<sub>2</sub> repeat-induced toxicity.</title><p>(<bold>A</bold>) Light microscopic images of the eyes in flies expressing both (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>42 or 89</sub> and either <italic>caz</italic> (<italic>FLAG-caz</italic>) or <italic>FUS-4</italic> (<italic>FLAG-FUS</italic>) using the <italic>GMR-Gal4</italic> driver. <italic>FUS-4</italic> is a different strain from those used in <xref ref-type="fig" rid="fig1">Figure 1</xref> and <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>. Scale bar: 100 μm. (<bold>B</bold>) Quantification of the eye size in (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> flies of the indicated genotypes (n = 10). (<bold>C</bold>, <bold>D</bold>) Quantification of eye pigmentation in (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> flies (<bold>C</bold>) or (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>42</sub> flies (<bold>D</bold>) of the indicated genotypes (n = 10). In (<bold>B–D</bold>), data are presented as the mean ± SEM; p&lt;0.0001, as assessed by one-way ANOVA; n.s., not significant, <sup>*</sup>p&lt;0.05, <sup>**</sup>p&lt;0.01, and <sup>***</sup>p&lt;0.001, as assessed by Tukey’s post hoc analysis. The detailed statistical information is summarized in <xref ref-type="supplementary-material" rid="fig4s1sdata1">Figure 4—figure supplement 1—source data 1</xref>.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Statistical data related to <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B–D</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-84338-fig4-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84338-fig4-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-5"><title>FUS directly binds to and modulates the G-quadruplex structure of G<sub>4</sub>C<sub>2</sub> repeat RNA, resulting in the suppression of RAN translation in vitro</title><p>We next confirmed the direct interaction of FUS with G<sub>4</sub>C<sub>2</sub> repeat RNA by the filter binding assay. We found that His-tagged FUS binds to the (G<sub>4</sub>C<sub>2</sub>)<sub>4</sub> RNA in a dose-dependent manner, but not to the control (AAAAAA)<sub>4</sub> RNA (<xref ref-type="fig" rid="fig5">Figure 5A</xref>), and His-tagged FUS-RRMmut had almost no binding affinity to the (G<sub>4</sub>C<sub>2</sub>)<sub>4</sub> RNA, consistent with a previous study (<xref ref-type="bibr" rid="bib48">Mori et al., 2013a</xref>). We also confirmed the interaction of FUS with the G<sub>4</sub>C<sub>2</sub> repeat RNA in our C9-ALS/FTD flies by showing the colocalization of FUS with the RNA foci (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>), consistent with a recent study using C9-ALS/FTD patient fibroblasts (<xref ref-type="bibr" rid="bib2">Bajc Česnik et al., 2019</xref>). Since G<sub>4</sub>C<sub>2</sub> repeat RNA was reported to form both G-quadruplex and hairpin structures (<xref ref-type="bibr" rid="bib14">Fratta et al., 2012</xref>; <xref ref-type="bibr" rid="bib24">Haeusler et al., 2014</xref>; <xref ref-type="bibr" rid="bib55">Reddy et al., 2013</xref>; <xref ref-type="bibr" rid="bib64">Su et al., 2014</xref>), we next characterized the interactions of FUS with G<sub>4</sub>C<sub>2</sub> repeat RNA having different structures. G<sub>4</sub>C<sub>2</sub> repeat RNA is known to form G-quadruplex structures in the presence of K<sup>+</sup>, whereas they form hairpin structures in the presence of Na<sup>+</sup> (<xref ref-type="bibr" rid="bib64">Su et al., 2014</xref>). Surface plasmon resonance (SPR) analyses demonstrated that FUS preferentially binds to (G<sub>4</sub>C<sub>2</sub>)<sub>4</sub> RNA with the G-quadruplex structure in KCl buffer (<xref ref-type="table" rid="table1">Table 1</xref>, dissociation constant (K<sub>D</sub>) = 1.5 × 10<sup>–8</sup> M) and weakly to (G<sub>4</sub>C<sub>2</sub>)<sub>4</sub> RNA with the hairpin structure in NaCl buffer (<xref ref-type="table" rid="table1">Table 1</xref>, K<sub>D</sub> = 1.3 × 10<sup>–7</sup> μM). We also confirmed that FUS has poor binding affinity to (G<sub>4</sub>C<sub>2</sub>)<sub>4</sub> RNA in LiCl buffer (<xref ref-type="table" rid="table1">Table 1</xref>, K<sub>D</sub> = 1.4 × 10<sup>–5</sup> μM), which destabilizes the G-quadruplex structure (<xref ref-type="bibr" rid="bib25">Hardin et al., 1992</xref>), and was an almost similar level to its binding affinity to the negative control (A<sub>4</sub>C<sub>2</sub>)<sub>4</sub> RNA (not shown). These results suggest the preferential binding of FUS to G<sub>4</sub>C<sub>2</sub> repeat RNA with the G-quadruplex structure, which is consistent with a previous report showing preferential binding of FUS to G-quadruplex structured Sc1 and DNMT RNAs (<xref ref-type="bibr" rid="bib53">Ozdilek et al., 2017</xref>). Considering that higher-order structures, including G-quadruplex and hairpin structures, are reported to be involved in RAN translation (<xref ref-type="bibr" rid="bib51">Mori et al., 2021</xref>; <xref ref-type="bibr" rid="bib61">Simone et al., 2018</xref>; <xref ref-type="bibr" rid="bib73">Wang et al., 2019</xref>; <xref ref-type="bibr" rid="bib80">Zu et al., 2011</xref>), we next investigated the effects of FUS on the structure of G<sub>4</sub>C<sub>2</sub> repeat RNA. The circular dichroism (CD) spectrum of (G<sub>4</sub>C<sub>2</sub>)<sub>4</sub> RNA in KCl buffer was found to exhibit a positive peak at approximately 260 nm and a negative peak at 240 nm (<xref ref-type="fig" rid="fig5">Figure 5B</xref>, black line), consistent with previous reports (<xref ref-type="bibr" rid="bib14">Fratta et al., 2012</xref>; <xref ref-type="bibr" rid="bib24">Haeusler et al., 2014</xref>; <xref ref-type="bibr" rid="bib55">Reddy et al., 2013</xref>; <xref ref-type="bibr" rid="bib64">Su et al., 2014</xref>). Interestingly, upon the addition of FUS, these two peaks were notably shifted to longer wavelengths with substantial CD spectrum changes, indicating a significant structural alteration in (G<sub>4</sub>C<sub>2</sub>)<sub>4</sub> RNA (<xref ref-type="fig" rid="fig5">Figure 5B</xref>, red line). We confirmed that the CD spectrum of FUS alone in the wavelength range of 240–300 nm was almost negligible (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2A</xref>, green line), indicating that this change in CD spectrum is attributed to structural changes in the (G<sub>4</sub>C<sub>2</sub>)<sub>4</sub> RNA. We also observed CD spectrum changes to some extent in the (G<sub>4</sub>C<sub>2</sub>)<sub>4</sub> RNA upon the addition of FUS in NaCl buffer, but not in LiCl buffer, confirming an interaction between FUS and hairpin-structured (G<sub>4</sub>C<sub>2</sub>)<sub>4</sub> RNA as well (<xref ref-type="fig" rid="fig5">Figure 5C and D</xref>). We further analyzed the interaction between FUS and G<sub>4</sub>C<sub>2</sub> repeat RNA by imino proton nuclear magnetic resonance (NMR). In KCl buffer, the NMR signals of the imino proton for the G-quadruplex structure of (G<sub>4</sub>C<sub>2</sub>)<sub>4</sub> RNA were detected in the region around 10–12 ppm (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2D</xref>), consistent with previous studies (<xref ref-type="bibr" rid="bib14">Fratta et al., 2012</xref>; <xref ref-type="bibr" rid="bib64">Su et al., 2014</xref>). Upon the addition of FUS, the NMR intensities of (G<sub>4</sub>C<sub>2</sub>)<sub>4</sub> RNA were decreased in an FUS concentration-dependent manner (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2D</xref>), further supporting the possibility that that FUS interacts with and modulates the G-quadruplex structure of (G<sub>4</sub>C<sub>2</sub>)<sub>4</sub> RNA. Collectively, these results indicate that FUS directly binds to G<sub>4</sub>C<sub>2</sub> repeat RNA, preferentially to its G-quadruplex form and modulates its higher-order structures. These structural alterations of G<sub>4</sub>C<sub>2</sub> repeat RNAs by FUS did not require ATP or interactions with other proteins, suggesting its role as an RNA chaperone for G<sub>4</sub>C<sub>2</sub> repeat RNA (<xref ref-type="bibr" rid="bib54">Rajkowitsch et al., 2007</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>FUS directly binds to and modulates the G-quadruplex structure of G<sub>4</sub>C<sub>2</sub> repeat RNA, resulting in the suppression of RAN translation in vitro.</title><p>(<bold>A</bold>) Analysis of the binding of His-tagged FUS proteins to biotinylated (G<sub>4</sub>C<sub>2</sub>)<sub>4</sub> RNA by the filter binding assay. The nitrocellulose membrane (left) traps RNA-bound FUS proteins, whereas unbound RNAs are recovered on the nylon membrane (right), and then the RNAs trapped on each of the membranes was probed with streptavidin-horseradish peroxidase (HRP). Biotinylated (AAAAAA)<sub>4</sub> and (UUAGGG)<sub>4</sub> were used as negative and positive controls, respectively. (<bold>B–D</bold>) CD spectra of (G<sub>4</sub>C<sub>2</sub>)<sub>4</sub> RNA incubated with or without FUS in the presence of 150 mM KCl (<bold>B</bold>), NaCl (<bold>C</bold>), or LiCl (<bold>D</bold>). The CD spectrum of FUS alone was subtracted from that of (G<sub>4</sub>C<sub>2</sub>)<sub>4</sub> RNA incubated with FUS. The original data are shown in <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2B–2D</xref>. (<bold>E</bold>) Schema of the template RNA containing the (G<sub>4</sub>C<sub>2</sub>)<sub>80</sub> sequence and 113 nucleotides of the 5′-flanking region of intron 1 of the human <italic>C9orf72</italic> G<sub>4</sub>C<sub>2</sub> repeat sequence. A Myc tag in the GA frame was introduced downstream of the (G<sub>4</sub>C<sub>2</sub>)<sub>80</sub> repeat sequence. (<bold>F</bold>) Western blot analysis of samples from in vitro translation using rabbit reticulocyte lysate in the presence or absence of increasing concentrations of FUS or FUS-RRMmut. The GA-Myc fusion protein was detected by western blotting using the anti-Myc antibody. (<bold>G</bold>) Quantification of the GA-Myc fusion protein in (<bold>F</bold>) (n = 3). In (<bold>G</bold>), data are presented as the mean ± SEM; <sup>*</sup>p&lt;0.05, <sup>**</sup>p&lt;0.01, and <sup>***</sup>p&lt;0.001, as assessed by the unpaired <italic>t</italic>-test. The detailed statistical information is summarized in <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Statistical data related to <xref ref-type="fig" rid="fig5">Figure 5G</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-84338-fig5-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5sdata2"><label>Figure 5—source data 2.</label><caption><title>Source data related to <xref ref-type="fig" rid="fig5">Figure 5F</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-84338-fig5-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84338-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>FUS colocalizes with G<sub>4</sub>C<sub>2</sub> RNA foci.</title><p>Combined fluorescence in situ hybridization (FISH) and immunohistochemical analyses of G<sub>4</sub>C<sub>2</sub> repeat RNA and FUS in the salivary glands of flies expressing both (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> and <italic>FUS</italic> using two copies of the <italic>GMR-Gal4</italic> driver. Arrowheads indicate colocalization of FUS with RNA foci. Scale bar: 10 μm (low magnification) and 5 μm (high magnification).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84338-fig5-figsupp1-v1.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>FUS modulates the G-quadruplex structure of G<sub>4</sub>C<sub>2</sub> repeat RNA.</title><p>(<bold>A–C</bold>) CD spectra of (G<sub>4</sub>C<sub>2</sub>)<sub>4</sub> RNA incubated with or without FUS in the presence of 150 mM KCl (<bold>A</bold>), NaCl (<bold>B</bold>), or LiCl (<bold>C</bold>). CD spectra of (G<sub>4</sub>C<sub>2</sub>)<sub>4</sub> RNA alone (black), FUS alone (green), sum of (G<sub>4</sub>C<sub>2</sub>)<sub>4</sub> RNA and FUS (blue), and the spectra of their coincubation (magenta) are shown. FUS interacts with (G<sub>4</sub>C<sub>2</sub>)<sub>4</sub> RNA under KCl or NaCl buffer conditions. (<bold>D</bold>) Imino proton NMR spectra of (G<sub>4</sub>C<sub>2</sub>)<sub>4</sub> RNA incubated with increasing amounts of FUS in the presence of 150 mM KCl.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84338-fig5-figsupp2-v1.tif"/></fig></fig-group><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Association (k<sub>a</sub>) and dissociation (k<sub>d</sub>) rate and dissociation constants (K<sub>D</sub>) between FUS and (G<sub>4</sub>C<sub>2</sub>)<sub>4</sub> RNA in different buffers as assessed by surface plasmon resonance (SPR) analysis.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Buffer</th><th align="left" valign="bottom">k<sub>a</sub> (M<sup>–1</sup>s<sup>–1</sup>) × 10<sup>6</sup></th><th align="left" valign="bottom">k<sub>d</sub> (s<sup>–1</sup>) × 10<sup>–3</sup></th><th align="left" valign="bottom">K<sub>D</sub> (M)</th></tr></thead><tbody><tr><td align="left" valign="bottom">KCl</td><td align="char" char="." valign="bottom">1.4</td><td align="char" char="." valign="bottom">22</td><td align="char" char="." valign="bottom">1.5 × 10<sup>–8</sup></td></tr><tr><td align="left" valign="bottom">NaCl</td><td align="char" char="." valign="bottom">0.41</td><td align="char" char="." valign="bottom">54</td><td align="char" char="." valign="bottom">1.3 × 10<sup>–7</sup></td></tr><tr><td align="left" valign="bottom">LiCl</td><td align="char" char="." valign="bottom">0.0018</td><td align="char" char="." valign="bottom">25</td><td align="char" char="." valign="bottom">1.4 × 10<sup>–5</sup></td></tr></tbody></table></table-wrap><p>To further clarify the direct link between the binding of FUS to G<sub>4</sub>C<sub>2</sub> repeat RNA and its effects on RAN translation, we employed a cell-free in vitro translation assay using rabbit reticulocyte lysate. We designed a reporter construct containing the 80 G<sub>4</sub>C<sub>2</sub> repeat sequence with the 5′ upstream intronic sequence of the <italic>C9orf72</italic> gene and the Myc tag sequence in the GA reading frame at the 3′ downstream (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). This upstream sequence contained multiple stop codons in each reading frame and lacked AUG initiation codons. We confirmed by western blotting that this reporter system indeed produces GA-Myc by RAN translation, consistent with previous studies (<xref ref-type="bibr" rid="bib23">Green et al., 2017</xref>; <xref ref-type="bibr" rid="bib65">Tabet et al., 2018</xref>). Notably, upon the addition to this translation system, FUS suppressed RAN translation efficiently, whereas FUS-RRMmut did not. FUS decreased the expression levels of GA-Myc at as low as 10 nM and nearly eliminated RAN translation activity at 100 nM. At 400 nM, FUS-RRMmut weakly suppressed the GA-Myc expression levels probably because of the residual RNA-binding activity (<xref ref-type="fig" rid="fig5">Figure 5F and G</xref>). Taken together, these results indicate that FUS suppresses RAN translation in vitro through direct interactions with G<sub>4</sub>C<sub>2</sub> repeat RNA as an RNA chaperone.</p></sec><sec id="s2-6"><title>Identification of G-quadruplex-targeting RBPs that suppress G<sub>4</sub>C<sub>2</sub> repeat-induced toxicity in C9-ALS/FTD flies</title><p>Considering that FUS suppresses G<sub>4</sub>C<sub>2</sub> repeat-induced toxicity as an RNA chaperone through its preferential binding to the G-quadruplex structure of G<sub>4</sub>C<sub>2</sub> repeat RNA (<xref ref-type="fig" rid="fig5">Figure 5</xref> and <xref ref-type="table" rid="table1">Table 1</xref>), we hypothesized that other G-quadruplex-targeting RBPs might have similar suppressive effects on G<sub>4</sub>C<sub>2</sub> repeat-induced toxicity. To investigate this possibility, we selected six representative G-quadruplex-targeting RBPs, all of which are known to bind to G<sub>4</sub>C<sub>2</sub> RNA as well (<xref ref-type="bibr" rid="bib9">Cooper-Knock et al., 2014</xref>; <xref ref-type="bibr" rid="bib24">Haeusler et al., 2014</xref>; <xref ref-type="bibr" rid="bib48">Mori et al., 2013a</xref>; <xref ref-type="bibr" rid="bib75">Xu et al., 2013</xref>; <xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref>). Intriguingly, coexpression of <italic>EWSR1</italic>, <italic>DDX3X</italic>, <italic>DDX5</italic>, or <italic>DDX17</italic> significantly suppressed eye degeneration in (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> flies without altering G<sub>4</sub>C<sub>2</sub> RNA expression (<xref ref-type="fig" rid="fig6">Figure 6A–D</xref>). As expected, these RBPs also decreased the number of poly(GA) aggregates in the eye imaginal discs (<xref ref-type="fig" rid="fig6">Figure 6E and F</xref>). Their effects on G<sub>4</sub>C<sub>2</sub> repeat-induced toxicity, repeat RNA expression, and RAN translation were consistent with those of FUS. In support of our results, DDX3X was previously reported to suppress RAN translation and G<sub>4</sub>C<sub>2</sub> repeat-induced toxicity in cell culture in a helicase-activity-dependent manner (<xref ref-type="bibr" rid="bib6">Cheng et al., 2019</xref>). On the other hand, coexpression of <italic>DHX9</italic> or <italic>DHX36</italic> suppressed eye degeneration by reducing G<sub>4</sub>C<sub>2</sub> repeat RNA levels (<xref ref-type="fig" rid="fig6">Figure 6A–D</xref>). Since G-quadruplex-targeting RBPs have diverse biological functions, including transcription, RNA processing, translation, and RNA stabilization (<xref ref-type="bibr" rid="bib13">Dumas et al., 2021</xref>), these different effects among G-quadruplex-targeting RBPs on G<sub>4</sub>C<sub>2</sub> repeat RNA expression might be attributed to their different roles in RNA metabolism. Thus, some G-quadruplex-targeting RBPs regulate RAN translation and G<sub>4</sub>C<sub>2</sub> repeat-induced toxicity by binding to and possibly by modulating the G-quadruplex structure of G<sub>4</sub>C<sub>2</sub> repeat RNA.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Identification of G-quadruplex-targeting RNA-binding proteins (RBPs) that suppress G<sub>4</sub>C<sub>2</sub> repeat-induced toxicity in C9-ALS/FTD flies.</title><p>(<bold>A</bold>) Light microscopic images of eyes in flies expressing both (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> and the indicated G-quadruplex-targeting RBPs using the <italic>GMR-Gal4</italic> driver. Scale bar: 100 μm. (<bold>B</bold>) Quantification of eye size in the flies of the indicated genotypes (n = 10). (<bold>C</bold>) Quantification of eye pigmentation in the flies of the indicated genotypes (n = 10). (<bold>D</bold>) Expression levels of (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> RNA in flies expressing both (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> and the indicated G-quadruplex-targeting RBPs using the <italic>GMR-Gal4</italic> driver (five independent experiments, n = 25 flies per each genotype). (<bold>E</bold>) Immunohistochemical analyses of poly(GA) stained with anti-GA antibody in the eye imaginal discs of fly larvae expressing both (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> and the indicated G-quadruplex-targeting RBPs using two copies of the <italic>GMR-Gal4</italic> driver (orange: poly(GA)). Arrowheads indicate cytoplasmic aggregates. Scale bars: 20 μm (low magnification) or 5 μm (high magnification). (<bold>F</bold>) Quantification of the number of poly(GA) aggregates from the immunohistochemical analyses in (<bold>E</bold>) (n = 10). In (<bold>B</bold>, <bold>C</bold>, <bold>D</bold>, <bold>F</bold>), data are presented as the mean ± SEM; p&lt;0.0001, as assessed by one-way ANOVA; n.s., not significant, <sup>*</sup>p&lt;0.05 and <sup>***</sup>p&lt;0.001, as assessed by Tukey’s post hoc analysis. The detailed statistical information is summarized in <xref ref-type="supplementary-material" rid="fig6sdata2">Figure 6—source data 2</xref>.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>RNA-binding proteins and their cDNA accession numbers screened in the genetic analyses in <xref ref-type="fig" rid="fig6">Figure 6</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-84338-fig6-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig6sdata2"><label>Figure 6—source data 2.</label><caption><title>Statistical data related to <xref ref-type="fig" rid="fig6">Figure 6B–D, F</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-84338-fig6-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84338-fig6-v1.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study, we revealed a novel regulatory mechanism of RAN translation from expanded G<sub>4</sub>C<sub>2</sub> repeat RNA by the ALS/FTD-linked RBP FUS, which suppresses DPR production and neurodegeneration in C9-ALS/FTD <italic>Drosophila</italic> models (<xref ref-type="fig" rid="fig1">Figures 1</xref>—<xref ref-type="fig" rid="fig4">4</xref>). FUS directly binds to G<sub>4</sub>C<sub>2</sub> repeat RNA and modulates its G-quadruplex structure as evident by CD and NMR analyses (<xref ref-type="fig" rid="fig5">Figure 5</xref>, <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>), and suppresses RNA foci formation in vivo (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>), suggesting its functional role as an RNA chaperone. This is reminiscent of our recent study on SCA31, in which we demonstrated a novel role of the ALS/FTD-linked RBPs TDP-43, FUS, and hnRNPA2B1 as RNA chaperones binding to UGGAA repeat RNA and altering its structure, resulting in the suppression of its neurotoxicity through reducing RNA foci formation and repeat polypeptide translation (<xref ref-type="bibr" rid="bib28">Ishiguro et al., 2017</xref>). Considering the similarities of the effects of FUS on G<sub>4</sub>C<sub>2</sub> repeat RNA and UGGAA repeat RNA, we conclude that FUS functions as an RNA chaperone also for G<sub>4</sub>C<sub>2</sub> repeat RNA to regulate its RAN translation.</p><p>The suppressive effects of RBPs in several noncoding repeat expansion diseases by the amelioration of their sequestration into RNA foci have been reported. For example, in myotonic dystrophy type 1, MBNL1 was shown to be sequestered into CUG repeat RNA foci, and overexpression of MBNL1 in a mouse model was found to compensate its functional loss, resulting in the reversal of myotonia (<xref ref-type="bibr" rid="bib30">Kanadia et al., 2006</xref>). Similarly, previous studies reported the suppressive effects of other RBPs on neurodegeneration, such as hnRNPA2B1 in fragile X ataxia/tremor syndrome (<xref ref-type="bibr" rid="bib62">Sofola et al., 2007</xref>), and Pur-α and Zfp106 in C9-ALS/FTD (<xref ref-type="bibr" rid="bib75">Xu et al., 2013</xref>; <xref ref-type="bibr" rid="bib4">Celona et al., 2017</xref>). The suppressive effects of these RBPs have been thought to result from the supplementation against their loss-of-function due to their sequestration into RNA foci, although their effects on gain-of-toxic disease pathomechanisms, that is, RAN translation and repeat RNA expression, remain to be elucidated. In contrast, in this study we demonstrated that FUS suppresses neurodegeneration in C9-ALS/FTD by directly targeting G<sub>4</sub>C<sub>2</sub> repeat RNA and inhibiting RAN translation as an RNA chaperone. Similar suppressive effects of RBPs by targeting UGGAA repeat RNA in SCA31 as RNA chaperones have also been reported (<xref ref-type="bibr" rid="bib28">Ishiguro et al., 2017</xref>). In addition, we also showed that the expression of IGF2BP1, hnRNPA2B1, DHX9, and DHX36 decreased G<sub>4</sub>C<sub>2</sub> repeat RNA expression and suppressed eye degeneration in our C9-ALS/FTD <italic>Drosophila</italic> model (<xref ref-type="fig" rid="fig1">Figures 1</xref> and <xref ref-type="fig" rid="fig6">6</xref>), likely via the reduction of DPR levels. Similarly, we recently reported that hnRNPA3 reduces G<sub>4</sub>C<sub>2</sub> repeat RNA expression levels, leading to the suppression of neurodegeneration in C9-ALS/FTD fly models (<xref ref-type="bibr" rid="bib66">Taminato et al., 2023</xref>). Interestingly, these RBPs have been reported to be involved in RNA decay pathways as components of the P-body or interactors with the RNA deadenylation machinery (<xref ref-type="bibr" rid="bib67">Tran et al., 2004</xref>; <xref ref-type="bibr" rid="bib31">Katahira et al., 2008</xref>; <xref ref-type="bibr" rid="bib18">Geissler et al., 2016</xref>; <xref ref-type="bibr" rid="bib26">Hubstenberger et al., 2017</xref>), possibly contributing to the reduced expression levels of G<sub>4</sub>C<sub>2</sub> repeat RNA. In myotonic dystrophy type 2 models, MBNL1 was also reported to retain CCUG repeat RNA in the nucleus, resulting in the suppression of RAN translation (<xref ref-type="bibr" rid="bib82">Zu et al., 2017</xref>), implying various mechanisms of the effects of RBPs depending on the combination of RBPs and repeat RNA. Nevertheless, our findings highlighted the previously unrecognized roles of RBPs directly interacting with repeat RNA and modulating gain-of-toxic pathomechanisms, including RAN translation in noncoding repeat expansion diseases.</p><p>Several studies have indicated the importance of higher-order structures of repeat RNA in RAN translation. In SCA8 models, hairpin-forming CAG repeat RNA was shown to be RAN-translated to produce polyglutamine proteins, but switching the CAG repeats to non-hairpin-forming CAA repeats abolished the RAN translation (<xref ref-type="bibr" rid="bib80">Zu et al., 2011</xref>). In C9-ALS/FTD, G<sub>4</sub>C<sub>2</sub> repeat RNA has been reported to form both hairpin and G-quadruplex structures (<xref ref-type="bibr" rid="bib14">Fratta et al., 2012</xref>; <xref ref-type="bibr" rid="bib24">Haeusler et al., 2014</xref>; <xref ref-type="bibr" rid="bib55">Reddy et al., 2013</xref>; <xref ref-type="bibr" rid="bib64">Su et al., 2014</xref>). Although the effect of each structure on RAN translation remains largely unknown, small molecules binding to the hairpin structure or the G-quadruplex structure were both reported to inhibit RAN translation from the G<sub>4</sub>C<sub>2</sub> repeat RNA, resulting in reduced DPR levels (<xref ref-type="bibr" rid="bib73">Wang et al., 2019</xref>; <xref ref-type="bibr" rid="bib51">Mori et al., 2021</xref>). These findings are in accordance with our results showing that FUS modifies the G-quadruplex structure as well as the hairpin structure of G<sub>4</sub>C<sub>2</sub> repeat RNA as an RNA chaperone and reduces DPR production. We further found that G-quadruplex-targeting RNA helicases, including DDX3X, DDX5, and DDX17, which are known to bind to G<sub>4</sub>C<sub>2</sub> repeat RNA (<xref ref-type="bibr" rid="bib9">Cooper-Knock et al., 2014</xref>; <xref ref-type="bibr" rid="bib24">Haeusler et al., 2014</xref>; <xref ref-type="bibr" rid="bib48">Mori et al., 2013a</xref>; <xref ref-type="bibr" rid="bib75">Xu et al., 2013</xref>), also suppress RAN translation and G<sub>4</sub>C<sub>2</sub> repeat-induced toxicity without altering the expression levels of G<sub>4</sub>C<sub>2</sub> repeat RNA in our <italic>Drosophila</italic> models. These results suggest that not only ATP-independent RNA chaperones, but also ATP-dependent RNA helicases may regulate RAN translation through modifying the higher-order structures of template repeat RNA. Consistently, a previous study also reported that DDX3X inhibits RAN translation from G<sub>4</sub>C<sub>2</sub> repeat RNA in a helicase activity-dependent manner (<xref ref-type="bibr" rid="bib6">Cheng et al., 2019</xref>). Knockdown of another RNA helicase, DHX36, has been reported to both promote (<xref ref-type="bibr" rid="bib6">Cheng et al., 2019</xref>) and inhibit (<xref ref-type="bibr" rid="bib41">Liu et al., 2021</xref>; <xref ref-type="bibr" rid="bib70">Tseng et al., 2021</xref>) RAN translation, possibly due to the different effects on repeat RNA structures depending on the experimental conditions. Unfortunately, most of these studies reporting the effects of RBPs on RAN translation have limitations of the detailed structural analyses of repeat RNA. In this study, focusing on FUS, we performed a series of molecular structural analyses, in vitro translation assays, and in vivo genetic analyses to clarify the structure–function relationship of G<sub>4</sub>C<sub>2</sub> repeat RNA and provide compelling evidence for the modifying effects of FUS on repeat RNA structures leading to the suppression of RAN translation and repeat-induced toxicity in vivo.</p><p>FUS has an RRM domain for RNA binding and a low complexity (LC) domain involved in protein interactions, and exerts multifaceted functions, such as RNA transcription, RNA splicing, RNA transport, and formation of membraneless organelles, such as stress granules and nuclear paraspeckles via liquid–liquid phase separation (<xref ref-type="bibr" rid="bib35">Lagier-Tourenne et al., 2010</xref>). Recent studies reported that arginine-rich DPRs, such as poly(GR) and poly(PR), interact with LC domain-containing RBPs, including FUS, and alter their liquid–liquid phase separation, resulting in the disruption of the dynamics and functions of membraneless organelles (<xref ref-type="bibr" rid="bib34">Kwon et al., 2014</xref>; <xref ref-type="bibr" rid="bib37">Lee et al., 2016</xref>; <xref ref-type="bibr" rid="bib40">Lin et al., 2016</xref>). These findings raise the possibility that FUS may exert its suppressive effects by directly interacting with DPRs. However, we showed that FUS does not suppress eye degeneration in DPR-only flies (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>), indicating that a direct interaction between FUS and DPRs is unlikely to be the mechanism of the suppression of DPR toxicity in our C9-ALS/FTD flies. This result supports our conclusion that FUS suppresses G<sub>4</sub>C<sub>2</sub> repeat-induced toxicity through direct binding to G<sub>4</sub>C<sub>2</sub> repeat RNA.</p><p>In summary, we here provided evidence that FUS modulates the structure of G<sub>4</sub>C<sub>2</sub> repeat RNA as an RNA chaperone and regulates RAN translation, resulting in the suppression of neurodegeneration in C9-ALS/FTD fly models. Recent advances in genome sequencing technology unveiled that such expansions of repeat sequences cause more than 50 monogenic human diseases (<xref ref-type="bibr" rid="bib43">Malik et al., 2021</xref>) and are also associated with psychiatric diseases such as autism (<xref ref-type="bibr" rid="bib46">Mitra et al., 2021</xref>; <xref ref-type="bibr" rid="bib69">Trost et al., 2020</xref>). Thus, our findings contribute to the elucidation of the repeat-associated pathogenic mechanisms underlying not only C9-ALS/FTD, but also a broader range of neuromuscular and neuropsychiatric diseases than previously thought, and will advance the development of potential therapies for these diseases.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain, strain background (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom"><italic>UAS</italic>-(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>n</sub>, <italic>UAS-FUS-2</italic>, <italic>UAS-FUS-RRMmut</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">See ‘Generation of constructs and transgenic flies’</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>UAS-RBP</italic><break/>(<italic>FUS-3; IGF2BP1; hnRNPA2B1; hnRNPR; SAFB2; SF3B3; hnRNPA1; hnRNPL; DHX30; SAFB; DHX15; ILF2; DDX21; hnRNPK; SFPQ; ILF3; NONO; ELAVL1; DDX3X; DDX5; DDX17; DHX9; DHX36</italic>)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">See ‘Generation of constructs and transgenic flies’</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>UAS-LDS-(G4C2)<sub>44</sub><sup>GR-GFP</sup></italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib22">Goodman et al., 2019</xref> (PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/31110321/">:31110321</ext-link>)</td><td align="left" valign="bottom">FLYB: FBtp0135960</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>UAS-FUS</italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib28">Ishiguro et al., 2017</xref> (PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/28343865/">:28343865</ext-link>)</td><td align="left" valign="bottom">FLYB: FBtp0117594</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>UAS-FUS-4</italic> (<italic>UAS-FLAG-FUS</italic>)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib72">Wang et al., 2011</xref> (PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/21881207/">:21881207</ext-link>)</td><td align="left" valign="bottom">FLYB: FBtp0070284</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>UAS-caz</italic> (<italic>UAS-FLAG-caz</italic>)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib72">Wang et al., 2011</xref> (PMID<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/21881207/">:21881207</ext-link>)</td><td align="left" valign="bottom">FLYB: FBtp0070279</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>caz<sup>2</sup></italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib16">Frickenhaus et al., 2015</xref> (PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/25772687/">:25772687</ext-link>)</td><td align="left" valign="bottom">FLYB: FBal0323133</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>UAS-TDP-43</italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib28">Ishiguro et al., 2017</xref> (PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/28343865/">:28343865</ext-link>)</td><td align="left" valign="bottom">FLYB: FBtp0117592</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>GMR-GAL4 driver</italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib76">Yamaguchi et al., 1999</xref> (PMID<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/10597285/">:10597285</ext-link>)</td><td align="left" valign="bottom">FLYB: FBtp0010074</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">Elav-GAL4 driver<italic>: P{w[+mC]=GAL4-elav.L}2/CyO</italic></td><td align="left" valign="bottom">Bloomington <italic>Drosophila</italic> Stock Center</td><td align="left" valign="bottom">BDSC: 8765; FLYB: FBst0008765</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">Elav-GeneSwitch GAL4 driver<italic>: y(1) w[*]; P{w[+mC]=elav-Switch.O}GSG301</italic></td><td align="left" valign="bottom">Bloomington <italic>Drosophila</italic> Stock Center</td><td align="left" valign="bottom">BDSC: 43642; FLYB: FBst0043642</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>UAS-EGFP: w[*]; P{w[+mC]=UAS-2xEGFP}AH2</italic></td><td align="left" valign="bottom">Bloomington <italic>Drosophila</italic> Stock Center</td><td align="left" valign="bottom">BDSC: 6874; FLYB: FBst0006874</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>UAS-DsRed: w[*]; P{w[+mC]=UAS-AUG-DsRed}A</italic></td><td align="left" valign="bottom">Bloomington <italic>Drosophila</italic> Stock Center</td><td align="left" valign="bottom">BDSC: 6282; FLYB: FBst0006282</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>UAS-EWSR1: w[1118]; P{w[+mC]=UAS-EWSR1.C}26</italic>M</td><td align="left" valign="bottom">Bloomington <italic>Drosophila</italic> Stock Center</td><td align="left" valign="bottom">BDSC: 79592; FLYB: FBst00079592</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>UAS-(GR)<sub>36</sub>: w[1118]; P{{y[+t7.7] w[+mC]=UAS-poly-GR.PO-36}attP40</italic></td><td align="left" valign="bottom">Bloomington <italic>Drosophila</italic> Stock Center</td><td align="left" valign="bottom">BDSC: 58692; FLYB: FBst00058692</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>UAS-(GA)<sub>36</sub>: w[1118]; P{{y[+t7.7] w[+mC]=UAS-poly-GA.PO-36}attP40</italic></td><td align="left" valign="bottom">Bloomington <italic>Drosophila</italic> Stock Center</td><td align="left" valign="bottom">BDSC: 58693; FLYB: FBst00058693</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>UAS-(GR)<sub>100</sub>: w[1118]; P{{y[+t7.7] w[+mC]=UAS-poly-GR.PO-100}attP40</italic></td><td align="left" valign="bottom">Bloomington <italic>Drosophila</italic> Stock Center</td><td align="left" valign="bottom">BDSC: 58696; FLYB: FBst00058696</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>UAS-(GA)<sub>100</sub>: w[1118]; P{{y[+t7.7] w[+mC]=UAS-poly-GA.PO-100}attP40</italic></td><td align="left" valign="bottom">Bloomington <italic>Drosophila</italic> Stock Center</td><td align="left" valign="bottom">BDSC: 58697; FLYB: FBst00058697</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">RNAi of <italic>GFP: w[1118]; P{w[+mC]=UAS-GFP.dsRNA.R}142</italic></td><td align="left" valign="bottom">Bloomington <italic>Drosophila</italic> Stock Center</td><td align="left" valign="bottom">BDSC: 9330; FLYB: FBst0009330</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">RNAi of <italic>caz:</italic> P{KK107486}VIE-260B</td><td align="left" valign="bottom">Vienna <italic>Drosophila</italic> Resource Center</td><td align="left" valign="bottom">VDRC: v100291; FLYB: FBst0472165</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat monoclonal anti-poly(GR) antibody (5A2)</td><td align="left" valign="bottom">Millipore</td><td align="left" valign="bottom">Car# MABN778; <break/>RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2728664">:AB_2728664</ext-link></td><td align="left" valign="bottom">IHC(1:1000), WB(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Mouse monoclonal anti-poly(GA) antibody (5E9)</td><td align="left" valign="bottom">Millipore</td><td align="left" valign="bottom">Car# MABN889; <break/>RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2728663">:AB_2728663</ext-link></td><td align="left" valign="bottom">IHC(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit polyclonal anti-poly(GA) antibody</td><td align="left" valign="bottom">Cosmo Bio</td><td align="left" valign="bottom">Cat# CAC-TIP-C9-P01</td><td align="left" valign="bottom">IHC(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit polyclonal anti-poly(GP) antibody</td><td align="left" valign="bottom">Novus Biologicals</td><td align="left" valign="bottom">Cat# NBP2-25018; <break/>RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2893239">:AB_2893239</ext-link></td><td align="left" valign="bottom">IHC(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit polyclonal anti-FUS antibody</td><td align="left" valign="bottom">Bethyl Laboratories</td><td align="left" valign="bottom">Cat# A300-302A; <break/>RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_309445">:AB_309445</ext-link></td><td align="left" valign="bottom">IHC(1:1000), WB(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Mouse monoclonal anti-EGFP antibody</td><td align="left" valign="bottom">Clontech</td><td align="left" valign="bottom">Cat# 632569</td><td align="left" valign="bottom">WB(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Mouse monoclonal anti-actin antibody (AC-40)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# A4700; RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_476730">:AB_476730</ext-link></td><td align="left" valign="bottom">WB(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Mouse monoclonal anti-c-Myc antibody (9E10)</td><td align="left" valign="bottom">Wako</td><td align="left" valign="bottom">Cat# 017-21876</td><td align="left" valign="bottom">WB(1:3000)</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pcDNA5/FRT-<italic>C9orf72</italic> intron1-(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>80</sub> (plasmid)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See ‘RNA synthesis for in vitro translation’</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>n</sub>_F(1)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">ATGAATGGGAGCAGTGGTGG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>n</sub>_R(1)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">TGTTGAGAGTCAGCAGTAGCC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>n</sub>_F(2)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">CCCAATCCATATGACTAGTAGATCC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>n</sub>_R(2)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">TGTAGGTAGTTTGTCCAATTATGTCA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>gal4</italic>_F</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib39">Li et al., 2008</xref> (PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/18449188/">18449188</ext-link>)</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">TTGAAATCGCGTCGAAGGA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>gal4</italic>_R</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib39">Li et al., 2008</xref> (PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/18449188/">18449188</ext-link>)</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">GGCTCCAATGGCTAATATGCA</named-content></td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">His-FUS</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">See ‘Filter binding assay’</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">His-FUS-RRMmut</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">See ‘Filter binding assay’</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">FUS (not tagged)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">See ‘Preparation of recombinant FUS protein’</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">FUS-RRMmut (not tagged)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">See ‘Preparation of recombinant FUS protein’</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">In-Fusion Cloning system</td><td align="left" valign="bottom">TaKaRa Bio</td><td align="left" valign="bottom">Cat# Z9645N</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">EZ-Tn5&lt;KAN-2&gt;Insertion Kit</td><td align="left" valign="bottom">Epicentre</td><td align="left" valign="bottom">Cat# EZI011RK</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">QuantiTect Reverse Transcription Kit</td><td align="left" valign="bottom">QIAGEN</td><td align="left" valign="bottom">Cat# 205314</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">mMESSAGE mMACHINE T7 Transcription Kit</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# AM1344</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Flexi Rabbit Reticulocyte Lysate System</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">Cat# L4540</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">RU486 (mifepristone)</td><td align="left" valign="bottom">Wako</td><td align="left" valign="bottom">M3321; CAS: 84371-65-3</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Formula 4-24 Instant <italic>Drosophila</italic> medium</td><td align="left" valign="bottom">Wako</td><td align="left" valign="bottom">Cat# 534-20571</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ZEN imaging software</td><td align="left" valign="bottom">Zeiss</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_013672">SCR_013672</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://www.zeiss.com/microscopy/en/products/software/zeiss-zen.html">https://www.zeiss.com/microscopy/en/products/software/zeiss-zen.html</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ImageJ</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib59">Schneider et al., 2012</xref> (PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/22930834/">22930834</ext-link>)</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_003070">SCR_003070</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/ij/">https://imagej.nih.gov/ij/</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GraphPad Prism version 8.4.3</td><td align="left" valign="bottom">GraphPad Software Inc.</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002798">SCR_002798</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com">https://www.graphpad.com</ext-link></td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Flies</title><p>All fly stocks were cultured and crossed at 23°C or 25°C in standard cornmeal-yeast-glucose medium. Male adult flies were used for the climbing assay and <italic>GeneSwitch</italic> experiments. 3- to 5-day-old female adult flies were used for the evaluation of eye phenotype using a stereoscopic microscope model SZX10 (Olympus). Female third-instar larvae were used for quantitative real-time polymerase chain reaction (PCR), RNA FISH, and immunohistochemistry experiments. The transgenic fly line bearing the <italic>GMR-Gal4</italic> transgene has been described previously (<xref ref-type="bibr" rid="bib76">Yamaguchi et al., 1999</xref>). The transgenic fly lines bearing <italic>elav-Gal4</italic> (#8765), <italic>elav-GeneSwitch</italic> (#43642), <italic>UAS-EGFP</italic> (#6874), <italic>UAS-DsRed</italic> (#6282), <italic>UAS-GFP-IR</italic> (inverted repeat) (#9330), <italic>UAS</italic>-(<italic>GR</italic>)<sub>36</sub> (#58692), <italic>UAS</italic>-(<italic>GA</italic>)<sub>36</sub> (#58693), <italic>UAS</italic>-(<italic>GR</italic>)<sub>100</sub> (#58696), <italic>UAS</italic>-(<italic>GA</italic>)<sub>100</sub> (#58697), and <italic>UAS-EWSR1</italic> (#79592) were obtained from Bloomington <italic>Drosophila</italic> Stock Center. The transgenic fly line bearing <italic>UAS-caz-IR</italic> (#100291) was obtained from Vienna <italic>Drosophila</italic> Resource Center. The fly line with the <italic>caz</italic> null allele (<italic>caz<sup>2</sup></italic>), <italic>UAS-LDS</italic>-(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>44</sub><sup>GR-GFP</sup>, and <italic>UAS-caz</italic> (<italic>UAS-FLAG-caz</italic>) and <italic>UAS-FUS</italic>-4 (<italic>UAS-FLAG-FUS</italic>) were kind gifts from Dr. Erik Storkebaum (<xref ref-type="bibr" rid="bib16">Frickenhaus et al., 2015</xref>), Dr. Nancy Bonini (<xref ref-type="bibr" rid="bib22">Goodman et al., 2019</xref>), and Dr. Brian McCabe (<xref ref-type="bibr" rid="bib72">Wang et al., 2011</xref>), respectively. Other transgenic fly lines were generated in this study. Full genotypes of the fly lines used in all figures and their cultured temperatures are described in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p></sec><sec id="s4-2"><title>Generation of constructs and transgenic flies</title><p>Artificially synthesized (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>50</sub> sequences flanked at the 5′ end with an <italic>Eag</italic>I recognition site and at the 3′ end with a <italic>PspOM</italic>I recognition site were subcloned into T-vector pMD20 (Takara Bio). To generate a longer repeat size, the pMD20-(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>50</sub> vector was digested with <italic>Eag</italic>I and <italic>PspOM</italic>I, followed by ligation into the pMD20-(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>50</sub> vector linearized by digestion with <italic>Eag</italic>I. This vector was digested with <italic>EcoR</italic>I and <italic>Hind</italic>III, and subcloned into the pcDNA3.1/<italic>myc</italic>-His(−)A vector (Thermo Fisher Scientific). We accidentally obtained the pcDNA3.1/<italic>myc</italic>-His(−)A-(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>9</sub> vector at this step. The pcDNA3.1/<italic>myc</italic>-His(−)A-(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>n</sub> vector was digested with <italic>EcoR</italic>I and <italic>Xba</italic>I, and subcloned into the <italic>Drosophila</italic> pUAST vector. These constructs have no start codon sequence (ATG) upstream of the G<sub>4</sub>C<sub>2</sub> repeat sequence (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). These pUAST-(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>n</sub> vectors were amplified with a recombinase-mutated SURE2 <italic>Escherichia coli</italic> strain (Agilent Technologies) at 28°C for 72 hr to prevent repeat length contraction. The number of G<sub>4</sub>C<sub>2</sub> repeats in the pUAST-(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>9 or 50</sub> vectors was determined by sequencing. To determine the number of G<sub>4</sub>C<sub>2</sub> repeats in the pUAST-(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub> vector, transposable element insertional mutagenesis using EZ-Tn5&lt;KAN-2&gt;Insertion Kit (Epicentre) and sequencing were performed. The entire sequence of the insert in the pUAST vector is shown in <xref ref-type="supplementary-material" rid="fig1s1sdata1">Figure 1—figure supplement 1—source data 1</xref>.</p><p>To generate pUAST-<italic>FUS</italic> or pUAST<italic>-TDP-43</italic> vectors, the Gateway Vector Conversion System (Thermo Fisher Scientific) was used. The human <italic>FUS</italic> or human <italic>TARDBP</italic> cDNA was subcloned into the pENTR/D-TOPO vector (Thermo Fisher Scientific). To generate the Gateway destination vector pUAST-DEST, we inserted the Gateway cassette A sequence (Thermo Fisher Scientific) into the pUAST vector. The pUAST-<italic>FUS</italic> or pUAST-<italic>TDP-43</italic> vectors were generated using Gateway recombination reactions (Thermo Fisher Scientific). The FUS RRM mutant construct (pUAST<italic>-FUS-RRMmut</italic>), in which leucine residues at positions 305, 341, 359, and 368 in the FUS protein were substituted to phenylalanine, was generated by PCR and the In-Fusion Cloning system (Takara Bio). To generate the other pUASTattB-<italic>RBP</italic> vectors, each cDNA encoding the RBP shown in <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref> and <xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref> was subcloned into the pUASTattB vector (VectorBuilder). To establish transgenic flies harboring <italic>UAS</italic>-(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>n</sub>, <italic>UAS-FUS</italic>, <italic>UAS-FUS</italic> line 2, <italic>UAS-FUS-RRMmut</italic>, and <italic>UAS-TDP-43</italic>, the pUAST-(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>n</sub>, pUAST-<italic>FUS</italic>, pUAST-<italic>FUS</italic> line 2, pUAST-<italic>FUS-RRMmut</italic>, and pUAST-<italic>TDP-43</italic> vectors, respectively, were injected into fly embryos of the <italic>w<sup>1118</sup></italic> strain. To establish transgenic flies harboring the other <italic>UAS-RBP</italic> constructs including <italic>UAS-FUS</italic> line 3, pUASTattB-<italic>RBP</italic> vectors were injected into fly embryos of the attP40 strain. By employing site-specific transgenesis using the pUASTattB vector, each transgene was inserted into the same locus of the genome and was expected to be expressed at the equivalent levels. These transgenic flies were established using standard methods at BestGene Inc.</p><p>The number of repeats in <italic>UAS</italic>-(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>9 or 42</sub> transgenic flies was determined by genomic PCR using the forward (5′-<named-content content-type="sequence">AACCAGCAACCAAGTAAATCAAC</named-content>-3′) and reverse (5′-<named-content content-type="sequence">TGTTGAGAGTCAGCAGTAGCC</named-content>-3′) primers, which amplifies a part of the <italic>UAS</italic>-(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>n</sub> sequence, including G<sub>4</sub>C<sub>2</sub> repeat sequence, followed by sequencing using the forward (5′-<named-content content-type="sequence">GCCAAGAAGTAATTATTGA</named-content>-3′) and/or reverse (5′-<named-content content-type="sequence">TCCAATTATGTCACACC</named-content>-3′) primers.</p></sec><sec id="s4-3"><title>Quantitative real-time PCR</title><p>Total RNA was extracted from female third-instar larvae of each genotype using TRIzol reagent (Thermo Fisher Scientific) according to the manufacturer’s instructions. First-strand cDNA was synthesized using QuantiTect Reverse Transcription Kit (QIAGEN). Real-time PCR was performed using SYBR Premix Ex Taq II (Takara Bio) and the Mx3000P Real-time quantitative PCR system (Agilent Technologies) or the CFX96 Real-Time PCR Detection System (Bio-Rad). For G<sub>4</sub>C<sub>2</sub> repeat RNA quantification of flies expressing (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>n</sub> in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>, the forward (5′-<named-content content-type="sequence">ATGAATGGGAGCAGTGGTGG</named-content>-3′) and reverse (5′-<named-content content-type="sequence">TGTTGAGAGTCAGCAGTAGCC</named-content>-3′) primers were used. For G<sub>4</sub>C<sub>2</sub> repeat RNA quantification of flies expressing (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub>(H) and FUS, FUS-RRMmut, other RNA-binding proteins, or <italic>caz-IR</italic> in <xref ref-type="fig" rid="fig1">Figures 1E</xref>, <xref ref-type="fig" rid="fig3">3C</xref>, <xref ref-type="fig" rid="fig4">4G</xref> and <xref ref-type="fig" rid="fig6">6D</xref>, the forward (5′-<named-content content-type="sequence">CCCAATCCATATGACTAGTAGATCC</named-content>-3′) and reverse (5′- <named-content content-type="sequence">TGTAGGTAGTTTGTCCAATTATGTCA</named-content>-3′) primers were used. Both of the abovementioned primer pairs recognize sequences downstream of the G<sub>4</sub>C<sub>2</sub> repeats. For <italic>gal4</italic> mRNA quantification, the forward (5′-<named-content content-type="sequence">TTGAAATCGCGTCGAAGGA</named-content>-3′) and reverse (5′-<named-content content-type="sequence">GGCTCCAATGGCTAATATGCA</named-content>-3′) primers were used (<xref ref-type="bibr" rid="bib39">Li et al., 2008</xref>). Data were analyzed using the standard curve method. The amounts of G<sub>4</sub>C<sub>2</sub> repeat transcripts were normalized to those of <italic>gal4</italic> transcripts expressed in the same tissue to avoid potential confounding derived from the difference in tissue viability between genotypes. At least three independent biological replicates per genotype were analyzed. Data were normalized by setting the values of the samples from flies expressing (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub>(H) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>), both (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub>(H) and <italic>EGFP</italic> (<xref ref-type="fig" rid="fig1">Figures 1E</xref>, <xref ref-type="fig" rid="fig3">3C</xref> and <xref ref-type="fig" rid="fig6">6D</xref>), or both (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub>(H) and <italic>GFP-IR</italic> (<xref ref-type="fig" rid="fig4">Figure 4G</xref>) as 100.</p></sec><sec id="s4-4"><title>Imaging and quantification of fly eyes</title><p>Light microscopic images of the eyes of 3- to 5-day-old female flies were taken using a stereoscopic microscope model SZX10 (Olympus) with a CCD camera DP21 (Olympus). Images shown are representative eye phenotypes of the fly crosses. Crosses were performed three times to validate the specific phenotypes. Eye size and pigmentation were quantified as previously reported (<xref ref-type="bibr" rid="bib58">Saitoh et al., 2015</xref>). 5 or 10 eyes per genotype were analyzed. Data were normalized by setting the values of samples from flies expressing one copy of <italic>EGFP</italic> (<xref ref-type="fig" rid="fig4">Figure 4D</xref>), those expressing two copies of <italic>EGFP</italic> (<xref ref-type="fig" rid="fig1">Figures 1B–D</xref>–<xref ref-type="fig" rid="fig2">2B, C,</xref>, <xref ref-type="fig" rid="fig6">6B and C</xref>, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B–D</xref>, and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B–D</xref>), or those expressing both <italic>EGFP</italic> and <italic>GFP-IR</italic> (<xref ref-type="fig" rid="fig4">Figure 4B</xref>), as 100.</p></sec><sec id="s4-5"><title>Egg-to-adult viability of flies</title><p>Mated female flies were placed on grape juice agar with yeast paste for 24 hr. Eggs were collected from the surface of the grape juice agar, and the number of eggs was counted and placed on new standard fly food. After eclosion, the number of adult flies was counted. Egg-to-adult viability was calculated by dividing the number of adult flies by the number of eggs. More than 500 eggs per genotype were used. Data were normalized by setting the values of samples from flies expressing two copies of EGFP as 100 (<xref ref-type="fig" rid="fig2">Figure 2D</xref>).</p></sec><sec id="s4-6"><title>Climbing assay</title><p>Twenty male flies were gently introduced into a glass vial. After a 5 min adaptation period, the bottom of the vial was gently tapped and the height the flies reached in 10 s was recorded using a digital video camera, and scored as follows: 0 (lower than 2 cm), 1 (from 2 to 3.9 cm), 2 (from 4 to 5.9 cm), 3 (from 6 to 7.9 cm), 4 (from 8 to 9.9 cm), and 5 (higher than 10 cm). Five trials were performed in each experiment at intervals of 20 s. The assay was performed between 8:00 and 10:00. Climbing scores were calculated as an average of five trials.</p></sec><sec id="s4-7"><title>GeneSwitch experiments</title><p>Flies were crossed in the absence of RU486 (mifepristone) on standard fly food. 1-day-old adult male flies were transferred to Formula 4-24 Instant <italic>Drosophila</italic> medium (Wako) with RU486 (100 µg/mL) for the indicated periods. Every 2 or 3 d, flies were transferred to new medium with RU486. Climbing assays were performed at 0, 7, and 14 d after the start of RU486 treatment (<xref ref-type="fig" rid="fig2">Figure 2E</xref>).</p></sec><sec id="s4-8"><title>RNA fluorescence in situ hybridization</title><p>Female third-instar larvae were dissected in ice-cold phosphate-buffered saline (PBS). Salivary glands were fixed with 4% paraformaldehyde (PFA) (pH 7.0) in PBS for 30 min and incubated in 100% methanol. Fixed samples were rehydrated in 75% (v/v), 50%, and 25% ethanol in PBS, and rinsed in PBS and distilled water (DW). Samples were then treated with 0.2 N HCl/DW for 20 min at room temperature (RT) and rinsed in DW. Next, the samples were permeabilized with 0.2% Triton X-100 in PBS for 10 min, rinsed in PBS for 5 min, fixed again in 4% PFA in PBS for 20 min, then washed twice for 5 min each in PBS, and incubated twice for 15 min each in 2 mg/mL glycine/PBS. After the acetylation treatment, samples were incubated for 1 hr at 37°C in hybridization buffer consisting of 50% formamide, 2× saline sodium citrate (SSC), 0.2 mg/mL yeast tRNA, and 0.5 mg/mL heparin. For hybridization, samples were incubated overnight at 80°C with a 5′ end Alexa 594-labeled (G<sub>2</sub>C<sub>4</sub>)<sub>4</sub> or Alexa 488-labeled (C<sub>2</sub>G<sub>4</sub>)<sub>4</sub> locked nucleic acid (LNA) probe (5 nM) in hybridization buffer. These LNA probes were synthesized by GeneDesign Inc. After the hybridization, samples were washed once for 5 min in 4× SSC at 80°C, three times for 20 min each in 2× SSC and 50% formamide at 80°C, three times for 40 min each in 0.1× SSC at 80°C, and once for 5 min in PBS containing 0.5% Triton X-100 (PBT) at RT. Nuclei were stained with 4',6-diamidino-2-phenylindole (DAPI) or 2'-(4-ethoxyphenyl)–5-(4-methyl-1-piperazinyl)–2,5'-bi-1-<italic>H</italic>-benzimidazole, trihydrochloride (Hoechst 33342). Stained samples were mounted in SlowFade Gold antifade reagent (Thermo Fisher Scientific) and observed under a Zeiss LSM710 or LSM880 confocal laser-scanning microscope.</p><p>After RNA FISH, samples were scanned using a Zeiss LSM710 or LSM880 confocal laser-scanning microscope along the z-axis direction. One z-stack image was taken per salivary gland using ZEN imaging software (Zeiss). RNA foci-positive nuclei in more than 30 cells per salivary gland were counted, and the percentage of nuclei containing RNA foci in the salivary gland was calculated. Ten salivary glands were analyzed for each genotype.</p></sec><sec id="s4-9"><title>Immunohistochemistry</title><p>Female third-instar larvae were dissected in ice-cold PBS. Eye imaginal discs and salivary glands were fixed with 4% PFA in PBS for 30 min and washed three times with PBT. After blocking with 5% goat serum/PBT, the samples were incubated overnight at 4°C with a rat monoclonal anti-poly(GR) antibody (clone 5A2, MABN778, Millipore), a mouse monoclonal anti-poly(GA) antibody (clone 5E9, MABN889, Millipore), a rabbit polyclonal anti-poly(GA) antibody (CAC-TIP-C9-P01, Cosmo Bio), a rabbit polyclonal anti-poly(GP) antibody (NBP2-25018, Novus Biologicals), or a rabbit polyclonal anti-FUS antibody (A300-302A, Bethyl Laboratories) at 1:1000 dilution as the primary antibody. After washing three times with PBT, the samples were incubated with an Alexa 633-conjugated anti-rat antibody (A-21094, Thermo Fisher Scientific), or an Alexa 488-conjugated or Alexa 555-conjugated anti-rabbit antibody (A-11008 or A-21428, respectively, Thermo Fisher Scientific) at 1:500 dilution as the secondary antibody. After washing three times with PBT, nuclei were stained with DAPI or Hoechst 33342. Stained samples were mounted in SlowFade Gold antifade reagent and observed using confocal laser-scanning microscopes (LSM710, LSM880 [Zeiss], and FV3000 [Olympus]).</p><p>The number of DPR aggregates in the eye discs was quantitatively measured using ZEN imaging software (Zeiss) and ImageJ (<xref ref-type="bibr" rid="bib59">Schneider et al., 2012</xref>), as follows: (1) selection of photoreceptor neurons within the 13 developing ommatidia in rows 2 and 3 at the posterior end of the eye discs (<xref ref-type="bibr" rid="bib58">Saitoh et al., 2015</xref>) by DAPI or Hoechst 33342 staining because these ommatidia are at similar stages of development and can be easily identified; and (2) counting of the number of DPR aggregates with a diameter of larger than 2 µm in the cytoplasm. 10–15 eye discs were analyzed for each genotype.</p></sec><sec id="s4-10"><title>Measurement of poly(GP) protein levels</title><p>The heads of 5-day-old female flies expressing both (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub>(H) and either <italic>EGFP</italic>, <italic>FUS</italic>, or <italic>FUS-RRMmut</italic> using the <italic>GMR-Gal4</italic> driver were collected and stored at –80°C. Samples were prepared using a previously reported method (<xref ref-type="bibr" rid="bib68">Tran et al., 2015</xref>). Poly(GP) levels were measured by a sandwich immunoassay that uses Meso Scale Discovery electrochemiluminescence detection technology, as described previously (<xref ref-type="bibr" rid="bib64">Su et al., 2014</xref>). Data were normalized by setting the values of samples from flies expressing (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>89</sub>(H) and <italic>EGFP</italic> (<xref ref-type="fig" rid="fig3">Figure 3F</xref>) as 100.</p></sec><sec id="s4-11"><title>Western blotting</title><p>To assess the expression levels of FUS and FUS-RRMmut (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>), or GR-GFP (<xref ref-type="fig" rid="fig3">Figure 3G–I</xref>), 10 heads of 5-day-old female flies expressing <italic>FUS</italic> or <italic>FUS-RRMmut</italic>, or both <italic>LDS</italic>-(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>44</sub><sup>GR-GFP</sup> and either <italic>FUS</italic> or <italic>FUS-RRMmut</italic> using the <italic>GMR-Gal4</italic> driver were homogenized in 100 µL of sodium dodecyl sulfate (SDS) sample buffer using a pestle, boiled for 5 min, and centrifuged at 10,000 × <italic>g</italic> for 3 min at 25°C. 5 µL of each supernatant were run on a 5–20% gradient polyacrylamide gel (Wako) and then transferred onto an Immun-Blot polyvinylidene fluoride membrane (Bio-Rad). Membranes were blocked with 5% skim milk in PBS containing 0.1% Tween-20 (PBST) or PVDF Blocking Reagent for Can Get Signal (TOYOBO) for 2 hr at RT, and then incubated overnight at 4°C with a rabbit polyclonal anti-FUS antibody (A300-302A, Bethyl Laboratories), a rat monoclonal anti-poly(GR) antibody (clone 5A2, MABN778, Millipore), a Living Colors EGFP mouse monoclonal antibody (632569, Clontech), or a mouse monoclonal anti-actin antibody (clone AC-40, A4700, Sigma-Aldrich) at 1:1000 dilution as the primary antibody. After washing three times with PBST, membranes were incubated for 2 hr at RT with either HRP-conjugated anti-rat, anti-rabbit, or anti-mouse antibody (31470, 31460, or 31430, respectively, Invitrogen) at 1:5000 dilution as the secondary antibody, washed three times with PBST, treated with SuperSignal West Dura chemiluminescent substrate (Thermo Fisher Scientific), and imaged using the LuminoGraphII imaging system (ATTO). Data were normalized by setting the average values of samples from flies expressing <italic>FUS</italic> (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>) or those expressing both <italic>LDS</italic>-(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>44</sub><sup>GR-GFP</sup> and <italic>DsRed</italic> as 100 (<xref ref-type="fig" rid="fig3">Figure 3H and I</xref>).</p></sec><sec id="s4-12"><title>Filter binding assay</title><p>For preparation of FUS proteins with an N-terminal His tag (His-FUS and His-FUS-RRMmut), cDNAs of the human FUS protein (wild type or RRM mutant) from pUAST-<italic>FUS</italic> or pUAST-<italic>FUS-RRMmut</italic> were cloned into the multiple cloning site (<italic>Xho</italic>I and <italic>Bam</italic>HI) of the plasmid vector pET-15b (Novagen) (<xref ref-type="bibr" rid="bib52">Nomura et al., 2014</xref>). After transfection of the plasmids into <italic>E. coli</italic> BL21 (DE3), the expression of His-FUS proteins was induced by culturing the transformed cells in the presence of 0.5 mM isopropyl β-<italic>D</italic>-thiogalactopyranoside (IPTG) at 20°C for 20 hr. Cells were lysed by ultrasonication in PBS (pH 7.4) containing 2% (v/v) Triton X-100, 1 M NaCl, DNase I, MgSO<sub>4</sub>, and ethylenediaminetetraacetic acid-free cOmplete Protease Inhibitor Cocktail (Roche Applied Sciences). After centrifugation at 20,000 × <italic>g</italic> for 30 min at 4°C, the pellets were redissolved in a buffer (pH 7.0) containing 6 M guanidine hydrochloride (GdnHCl), 50 mM Tris, and 1 M NaCl. His-FUS proteins in the pellets were purified by Ni<sup>2+</sup> affinity chromatography. In brief, the His-FUS proteins were mixed with Profinity IMAC Ni<sup>2+</sup>-charged resin (Bio-Rad) for 30 min at 20°C. Then, FUS proteins bound to the resin were washed with wash buffer (6 M GdnHCl, 50 mM Tris, and 1 M NaCl, pH 7.0), and eluted with elution buffer (6 M GdnHCl, 50 mM Tris, 100 mM NaCl, and 250 mM imidazole, pH 7.0). For preparation of soluble, refolded FUS, FUS proteins (200 μM) in the elution buffer were diluted 20-fold with a buffer (pH 7.0) containing 50 mM Tris, 100 mM NaCl, 10% (v/v) glycerol, and 5 mM Tris (2-carboxyethyl) phosphine (buffer A), which, however, produced significant amounts of precipitate. This insoluble material was removed by centrifugation at 20,000 × <italic>g</italic> for 10 min at 4°C, resulting in the recovery of soluble FUS proteins in the supernatant fraction. Protein concentrations were spectroscopically determined from the absorbance at 280 nm using the following extinction coefficients: 71,630 cm<sup>−1</sup> M<sup>−1</sup> for both FUS and FUS-RRMmut.</p><p>Biotinylated RNAs were synthesized by GeneDesign Inc. 10 nM biotin-(G<sub>4</sub>C<sub>2</sub>)<sub>4</sub>, 10 nM biotin-(AAAAAA)<sub>4</sub>, or 10 nM biotin-(UUAGGG)<sub>4</sub> (telomeric repeat-containing RNA: TERRA) were incubated with soluble FUS proteins (5, 10, or 50 nM) in buffer A with 0.4 U/µL RNase inhibitor (RNasin Plus RNase Inhibitor, Promega). Biotinylated (AAAAAA)<sub>4</sub> and TERRA are negative and positive controls, respectively. After an hour at RT, the mixture was filtered through a nitrocellulose membrane (PROTRAN, 0.2 μm, Amersham Biosciences) overlaid on a nylon membrane (Hybond-N<sup>+</sup>, 0.45 μm, Schleicher &amp; Schuell) in a 96-well slot-blot apparatus (ATTO) (<xref ref-type="bibr" rid="bib17">Furukawa et al., 2011</xref>). After extensive washing of the membranes with buffer A, the bound RNAs were crosslinked to the membranes using ultraviolet radiation (254 nm; UV Stratalinker, Stratagene) at an energy level of 0.12 J. After blocking with 3% (w/v) BSA in Tris-buffered saline with 0.1% Tween-20, the membranes were incubated with streptavidin-HRP (1:5000; Nacalai Tesque), and the biotinylated RNAs on the membranes were detected with ImmunoStar LD reagent (Wako).</p></sec><sec id="s4-13"><title>Preparation of recombinant FUS protein</title><p>For preparation of the FUS proteins, the human <italic>FUS</italic> (WT) and <italic>FUS-RRMmut</italic> genes flanked at the 5′ end with an <italic>Nde</italic>I recognition site and at the 3′ end with a <italic>Xho</italic>I recognition site was amplified by PCR from pUAST-<italic>FUS</italic> and pUAST- <italic>FUS-RRMmut</italic>, respectively. PCR fragments were digested with <italic>Nde</italic>I and <italic>Xho</italic>I. These fragments were ligated into the cloning sites of the plasmid vector pET-21b (Novagen) between <italic>Nde</italic>I and <italic>Xho</italic>I. After transfection of the plasmids into <italic>E. coli</italic> BL21 (DE3), expression of the FUS protein was induced by culturing the transformed cells in the presence of 0.5 mM IPTG at 37°C for 6 hr. Cells were harvested by centrifugation and suspended with buffer B (10% glycerol, 20 mM 4-(2-hydroxyethyl)–1-piperazineethanesulfonic acid [HEPES]-NaOH [pH 7.0], 300 mM NaCl, 1 mM dithiothreitol [DTT], 1 mM ethylenediaminetetraacetic acid [EDTA], 0.1% Tween-20, and 0.1% benzamidine hydrochloride) containing 1.5 mg/mL lysozyme, and stored for 30 min on ice. Cell lysates were sonicated, and insoluble protein was collected by centrifugation. The pellet was solubilized in buffer C (6 M urea, 10% glycerol, 20 mM HEPES-NaOH [pH 7.0], 1 mM DTT, 1 mM EDTA, and 0.1% benzamidine hydrochloride). After centrifugation, supernatants were loaded onto a DE52 (GE Healthcare) open column. The flow-through fraction was loaded onto a CM52 (GE Healthcare) open column. The flow-through fraction of DE52 was applied to a CAPTO S column (GE Healthcare), and the flow-through fraction was collected using the ÄKTAexplorer 10S/100 system (GE Healthcare). The flow-through fraction was applied to a Mono S column (GE Healthcare). Proteins were fractionated with a 0–500 mM linear gradient of NaCl in buffer D (6 M urea, 10% glycerol, 20 mM HEPES-NaOH [pH 7.0], 1 mM DTT, and 1 mM EDTA) using ÄKTA explorer 10S/100 system. The FUS fraction was eluted at 150–200 mM NaCl. For refolding, the eluted peak fraction was diluted fivefold using refolding buffer (900 mM arginine, 100 mM N-cyclohexyl-2-hydroxyl-3-aminopropanesulfonic acid [pH 9.5], 0.3 mM reduced glutathione, 0.03 mM oxidized glutathione, and 1 mM ZnCl<sub>2</sub>), and stored overnight at RT. The solution was concentrated using a centrifugal filter (Vivaspin 6–10 kDa; GE Healthcare) to 1–2 mg/mL, and then dialyzed against buffer E (10% glycerol, 20 mM HEPES-NaOH [pH 6.8], 300 mM NaCl, 0.1 mM EDTA, and 10 mM β-cyclodextrin), and stored frozen at −80°C.</p></sec><sec id="s4-14"><title>Surface plasmon resonance analyses</title><p>The binding of FUS to (G<sub>4</sub>C<sub>2</sub>)<sub>4</sub> RNA was analyzed using a Biacore T200 instrument (GE Healthcare). (G<sub>4</sub>C<sub>2</sub>)<sub>4</sub> RNAs biotinylated at the 5′ end in 10 mM HEPES pH 6.8 and 500 mM MCl (M=K, Na, or Li) was injected over the streptavidin-coated surface of a sensor chip SA (GE Healthcare). The amount of immobilized RNA was as follows: 240 resonance unit (RU) in KCl, 363 RU in NaCl, or 319 RU in LiCl buffer condition. Binding experiments were performed using the single-cycle kinetics method. The running buffer used was 20 mM HEPES (pH 6.8), 1 mM MgCl<sub>2</sub>, 0.05% Tween-20, and 150 mM KCl, NaCl, or LiCl. FUS was diluted in the running buffer and injected sequentially over the RNA-immobilized sensor surface in increasing concentrations (0.016, 0.031, 0.063, 0.13, or 0.25 µM). Sensorgrams were obtained at 25°C, 30 µL/min flow rate, 60 s of contact time, and 120 s of dissociation time.</p></sec><sec id="s4-15"><title>Circular dichroism spectroscopy</title><p>CD spectra were measured at 25°C using a spectropolarimeter model J-820 (JASCO). (G<sub>4</sub>C<sub>2</sub>)<sub>4</sub> RNA was synthesized by GeneDesign Inc and dissolved in 20 mM HEPES (pH 6.8), 18.75 mM NaCl, 10 mM MgCl<sub>2</sub>, 0.625% glycerol, 0.625 mM β-cyclodextrin, and 0.0625 mM EDTA with 150 mM KCl, NaCl, or LiCl. RNA samples containing 150 mM KCl were first heated at 95°C for 5 min and then cooled to RT to form the G-quadruplex structure. The other samples were not heated. FUS (1 μM) was added to the RNA sample (4 μM) and mixed before recording the spectrum. CD spectra were recorded at a speed of 50 nm min<sup>–1</sup> and a resolution of 1 nm, and 10 scans were averaged.</p></sec><sec id="s4-16"><title>Nuclear magnetic resonance spectroscopy</title><p>All one-dimensional <sup>1</sup>H NMR spectral data were recorded using AVANCE III 800 MHz NMR spectrometers equipped with a TXI cryogenic probe (Bruker BioSpin) at 25°C. (G<sub>4</sub>C<sub>2</sub>)<sub>4</sub> RNA dissolved in 20 mM HEPES (pH 6.8), 150 mM KCl, 18.75 mM NaCl, 10 mM MgCl<sub>2</sub>, 0.625% glycerol, 0.625 mM β-cyclodextrin, and 0.0625 mM EDTA was first heated at 95°C for 5 min and then cooled to room temperature to form the G-quadruplex structure. The RNA (10 μM) was mixed with FUS at molar ratios (RNA:FUS) of 1:0, 1:0.2, 1:0.4, and 0:1. The samples were then prepared at a final concentration of 10% D<sub>2</sub>O before recording their spectra. <sup>1</sup>H NMR data were acquired using simple single 90° hard-pulse excitations following solvent signal suppression with a jump-and-return pulse scheme. Free induction decay data (1600 points in total) were collected by repeating the scans (2600 times) with an interscan delay of 2.5 s. All NMR data were processed using Topspin 3.6 software (Bruker BioSpin).</p></sec><sec id="s4-17"><title>RNA synthesis for in vitro translation</title><p>For preparation of the C9-RAN reporter plasmid, the pEF6-<italic>C9orf72</italic> intron1-(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>80</sub> vector was digested with <italic>HindIII</italic> and <italic>NotI</italic> to obtain the fragment <italic>C9orf72</italic> intron1-(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>80</sub> and subcloned into the pcDNA5/FRT vector (Thermo Fisher Scientific). To add the T7 promoter upstream of the <italic>C9orf72</italic> intron 1 sequence in this pcDNA5/FRT-<italic>C9orf72</italic> intron1-(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>80</sub> vector, a forward primer including T7 promoter sequences with the 5′-terminal region of <italic>C9orf72</italic> intron 1 flanked at the 5′ end with an <italic>HindIII</italic> recognition site, and a reverse primer recognizing the 3′-terminal region of <italic>C9orf72</italic> intron 1 sequences including a <italic>BssHII</italic> recognition site were designed, and used to amplify a fragment containing <italic>C9orf72</italic> intron 1 with a T7 promoter by PCR. Then, this fragment was subcloned into the pcDNA5/FRT-<italic>C9orf72</italic> intron1-(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>80</sub> vector digested by <italic>HindIII</italic> and <italic>BssHII</italic>. In addition to the T7 promoter, the Myc tag in the GA frame downstream of (<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>80</sub> was introduced into this vector.</p><p>The reporter plasmids were linearized with <italic>XbaI</italic>. Linearized DNA was in vitro transcribed using mMESSAGE mMACHINE T7 Transcription Kit (Invitrogen) according to the manufacturer’s instructions. T7 reactions were carried out at 37°C for 2 hr, treated with TURBO DNaseI for 15 min at 37°C to remove the DNA template, and then polyadenylated with <italic>E. coli</italic> Poly-A Polymerase (NEB) for 1 hr at 37°C. Synthesized mRNAs were purified by LiCl precipitation. The size and quality of the synthesized mRNAs were verified on a denaturing RNA gel.</p></sec><sec id="s4-18"><title>In vitro translation assay</title><p>mRNAs of <italic>C9orf72</italic> intron1-(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>80</sub> with a Myc tag in the GA frame were in vitro translated with Flexi Rabbit Reticulocyte Lysate System (Promega) according to the manufacturer’s instructions. Translation reactions were performed with 10 ng/μL mRNA and contained 30% rabbit reticulocyte lysate, 10 μM amino-acid mix minus methionine, 10 μM amino-acid mix minus leucine, 0.5 mM MgOAc, 100 mM KCl, and 0.8 U/μL Murine RNAse Inhibitor (NEB). FUS or FUS-RRMmut at each concentration (10, 100, 200, 400, and 1000 nM) was preincubated with mRNA for 10 min to facilitate the interaction between FUS protein and G<sub>4</sub>C<sub>2</sub> repeat RNA, and added for translation in the lysate. Samples were incubated at 30°C for 90 min before termination by incubation on ice. 10 μL of samples were analyzed by 13% SDS-polyacrylamide gel electrophoresis and western blotting using a mouse monoclonal anti-c-Myc antibody (clone 9E10, Wako) as the primary antibody.</p></sec><sec id="s4-19"><title>Quantification and statistical analysis</title><p>Statistical parameters including the definitions and exact values of n (e.g. number of experiments, number of flies, number of eye imaginal discs, etc.), distributions, and deviations are stated in the figures and corresponding figure legends. Multiple-comparison tests using one-way ANOVA with Tukey’s post hoc analysis were performed for <xref ref-type="fig" rid="fig1">Figures 1B–E</xref>—<xref ref-type="fig" rid="fig4">4B, D,</xref>, <xref ref-type="fig" rid="fig6">6B–D, F</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C and D</xref>, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B–D</xref>, and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B–D</xref>, multiple-comparison test using two-way repeated measures ANOVA with Tukey’s post hoc analysis was performed for <xref ref-type="fig" rid="fig2">Figure 2E</xref>, and the unpaired <italic>t</italic>-test was used for <xref ref-type="fig" rid="fig4">Figures 4F, G, I</xref>, <xref ref-type="fig" rid="fig5">5G</xref>, and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>. Differences in means were considered statistically significant at p&lt;0.05. All statistical analyses were performed using GraphPad Prism version 8.3.4 (GraphPad Software, LLC).</p><p>As the sample sizes used in this study were similar to previous publications (<xref ref-type="bibr" rid="bib15">Freibaum et al., 2015</xref>; <xref ref-type="bibr" rid="bib22">Goodman et al., 2019</xref>; <xref ref-type="bibr" rid="bib47">Mizielinska et al., 2014</xref>; <xref ref-type="bibr" rid="bib75">Xu et al., 2013</xref>), statistical analyses were performed afterward without interim data analysis. Data were not excluded and were collected and processed randomly. Sample collection and analyses for the measurement of poly(GP) protein levels were performed in a double-blind manner. Data collection and analyses for other experiments were not performed in a blind manner regarding the conditions of the experiments.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>He previously belonged to the Department of Neurotherapeutics, Osaka University Graduate School of Medicine, that is an endowment department supported by Nihon Medi-Physics Co., AbbVie GK., Otsuka Pharm Co., Kyowakai Med. Co., Fujiikai Med. Co., Yukioka Hosp., Osaka Gyoumeikan Hosp., Kyorin Co., and Tokuyukai Med. Co</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Resources, Data curation, Formal analysis, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con3"><p>Conceptualization</p></fn><fn fn-type="con" id="con4"><p>Data curation, Formal analysis, Investigation, Visualization, Methodology</p></fn><fn fn-type="con" id="con5"><p>Resources, Data curation, Formal analysis, Investigation, Visualization, Methodology</p></fn><fn fn-type="con" id="con6"><p>Data curation, Formal analysis, Investigation, Visualization, Methodology</p></fn><fn fn-type="con" id="con7"><p>Data curation, Formal analysis, Investigation, Visualization, Methodology</p></fn><fn fn-type="con" id="con8"><p>Resources, Data curation, Formal analysis, Funding acquisition, Investigation, Visualization, Methodology</p></fn><fn fn-type="con" id="con9"><p>Data curation, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con10"><p>Resources, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology</p></fn><fn fn-type="con" id="con11"><p>Resources, Data curation, Formal analysis, Investigation, Visualization, Methodology</p></fn><fn fn-type="con" id="con12"><p>Supervision</p></fn><fn fn-type="con" id="con13"><p>Resources</p></fn><fn fn-type="con" id="con14"><p>Resources</p></fn><fn fn-type="con" id="con15"><p>Investigation</p></fn><fn fn-type="con" id="con16"><p>Supervision</p></fn><fn fn-type="con" id="con17"><p>Supervision, Funding acquisition</p></fn><fn fn-type="con" id="con18"><p>Supervision, Funding acquisition</p></fn><fn fn-type="con" id="con19"><p>Supervision</p></fn><fn fn-type="con" id="con20"><p>Supervision</p></fn><fn fn-type="con" id="con21"><p>Supervision</p></fn><fn fn-type="con" id="con22"><p>Supervision</p></fn><fn fn-type="con" id="con23"><p>Supervision</p></fn><fn fn-type="con" id="con24"><p>Supervision</p></fn><fn fn-type="con" id="con25"><p>Resources, Supervision</p></fn><fn fn-type="con" id="con26"><p>Supervision</p></fn><fn fn-type="con" id="con27"><p>Supervision</p></fn><fn fn-type="con" id="con28"><p>Supervision</p></fn><fn fn-type="con" id="con29"><p>Conceptualization, Supervision, Funding acquisition, Validation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Full genotypes of the fly lines and their cultured temperatures.</title></caption><media xlink:href="elife-84338-supp1-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-84338-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Drs E Storkebaum (Radboud University), N Bonini (University of Pennsylvania), and B McCabe (École Polytechnique Fédérale de Lausanne) for kindly providing the <italic>caz</italic> mutant, <italic>UAS-LDS</italic>-(<italic>G<sub>4</sub>C<sub>2</sub></italic>)<sub>44</sub><sup>GR-GFP</sup>, and <italic>UAS-FLAG-caz</italic> and <italic>UAS-FLAG-FUS</italic> flies, respectively. We acknowledge Bloomington <italic>Drosophila</italic> Stock Center and Vienna <italic>Drosophila</italic> Resource Center for providing various fly stocks. We thank Drs H Imataka and K Machida (University of Hyogo) for kindly providing human tRNAs for in vitro translation. We also thank the members of our laboratory for helpful discussions, K Yamamoto, E Wakisaka, T Yamashita, and A Sugai for their technical assistance, Dr. H Akiko Popiel for critical reading and English editing of the manuscript, and the Center for Medical Research and Education, Graduate School of Medicine, Osaka University, for supplying experimental equipment.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ash</surname><given-names>PEA</given-names></name><name><surname>Bieniek</surname><given-names>KF</given-names></name><name><surname>Gendron</surname><given-names>TF</given-names></name><name><surname>Caulfield</surname><given-names>T</given-names></name><name><surname>Lin</surname><given-names>W-L</given-names></name><name><surname>Dejesus-Hernandez</surname><given-names>M</given-names></name><name><surname>van Blitterswijk</surname><given-names>MM</given-names></name><name><surname>Jansen-West</surname><given-names>K</given-names></name><name><surname>Paul</surname><given-names>JW</given-names></name><name><surname>Rademakers</surname><given-names>R</given-names></name><name><surname>Boylan</surname><given-names>KB</given-names></name><name><surname>Dickson</surname><given-names>DW</given-names></name><name><surname>Petrucelli</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Unconventional translation of C9Orf72 GGGGCC expansion generates insoluble Polypeptides specific to C9Ftd/ALS</article-title><source>Neuron</source><volume>77</volume><fpage>639</fpage><lpage>646</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.02.004</pub-id><pub-id pub-id-type="pmid">23415312</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bajc Česnik</surname><given-names>A</given-names></name><name><surname>Darovic</surname><given-names>S</given-names></name><name><surname>Prpar Mihevc</surname><given-names>S</given-names></name><name><surname>Štalekar</surname><given-names>M</given-names></name><name><surname>Malnar</surname><given-names>M</given-names></name><name><surname>Motaln</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>YB</given-names></name><name><surname>Mazej</surname><given-names>J</given-names></name><name><surname>Pohleven</surname><given-names>J</given-names></name><name><surname>Grosch</surname><given-names>M</given-names></name><name><surname>Modic</surname><given-names>M</given-names></name><name><surname>Fonovič</surname><given-names>M</given-names></name><name><surname>Turk</surname><given-names>B</given-names></name><name><surname>Drukker</surname><given-names>M</given-names></name><name><surname>Shaw</surname><given-names>CE</given-names></name><name><surname>Rogelj</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Nuclear RNA foci from <italic>C9Orf72</italic> expansion Mutation form Paraspeckle-like bodies</article-title><source>Journal of Cell Science</source><volume>132</volume><elocation-id>jcs224303</elocation-id><pub-id pub-id-type="doi">10.1242/jcs.224303</pub-id><pub-id pub-id-type="pmid">30745340</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boivin</surname><given-names>M</given-names></name><name><surname>Pfister</surname><given-names>V</given-names></name><name><surname>Gaucherot</surname><given-names>A</given-names></name><name><surname>Ruffenach</surname><given-names>F</given-names></name><name><surname>Negroni</surname><given-names>L</given-names></name><name><surname>Sellier</surname><given-names>C</given-names></name><name><surname>Charlet-Berguerand</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Reduced Autophagy upon C9Orf72 loss Synergizes with Dipeptide repeat protein toxicity in G4C2 repeat expansion disorders</article-title><source>The EMBO Journal</source><volume>39</volume><elocation-id>e100574</elocation-id><pub-id pub-id-type="doi">10.15252/embj.2018100574</pub-id><pub-id pub-id-type="pmid">31930538</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Celona</surname><given-names>B</given-names></name><name><surname>Crinò</surname><given-names>C</given-names></name><name><surname>Giudice</surname><given-names>E</given-names></name><name><surname>Pietro</surname><given-names>SD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Evaluation of Pericardial effusion in dogs and successful treatment using a Hemodialysis Fistula needle: A retrospective study</article-title><source>Topics in Companion Animal Medicine</source><volume>32</volume><fpage>72</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1053/j.tcam.2017.08.004</pub-id><pub-id pub-id-type="pmid">28992908</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Mestre</surname><given-names>AA</given-names></name><name><surname>Fu</surname><given-names>C</given-names></name><name><surname>Makarem</surname><given-names>A</given-names></name><name><surname>Xian</surname><given-names>F</given-names></name><name><surname>Hayes</surname><given-names>LR</given-names></name><name><surname>Lopez-Gonzalez</surname><given-names>R</given-names></name><name><surname>Drenner</surname><given-names>K</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Cleveland</surname><given-names>DW</given-names></name><name><surname>Sun</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>C9Orf72 GGGGCC repeat-associated non-AUG translation is upregulated by stress through Eif2Α Phosphorylation</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>51</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-02495-z</pub-id><pub-id pub-id-type="pmid">29302060</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Morgens</surname><given-names>DW</given-names></name><name><surname>Hayes</surname><given-names>LR</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Portz</surname><given-names>B</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Nguyen</surname><given-names>BV</given-names></name><name><surname>Haney</surname><given-names>MS</given-names></name><name><surname>Yan</surname><given-names>S</given-names></name><name><surname>Dong</surname><given-names>D</given-names></name><name><surname>Coyne</surname><given-names>AN</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Xian</surname><given-names>F</given-names></name><name><surname>Cleveland</surname><given-names>DW</given-names></name><name><surname>Qiu</surname><given-names>Z</given-names></name><name><surname>Rothstein</surname><given-names>JD</given-names></name><name><surname>Shorter</surname><given-names>J</given-names></name><name><surname>Gao</surname><given-names>FB</given-names></name><name><surname>Bassik</surname><given-names>MC</given-names></name><name><surname>Sun</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>CRISPR-Cas9 screens identify the RNA Helicase Ddx3X as a Repressor of C9Orf72 (GGGGCC)N repeat-associated non-AUG translation</article-title><source>Neuron</source><volume>104</volume><fpage>885</fpage><lpage>898</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2019.09.003</pub-id><pub-id pub-id-type="pmid">31587919</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>SY</given-names></name><name><surname>Lopez-Gonzalez</surname><given-names>R</given-names></name><name><surname>Krishnan</surname><given-names>G</given-names></name><name><surname>Phillips</surname><given-names>HL</given-names></name><name><surname>Li</surname><given-names>AN</given-names></name><name><surname>Seeley</surname><given-names>WW</given-names></name><name><surname>Yao</surname><given-names>WD</given-names></name><name><surname>Almeida</surname><given-names>S</given-names></name><name><surname>Gao</surname><given-names>FB</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>C9Orf72-ALS/FTD-associated Poly(GR) binds Atp5A1 and compromises mitochondrial function in vivo</article-title><source>Nature Neuroscience</source><volume>22</volume><fpage>851</fpage><lpage>862</lpage><pub-id pub-id-type="doi">10.1038/s41593-019-0397-0</pub-id><pub-id pub-id-type="pmid">31086314</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conlon</surname><given-names>EG</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Sharma</surname><given-names>A</given-names></name><name><surname>Yamazaki</surname><given-names>T</given-names></name><name><surname>Tang</surname><given-names>T</given-names></name><name><surname>Shneider</surname><given-names>NA</given-names></name><name><surname>Manley</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The C9Orf72 GGGGCC expansion forms RNA G-Quadruplex inclusions and Sequesters hnRNP H to disrupt splicing in ALS brains</article-title><source>eLife</source><volume>5</volume><elocation-id>e17820</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.17820</pub-id><pub-id pub-id-type="pmid">27623008</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper-Knock</surname><given-names>J</given-names></name><name><surname>Walsh</surname><given-names>MJ</given-names></name><name><surname>Higginbottom</surname><given-names>A</given-names></name><name><surname>Robin Highley</surname><given-names>J</given-names></name><name><surname>Dickman</surname><given-names>MJ</given-names></name><name><surname>Edbauer</surname><given-names>D</given-names></name><name><surname>Ince</surname><given-names>PG</given-names></name><name><surname>Wharton</surname><given-names>SB</given-names></name><name><surname>Wilson</surname><given-names>SA</given-names></name><name><surname>Kirby</surname><given-names>J</given-names></name><name><surname>Hautbergue</surname><given-names>GM</given-names></name><name><surname>Shaw</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Sequestration of multiple RNA recognition motif-containing proteins by C9Orf72 repeat expansions</article-title><source>Brain</source><volume>137</volume><fpage>2040</fpage><lpage>2051</lpage><pub-id pub-id-type="doi">10.1093/brain/awu120</pub-id><pub-id pub-id-type="pmid">24866055</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daigle</surname><given-names>JG</given-names></name><name><surname>Lanson</surname><given-names>NA</given-names></name><name><surname>Smith</surname><given-names>RB</given-names></name><name><surname>Casci</surname><given-names>I</given-names></name><name><surname>Maltare</surname><given-names>A</given-names></name><name><surname>Monaghan</surname><given-names>J</given-names></name><name><surname>Nichols</surname><given-names>CD</given-names></name><name><surname>Kryndushkin</surname><given-names>D</given-names></name><name><surname>Shewmaker</surname><given-names>F</given-names></name><name><surname>Pandey</surname><given-names>UB</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic Mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations</article-title><source>Human Molecular Genetics</source><volume>22</volume><fpage>1193</fpage><lpage>1205</lpage><pub-id pub-id-type="doi">10.1093/hmg/dds526</pub-id><pub-id pub-id-type="pmid">23257289</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeJesus-Hernandez</surname><given-names>M</given-names></name><name><surname>Mackenzie</surname><given-names>IR</given-names></name><name><surname>Boeve</surname><given-names>BF</given-names></name><name><surname>Boxer</surname><given-names>AL</given-names></name><name><surname>Baker</surname><given-names>M</given-names></name><name><surname>Rutherford</surname><given-names>NJ</given-names></name><name><surname>Nicholson</surname><given-names>AM</given-names></name><name><surname>Finch</surname><given-names>NA</given-names></name><name><surname>Flynn</surname><given-names>H</given-names></name><name><surname>Adamson</surname><given-names>J</given-names></name><name><surname>Kouri</surname><given-names>N</given-names></name><name><surname>Wojtas</surname><given-names>A</given-names></name><name><surname>Sengdy</surname><given-names>P</given-names></name><name><surname>Hsiung</surname><given-names>GYR</given-names></name><name><surname>Karydas</surname><given-names>A</given-names></name><name><surname>Seeley</surname><given-names>WW</given-names></name><name><surname>Josephs</surname><given-names>KA</given-names></name><name><surname>Coppola</surname><given-names>G</given-names></name><name><surname>Geschwind</surname><given-names>DH</given-names></name><name><surname>Wszolek</surname><given-names>ZK</given-names></name><name><surname>Feldman</surname><given-names>H</given-names></name><name><surname>Knopman</surname><given-names>DS</given-names></name><name><surname>Petersen</surname><given-names>RC</given-names></name><name><surname>Miller</surname><given-names>BL</given-names></name><name><surname>Dickson</surname><given-names>DW</given-names></name><name><surname>Boylan</surname><given-names>KB</given-names></name><name><surname>Graff-Radford</surname><given-names>NR</given-names></name><name><surname>Rademakers</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Expanded GGGGCC hexanucleotide repeat in noncoding region of C9Orf72 causes chromosome 9p-linked FTD and ALS</article-title><source>Neuron</source><volume>72</volume><fpage>245</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.09.011</pub-id><pub-id pub-id-type="pmid">21944778</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donnelly</surname><given-names>CJ</given-names></name><name><surname>Zhang</surname><given-names>PW</given-names></name><name><surname>Pham</surname><given-names>JT</given-names></name><name><surname>Haeusler</surname><given-names>AR</given-names></name><name><surname>Mistry</surname><given-names>NA</given-names></name><name><surname>Vidensky</surname><given-names>S</given-names></name><name><surname>Daley</surname><given-names>EL</given-names></name><name><surname>Poth</surname><given-names>EM</given-names></name><name><surname>Hoover</surname><given-names>B</given-names></name><name><surname>Fines</surname><given-names>DM</given-names></name><name><surname>Maragakis</surname><given-names>N</given-names></name><name><surname>Tienari</surname><given-names>PJ</given-names></name><name><surname>Petrucelli</surname><given-names>L</given-names></name><name><surname>Traynor</surname><given-names>BJ</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Rigo</surname><given-names>F</given-names></name><name><surname>Bennett</surname><given-names>CF</given-names></name><name><surname>Blackshaw</surname><given-names>S</given-names></name><name><surname>Sattler</surname><given-names>R</given-names></name><name><surname>Rothstein</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>RNA toxicity from the ALS/FTD C9Orf72 expansion is mitigated by Antisense intervention</article-title><source>Neuron</source><volume>80</volume><fpage>415</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.10.015</pub-id><pub-id pub-id-type="pmid">24139042</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dumas</surname><given-names>L</given-names></name><name><surname>Herviou</surname><given-names>P</given-names></name><name><surname>Dassi</surname><given-names>E</given-names></name><name><surname>Cammas</surname><given-names>A</given-names></name><name><surname>Millevoi</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>G-Quadruplexes in RNA biology: recent advances and future directions</article-title><source>Trends in Biochemical Sciences</source><volume>46</volume><fpage>270</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2020.11.001</pub-id><pub-id pub-id-type="pmid">33303320</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fratta</surname><given-names>P</given-names></name><name><surname>Mizielinska</surname><given-names>S</given-names></name><name><surname>Nicoll</surname><given-names>AJ</given-names></name><name><surname>Zloh</surname><given-names>M</given-names></name><name><surname>Fisher</surname><given-names>EMC</given-names></name><name><surname>Parkinson</surname><given-names>G</given-names></name><name><surname>Isaacs</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>C9Orf72 Hexanucleotide repeat associated with Amyotrophic lateral sclerosis and Frontotemporal dementia forms RNA G-Quadruplexes</article-title><source>Scientific Reports</source><volume>2</volume><elocation-id>1016</elocation-id><pub-id pub-id-type="doi">10.1038/srep01016</pub-id><pub-id pub-id-type="pmid">23264878</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freibaum</surname><given-names>BD</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Lopez-Gonzalez</surname><given-names>R</given-names></name><name><surname>Kim</surname><given-names>NC</given-names></name><name><surname>Almeida</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>KH</given-names></name><name><surname>Badders</surname><given-names>N</given-names></name><name><surname>Valentine</surname><given-names>M</given-names></name><name><surname>Miller</surname><given-names>BL</given-names></name><name><surname>Wong</surname><given-names>PC</given-names></name><name><surname>Petrucelli</surname><given-names>L</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Gao</surname><given-names>FB</given-names></name><name><surname>Taylor</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>GGGGCC repeat expansion in C9Orf72 compromises Nucleocytoplasmic transport</article-title><source>Nature</source><volume>525</volume><fpage>129</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1038/nature14974</pub-id><pub-id pub-id-type="pmid">26308899</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frickenhaus</surname><given-names>M</given-names></name><name><surname>Wagner</surname><given-names>M</given-names></name><name><surname>Mallik</surname><given-names>M</given-names></name><name><surname>Catinozzi</surname><given-names>M</given-names></name><name><surname>Storkebaum</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Highly efficient cell-type-specific gene inactivation reveals a key function for the <italic>Drosophila</italic> FUS Homolog Cabeza in neurons</article-title><source>Scientific Reports</source><volume>5</volume><elocation-id>9107</elocation-id><pub-id pub-id-type="doi">10.1038/srep09107</pub-id><pub-id pub-id-type="pmid">25772687</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furukawa</surname><given-names>Y</given-names></name><name><surname>Kaneko</surname><given-names>K</given-names></name><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Yamanaka</surname><given-names>K</given-names></name><name><surname>Nukina</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A seeding reaction Recapitulates intracellular formation of Sarkosyl-insoluble Transactivation response element (TAR) DNA-binding Protein-43 inclusions</article-title><source>The Journal of Biological Chemistry</source><volume>286</volume><fpage>18664</fpage><lpage>18672</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.231209</pub-id><pub-id pub-id-type="pmid">21454603</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geissler</surname><given-names>R</given-names></name><name><surname>Simkin</surname><given-names>A</given-names></name><name><surname>Floss</surname><given-names>D</given-names></name><name><surname>Patel</surname><given-names>R</given-names></name><name><surname>Fogarty</surname><given-names>EA</given-names></name><name><surname>Scheller</surname><given-names>J</given-names></name><name><surname>Grimson</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A widespread sequence-specific mRNA decay pathway mediated by hnRNPs A1 and A2/B1</article-title><source>Genes &amp; Development</source><volume>30</volume><fpage>1070</fpage><lpage>1085</lpage><pub-id pub-id-type="doi">10.1101/gad.277392.116</pub-id><pub-id pub-id-type="pmid">27151978</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gendron</surname><given-names>TF</given-names></name><name><surname>Bieniek</surname><given-names>KF</given-names></name><name><surname>Zhang</surname><given-names>YJ</given-names></name><name><surname>Jansen-West</surname><given-names>K</given-names></name><name><surname>Ash</surname><given-names>PEA</given-names></name><name><surname>Caulfield</surname><given-names>T</given-names></name><name><surname>Daughrity</surname><given-names>L</given-names></name><name><surname>Dunmore</surname><given-names>JH</given-names></name><name><surname>Castanedes-Casey</surname><given-names>M</given-names></name><name><surname>Chew</surname><given-names>J</given-names></name><name><surname>Cosio</surname><given-names>DM</given-names></name><name><surname>van Blitterswijk</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>WC</given-names></name><name><surname>Rademakers</surname><given-names>R</given-names></name><name><surname>Boylan</surname><given-names>KB</given-names></name><name><surname>Dickson</surname><given-names>DW</given-names></name><name><surname>Petrucelli</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Antisense transcripts of the expanded C9Orf72 Hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in C9Ftd/ALS</article-title><source>Acta Neuropathologica</source><volume>126</volume><fpage>829</fpage><lpage>844</lpage><pub-id pub-id-type="doi">10.1007/s00401-013-1192-8</pub-id><pub-id pub-id-type="pmid">24129584</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gendron</surname><given-names>TF</given-names></name><name><surname>Chew</surname><given-names>J</given-names></name><name><surname>Stankowski</surname><given-names>JN</given-names></name><name><surname>Hayes</surname><given-names>LR</given-names></name><name><surname>Zhang</surname><given-names>YJ</given-names></name><name><surname>Prudencio</surname><given-names>M</given-names></name><name><surname>Carlomagno</surname><given-names>Y</given-names></name><name><surname>Daughrity</surname><given-names>LM</given-names></name><name><surname>Jansen-West</surname><given-names>K</given-names></name><name><surname>Perkerson</surname><given-names>EA</given-names></name><name><surname>O’Raw</surname><given-names>A</given-names></name><name><surname>Cook</surname><given-names>C</given-names></name><name><surname>Pregent</surname><given-names>L</given-names></name><name><surname>Belzil</surname><given-names>V</given-names></name><name><surname>van Blitterswijk</surname><given-names>M</given-names></name><name><surname>Tabassian</surname><given-names>LJ</given-names></name><name><surname>Lee</surname><given-names>CW</given-names></name><name><surname>Yue</surname><given-names>M</given-names></name><name><surname>Tong</surname><given-names>J</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Castanedes-Casey</surname><given-names>M</given-names></name><name><surname>Rousseau</surname><given-names>L</given-names></name><name><surname>Phillips</surname><given-names>V</given-names></name><name><surname>Dickson</surname><given-names>DW</given-names></name><name><surname>Rademakers</surname><given-names>R</given-names></name><name><surname>Fryer</surname><given-names>JD</given-names></name><name><surname>Rush</surname><given-names>BK</given-names></name><name><surname>Pedraza</surname><given-names>O</given-names></name><name><surname>Caputo</surname><given-names>AM</given-names></name><name><surname>Desaro</surname><given-names>P</given-names></name><name><surname>Palmucci</surname><given-names>C</given-names></name><name><surname>Robertson</surname><given-names>A</given-names></name><name><surname>Heckman</surname><given-names>MG</given-names></name><name><surname>Diehl</surname><given-names>NN</given-names></name><name><surname>Wiggs</surname><given-names>E</given-names></name><name><surname>Tierney</surname><given-names>M</given-names></name><name><surname>Braun</surname><given-names>L</given-names></name><name><surname>Farren</surname><given-names>J</given-names></name><name><surname>Lacomis</surname><given-names>D</given-names></name><name><surname>Ladha</surname><given-names>S</given-names></name><name><surname>Fournier</surname><given-names>CN</given-names></name><name><surname>McCluskey</surname><given-names>LF</given-names></name><name><surname>Elman</surname><given-names>LB</given-names></name><name><surname>Toledo</surname><given-names>JB</given-names></name><name><surname>McBride</surname><given-names>JD</given-names></name><name><surname>Tiloca</surname><given-names>C</given-names></name><name><surname>Morelli</surname><given-names>C</given-names></name><name><surname>Poletti</surname><given-names>B</given-names></name><name><surname>Solca</surname><given-names>F</given-names></name><name><surname>Prelle</surname><given-names>A</given-names></name><name><surname>Wuu</surname><given-names>J</given-names></name><name><surname>Jockel-Balsarotti</surname><given-names>J</given-names></name><name><surname>Rigo</surname><given-names>F</given-names></name><name><surname>Ambrose</surname><given-names>C</given-names></name><name><surname>Datta</surname><given-names>A</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Raitcheva</surname><given-names>D</given-names></name><name><surname>Antognetti</surname><given-names>G</given-names></name><name><surname>McCampbell</surname><given-names>A</given-names></name><name><surname>Van Swieten</surname><given-names>JC</given-names></name><name><surname>Miller</surname><given-names>BL</given-names></name><name><surname>Boxer</surname><given-names>AL</given-names></name><name><surname>Brown</surname><given-names>RH</given-names></name><name><surname>Bowser</surname><given-names>R</given-names></name><name><surname>Miller</surname><given-names>TM</given-names></name><name><surname>Trojanowski</surname><given-names>JQ</given-names></name><name><surname>Grossman</surname><given-names>M</given-names></name><name><surname>Berry</surname><given-names>JD</given-names></name><name><surname>Hu</surname><given-names>WT</given-names></name><name><surname>Ratti</surname><given-names>A</given-names></name><name><surname>Traynor</surname><given-names>BJ</given-names></name><name><surname>Disney</surname><given-names>MD</given-names></name><name><surname>Benatar</surname><given-names>M</given-names></name><name><surname>Silani</surname><given-names>V</given-names></name><name><surname>Glass</surname><given-names>JD</given-names></name><name><surname>Floeter</surname><given-names>MK</given-names></name><name><surname>Rothstein</surname><given-names>JD</given-names></name><name><surname>Boylan</surname><given-names>KB</given-names></name><name><surname>Petrucelli</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Poly(GP) proteins are a useful pharmacodynamic marker for <italic>C9Orf72</italic>-Associated Amyotrophic lateral sclerosis</article-title><source>Science Translational Medicine</source><volume>9</volume><elocation-id>eaai7866</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.aai7866</pub-id><pub-id pub-id-type="pmid">28356511</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gijselinck</surname><given-names>I</given-names></name><name><surname>Van Langenhove</surname><given-names>T</given-names></name><name><surname>van der Zee</surname><given-names>J</given-names></name><name><surname>Sleegers</surname><given-names>K</given-names></name><name><surname>Philtjens</surname><given-names>S</given-names></name><name><surname>Kleinberger</surname><given-names>G</given-names></name><name><surname>Janssens</surname><given-names>J</given-names></name><name><surname>Bettens</surname><given-names>K</given-names></name><name><surname>Van Cauwenberghe</surname><given-names>C</given-names></name><name><surname>Pereson</surname><given-names>S</given-names></name><name><surname>Engelborghs</surname><given-names>S</given-names></name><name><surname>Sieben</surname><given-names>A</given-names></name><name><surname>De Jonghe</surname><given-names>P</given-names></name><name><surname>Vandenberghe</surname><given-names>R</given-names></name><name><surname>Santens</surname><given-names>P</given-names></name><name><surname>De Bleecker</surname><given-names>J</given-names></name><name><surname>Maes</surname><given-names>G</given-names></name><name><surname>Bäumer</surname><given-names>V</given-names></name><name><surname>Dillen</surname><given-names>L</given-names></name><name><surname>Joris</surname><given-names>G</given-names></name><name><surname>Cuijt</surname><given-names>I</given-names></name><name><surname>Corsmit</surname><given-names>E</given-names></name><name><surname>Elinck</surname><given-names>E</given-names></name><name><surname>Van Dongen</surname><given-names>J</given-names></name><name><surname>Vermeulen</surname><given-names>S</given-names></name><name><surname>Van den Broeck</surname><given-names>M</given-names></name><name><surname>Vaerenberg</surname><given-names>C</given-names></name><name><surname>Mattheijssens</surname><given-names>M</given-names></name><name><surname>Peeters</surname><given-names>K</given-names></name><name><surname>Robberecht</surname><given-names>W</given-names></name><name><surname>Cras</surname><given-names>P</given-names></name><name><surname>Martin</surname><given-names>JJ</given-names></name><name><surname>De Deyn</surname><given-names>PP</given-names></name><name><surname>Cruts</surname><given-names>M</given-names></name><name><surname>Van Broeckhoven</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A C9Orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the Frontotemporal Lobar degeneration-Amyotrophic lateral sclerosis spectrum: a gene identification study</article-title><source>The Lancet. Neurology</source><volume>11</volume><fpage>54</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(11)70261-7</pub-id><pub-id pub-id-type="pmid">22154785</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodman</surname><given-names>LD</given-names></name><name><surname>Prudencio</surname><given-names>M</given-names></name><name><surname>Kramer</surname><given-names>NJ</given-names></name><name><surname>Martinez-Ramirez</surname><given-names>LF</given-names></name><name><surname>Srinivasan</surname><given-names>AR</given-names></name><name><surname>Lan</surname><given-names>M</given-names></name><name><surname>Parisi</surname><given-names>MJ</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Chew</surname><given-names>J</given-names></name><name><surname>Cook</surname><given-names>CN</given-names></name><name><surname>Berson</surname><given-names>A</given-names></name><name><surname>Gitler</surname><given-names>AD</given-names></name><name><surname>Petrucelli</surname><given-names>L</given-names></name><name><surname>Bonini</surname><given-names>NM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Toxic expanded GGGGCC repeat transcription is mediated by the Paf1 complex in C9Orf72-associated FTD</article-title><source>Nature Neuroscience</source><volume>22</volume><fpage>863</fpage><lpage>874</lpage><pub-id pub-id-type="doi">10.1038/s41593-019-0396-1</pub-id><pub-id pub-id-type="pmid">31110321</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>KM</given-names></name><name><surname>Glineburg</surname><given-names>MR</given-names></name><name><surname>Kearse</surname><given-names>MG</given-names></name><name><surname>Flores</surname><given-names>BN</given-names></name><name><surname>Linsalata</surname><given-names>AE</given-names></name><name><surname>Fedak</surname><given-names>SJ</given-names></name><name><surname>Goldstrohm</surname><given-names>AC</given-names></name><name><surname>Barmada</surname><given-names>SJ</given-names></name><name><surname>Todd</surname><given-names>PK</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>RAN translation at C9Orf72-associated repeat expansions is selectively enhanced by the integrated stress response</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>2005</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-02200-0</pub-id><pub-id pub-id-type="pmid">29222490</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haeusler</surname><given-names>AR</given-names></name><name><surname>Donnelly</surname><given-names>CJ</given-names></name><name><surname>Periz</surname><given-names>G</given-names></name><name><surname>Simko</surname><given-names>EAJ</given-names></name><name><surname>Shaw</surname><given-names>PG</given-names></name><name><surname>Kim</surname><given-names>MS</given-names></name><name><surname>Maragakis</surname><given-names>NJ</given-names></name><name><surname>Troncoso</surname><given-names>JC</given-names></name><name><surname>Pandey</surname><given-names>A</given-names></name><name><surname>Sattler</surname><given-names>R</given-names></name><name><surname>Rothstein</surname><given-names>JD</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>C9Orf72 nucleotide repeat structures initiate molecular cascades of disease</article-title><source>Nature</source><volume>507</volume><fpage>195</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1038/nature13124</pub-id><pub-id pub-id-type="pmid">24598541</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardin</surname><given-names>CC</given-names></name><name><surname>Watson</surname><given-names>T</given-names></name><name><surname>Corregan</surname><given-names>M</given-names></name><name><surname>Bailey</surname><given-names>C</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Cation-dependent transition between the Quadruplex and Watson-crick hairpin forms of D(Cgcg3Gcg)</article-title><source>Biochemistry</source><volume>31</volume><fpage>833</fpage><lpage>841</lpage><pub-id pub-id-type="doi">10.1021/bi00118a028</pub-id><pub-id pub-id-type="pmid">1731941</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hubstenberger</surname><given-names>A</given-names></name><name><surname>Courel</surname><given-names>M</given-names></name><name><surname>Bénard</surname><given-names>M</given-names></name><name><surname>Souquere</surname><given-names>S</given-names></name><name><surname>Ernoult-Lange</surname><given-names>M</given-names></name><name><surname>Chouaib</surname><given-names>R</given-names></name><name><surname>Yi</surname><given-names>Z</given-names></name><name><surname>Morlot</surname><given-names>JB</given-names></name><name><surname>Munier</surname><given-names>A</given-names></name><name><surname>Fradet</surname><given-names>M</given-names></name><name><surname>Daunesse</surname><given-names>M</given-names></name><name><surname>Bertrand</surname><given-names>E</given-names></name><name><surname>Pierron</surname><given-names>G</given-names></name><name><surname>Mozziconacci</surname><given-names>J</given-names></name><name><surname>Kress</surname><given-names>M</given-names></name><name><surname>Weil</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>P-body purification reveals the condensation of repressed mRNA Regulons</article-title><source>Molecular Cell</source><volume>68</volume><fpage>144</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.09.003</pub-id><pub-id pub-id-type="pmid">28965817</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutten</surname><given-names>S</given-names></name><name><surname>Usluer</surname><given-names>S</given-names></name><name><surname>Bourgeois</surname><given-names>B</given-names></name><name><surname>Simonetti</surname><given-names>F</given-names></name><name><surname>Odeh</surname><given-names>HM</given-names></name><name><surname>Fare</surname><given-names>CM</given-names></name><name><surname>Czuppa</surname><given-names>M</given-names></name><name><surname>Hruska-Plochan</surname><given-names>M</given-names></name><name><surname>Hofweber</surname><given-names>M</given-names></name><name><surname>Polymenidou</surname><given-names>M</given-names></name><name><surname>Shorter</surname><given-names>J</given-names></name><name><surname>Edbauer</surname><given-names>D</given-names></name><name><surname>Madl</surname><given-names>T</given-names></name><name><surname>Dormann</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Nuclear import receptors directly bind to arginine-rich Dipeptide repeat proteins and suppress their pathological interactions</article-title><source>Cell Reports</source><volume>33</volume><elocation-id>108538</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.108538</pub-id><pub-id pub-id-type="pmid">33357437</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishiguro</surname><given-names>T</given-names></name><name><surname>Sato</surname><given-names>N</given-names></name><name><surname>Ueyama</surname><given-names>M</given-names></name><name><surname>Fujikake</surname><given-names>N</given-names></name><name><surname>Sellier</surname><given-names>C</given-names></name><name><surname>Kanegami</surname><given-names>A</given-names></name><name><surname>Tokuda</surname><given-names>E</given-names></name><name><surname>Zamiri</surname><given-names>B</given-names></name><name><surname>Gall-Duncan</surname><given-names>T</given-names></name><name><surname>Mirceta</surname><given-names>M</given-names></name><name><surname>Furukawa</surname><given-names>Y</given-names></name><name><surname>Yokota</surname><given-names>T</given-names></name><name><surname>Wada</surname><given-names>K</given-names></name><name><surname>Taylor</surname><given-names>JP</given-names></name><name><surname>Pearson</surname><given-names>CE</given-names></name><name><surname>Charlet-Berguerand</surname><given-names>N</given-names></name><name><surname>Mizusawa</surname><given-names>H</given-names></name><name><surname>Nagai</surname><given-names>Y</given-names></name><name><surname>Ishikawa</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Regulatory role of RNA chaperone TDP-43 for RNA Misfolding and repeat-associated translation in Sca31</article-title><source>Neuron</source><volume>94</volume><fpage>108</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.02.046</pub-id><pub-id pub-id-type="pmid">28343865</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jovičić</surname><given-names>A</given-names></name><name><surname>Mertens</surname><given-names>J</given-names></name><name><surname>Boeynaems</surname><given-names>S</given-names></name><name><surname>Bogaert</surname><given-names>E</given-names></name><name><surname>Chai</surname><given-names>N</given-names></name><name><surname>Yamada</surname><given-names>SB</given-names></name><name><surname>Paul</surname><given-names>JW</given-names></name><name><surname>Sun</surname><given-names>S</given-names></name><name><surname>Herdy</surname><given-names>JR</given-names></name><name><surname>Bieri</surname><given-names>G</given-names></name><name><surname>Kramer</surname><given-names>NJ</given-names></name><name><surname>Gage</surname><given-names>FH</given-names></name><name><surname>Van Den Bosch</surname><given-names>L</given-names></name><name><surname>Robberecht</surname><given-names>W</given-names></name><name><surname>Gitler</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Modifiers of C9Orf72 Dipeptide repeat toxicity connect Nucleocytoplasmic transport defects to FTD/ALS</article-title><source>Nature Neuroscience</source><volume>18</volume><fpage>1226</fpage><lpage>1229</lpage><pub-id pub-id-type="doi">10.1038/nn.4085</pub-id><pub-id pub-id-type="pmid">26308983</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanadia</surname><given-names>RN</given-names></name><name><surname>Shin</surname><given-names>J</given-names></name><name><surname>Yuan</surname><given-names>Y</given-names></name><name><surname>Beattie</surname><given-names>SG</given-names></name><name><surname>Wheeler</surname><given-names>TM</given-names></name><name><surname>Thornton</surname><given-names>CA</given-names></name><name><surname>Swanson</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Reversal of RNA Missplicing and Myotonia after Muscleblind overexpression in a mouse Poly(CUG) model for myotonic dystrophy</article-title><source>PNAS</source><volume>103</volume><fpage>11748</fpage><lpage>11753</lpage><pub-id pub-id-type="doi">10.1073/pnas.0604970103</pub-id><pub-id pub-id-type="pmid">16864772</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katahira</surname><given-names>J</given-names></name><name><surname>Miki</surname><given-names>T</given-names></name><name><surname>Takano</surname><given-names>K</given-names></name><name><surname>Maruhashi</surname><given-names>M</given-names></name><name><surname>Uchikawa</surname><given-names>M</given-names></name><name><surname>Tachibana</surname><given-names>T</given-names></name><name><surname>Yoneda</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Nuclear RNA export factor 7 is localized in processing bodies and neuronal RNA granules through interactions with shuttling hnRNPs</article-title><source>Nucleic Acids Research</source><volume>36</volume><fpage>616</fpage><lpage>628</lpage><pub-id pub-id-type="doi">10.1093/nar/gkm556</pub-id><pub-id pub-id-type="pmid">18063567</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnan</surname><given-names>G</given-names></name><name><surname>Raitcheva</surname><given-names>D</given-names></name><name><surname>Bartlett</surname><given-names>D</given-names></name><name><surname>Prudencio</surname><given-names>M</given-names></name><name><surname>McKenna-Yasek</surname><given-names>DM</given-names></name><name><surname>Douthwright</surname><given-names>C</given-names></name><name><surname>Oskarsson</surname><given-names>BE</given-names></name><name><surname>Ladha</surname><given-names>S</given-names></name><name><surname>King</surname><given-names>OD</given-names></name><name><surname>Barmada</surname><given-names>SJ</given-names></name><name><surname>Miller</surname><given-names>TM</given-names></name><name><surname>Bowser</surname><given-names>R</given-names></name><name><surname>Watts</surname><given-names>JK</given-names></name><name><surname>Petrucelli</surname><given-names>L</given-names></name><name><surname>Brown</surname><given-names>RH</given-names></name><name><surname>Kankel</surname><given-names>MW</given-names></name><name><surname>Gao</surname><given-names>FB</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Poly(GR) and Poly(GA) in cerebrospinal fluid as potential biomarkers for C9Orf72-ALS/FTD</article-title><source>Nature Communications</source><volume>13</volume><elocation-id>2799</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-022-30387-4</pub-id><pub-id pub-id-type="pmid">35589711</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwan</surname><given-names>T</given-names></name><name><surname>Thompson</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Noncanonical translation initiation in Eukaryotes</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>11</volume><elocation-id>a032672</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a032672</pub-id><pub-id pub-id-type="pmid">29959190</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>I</given-names></name><name><surname>Xiang</surname><given-names>S</given-names></name><name><surname>Kato</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Theodoropoulos</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Yun</surname><given-names>J</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>McKnight</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Poly-Dipeptides encoded by the C9Orf72 repeats bind nucleoli, impede RNA Biogenesis, and kill cells</article-title><source>Science</source><volume>345</volume><fpage>1139</fpage><lpage>1145</lpage><pub-id pub-id-type="doi">10.1126/science.1254917</pub-id><pub-id pub-id-type="pmid">25081482</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lagier-Tourenne</surname><given-names>C</given-names></name><name><surname>Polymenidou</surname><given-names>M</given-names></name><name><surname>Cleveland</surname><given-names>DW</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration</article-title><source>Human Molecular Genetics</source><volume>19</volume><fpage>R46</fpage><lpage>R64</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddq137</pub-id><pub-id pub-id-type="pmid">20400460</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>YB</given-names></name><name><surname>Chen</surname><given-names>HJ</given-names></name><name><surname>Peres</surname><given-names>JN</given-names></name><name><surname>Gomez-Deza</surname><given-names>J</given-names></name><name><surname>Attig</surname><given-names>J</given-names></name><name><surname>Stalekar</surname><given-names>M</given-names></name><name><surname>Troakes</surname><given-names>C</given-names></name><name><surname>Nishimura</surname><given-names>AL</given-names></name><name><surname>Scotter</surname><given-names>EL</given-names></name><name><surname>Vance</surname><given-names>C</given-names></name><name><surname>Adachi</surname><given-names>Y</given-names></name><name><surname>Sardone</surname><given-names>V</given-names></name><name><surname>Miller</surname><given-names>JW</given-names></name><name><surname>Smith</surname><given-names>BN</given-names></name><name><surname>Gallo</surname><given-names>JM</given-names></name><name><surname>Ule</surname><given-names>J</given-names></name><name><surname>Hirth</surname><given-names>F</given-names></name><name><surname>Rogelj</surname><given-names>B</given-names></name><name><surname>Houart</surname><given-names>C</given-names></name><name><surname>Shaw</surname><given-names>CE</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, Sequester RNA binding proteins, and are neurotoxic</article-title><source>Cell Reports</source><volume>5</volume><fpage>1178</fpage><lpage>1186</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2013.10.049</pub-id><pub-id pub-id-type="pmid">24290757</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KH</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Mitrea</surname><given-names>DM</given-names></name><name><surname>Sarkar</surname><given-names>M</given-names></name><name><surname>Freibaum</surname><given-names>BD</given-names></name><name><surname>Cika</surname><given-names>J</given-names></name><name><surname>Coughlin</surname><given-names>M</given-names></name><name><surname>Messing</surname><given-names>J</given-names></name><name><surname>Molliex</surname><given-names>A</given-names></name><name><surname>Maxwell</surname><given-names>BA</given-names></name><name><surname>Kim</surname><given-names>NC</given-names></name><name><surname>Temirov</surname><given-names>J</given-names></name><name><surname>Moore</surname><given-names>J</given-names></name><name><surname>Kolaitis</surname><given-names>RM</given-names></name><name><surname>Shaw</surname><given-names>TI</given-names></name><name><surname>Bai</surname><given-names>B</given-names></name><name><surname>Peng</surname><given-names>J</given-names></name><name><surname>Kriwacki</surname><given-names>RW</given-names></name><name><surname>Taylor</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>C9Orf72 Dipeptide repeats impair the assembly, Dynamics, and function of membrane-less organelles</article-title><source>Cell</source><volume>167</volume><fpage>774</fpage><lpage>788</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.10.002</pub-id><pub-id pub-id-type="pmid">27768896</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehmer</surname><given-names>C</given-names></name><name><surname>Oeckl</surname><given-names>P</given-names></name><name><surname>Weishaupt</surname><given-names>JH</given-names></name><name><surname>Volk</surname><given-names>AE</given-names></name><name><surname>Diehl-Schmid</surname><given-names>J</given-names></name><name><surname>Schroeter</surname><given-names>ML</given-names></name><name><surname>Lauer</surname><given-names>M</given-names></name><name><surname>Kornhuber</surname><given-names>J</given-names></name><name><surname>Levin</surname><given-names>J</given-names></name><name><surname>Fassbender</surname><given-names>K</given-names></name><name><surname>Landwehrmeyer</surname><given-names>B</given-names></name><collab>German Consortium for Frontotemporal Lobar Degeneration</collab><name><surname>Schludi</surname><given-names>MH</given-names></name><name><surname>Arzberger</surname><given-names>T</given-names></name><name><surname>Kremmer</surname><given-names>E</given-names></name><name><surname>Flatley</surname><given-names>A</given-names></name><name><surname>Feederle</surname><given-names>R</given-names></name><name><surname>Steinacker</surname><given-names>P</given-names></name><name><surname>Weydt</surname><given-names>P</given-names></name><name><surname>Ludolph</surname><given-names>AC</given-names></name><name><surname>Edbauer</surname><given-names>D</given-names></name><name><surname>Otto</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Poly-GP in cerebrospinal fluid links <italic>C9Orf72</italic>-Associated Dipeptide repeat expression to the asymptomatic phase of ALS/FTD</article-title><source>EMBO Molecular Medicine</source><volume>9</volume><fpage>859</fpage><lpage>868</lpage><pub-id pub-id-type="doi">10.15252/emmm.201607486</pub-id><pub-id pub-id-type="pmid">28408402</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>LB</given-names></name><name><surname>Yu</surname><given-names>Z</given-names></name><name><surname>Teng</surname><given-names>X</given-names></name><name><surname>Bonini</surname><given-names>NM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>RNA toxicity is a component of Ataxin-3 degeneration in <italic>Drosophila</italic></article-title><source>Nature</source><volume>453</volume><fpage>1107</fpage><lpage>1111</lpage><pub-id pub-id-type="doi">10.1038/nature06909</pub-id><pub-id pub-id-type="pmid">18449188</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Mori</surname><given-names>E</given-names></name><name><surname>Kato</surname><given-names>M</given-names></name><name><surname>Xiang</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Kwon</surname><given-names>I</given-names></name><name><surname>McKnight</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Toxic PR poly-Dipeptides encoded by the C9Orf72 repeat expansion target LC domain polymers</article-title><source>Cell</source><volume>167</volume><fpage>789</fpage><lpage>802</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.10.003</pub-id><pub-id pub-id-type="pmid">27768897</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Lu</surname><given-names>YN</given-names></name><name><surname>Paul</surname><given-names>T</given-names></name><name><surname>Periz</surname><given-names>G</given-names></name><name><surname>Banco</surname><given-names>MT</given-names></name><name><surname>Ferré-D’Amaré</surname><given-names>AR</given-names></name><name><surname>Rothstein</surname><given-names>JD</given-names></name><name><surname>Hayes</surname><given-names>LR</given-names></name><name><surname>Myong</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A Helicase Unwinds Hexanucleotide repeat RNA G-Quadruplexes and facilitates repeat-associated non-AUG translation</article-title><source>Journal of the American Chemical Society</source><volume>143</volume><fpage>7368</fpage><lpage>7379</lpage><pub-id pub-id-type="doi">10.1021/jacs.1c00131</pub-id><pub-id pub-id-type="pmid">33855846</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maharana</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Papadopoulos</surname><given-names>DK</given-names></name><name><surname>Richter</surname><given-names>D</given-names></name><name><surname>Pozniakovsky</surname><given-names>A</given-names></name><name><surname>Poser</surname><given-names>I</given-names></name><name><surname>Bickle</surname><given-names>M</given-names></name><name><surname>Rizk</surname><given-names>S</given-names></name><name><surname>Guillén-Boixet</surname><given-names>J</given-names></name><name><surname>Franzmann</surname><given-names>TM</given-names></name><name><surname>Jahnel</surname><given-names>M</given-names></name><name><surname>Marrone</surname><given-names>L</given-names></name><name><surname>Chang</surname><given-names>YT</given-names></name><name><surname>Sterneckert</surname><given-names>J</given-names></name><name><surname>Tomancak</surname><given-names>P</given-names></name><name><surname>Hyman</surname><given-names>AA</given-names></name><name><surname>Alberti</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>RNA buffers the phase separation behavior of Prion-like RNA binding proteins</article-title><source>Science</source><volume>360</volume><fpage>918</fpage><lpage>921</lpage><pub-id pub-id-type="doi">10.1126/science.aar7366</pub-id><pub-id pub-id-type="pmid">29650702</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malik</surname><given-names>I</given-names></name><name><surname>Kelley</surname><given-names>CP</given-names></name><name><surname>Wang</surname><given-names>ET</given-names></name><name><surname>Todd</surname><given-names>PK</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Author correction: molecular mechanisms underlying nucleotide repeat expansion disorders</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>22</volume><elocation-id>644</elocation-id><pub-id pub-id-type="doi">10.1038/s41580-021-00396-0</pub-id><pub-id pub-id-type="pmid">34230651</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mann</surname><given-names>JR</given-names></name><name><surname>Gleixner</surname><given-names>AM</given-names></name><name><surname>Mauna</surname><given-names>JC</given-names></name><name><surname>Gomes</surname><given-names>E</given-names></name><name><surname>DeChellis-Marks</surname><given-names>MR</given-names></name><name><surname>Needham</surname><given-names>PG</given-names></name><name><surname>Copley</surname><given-names>KE</given-names></name><name><surname>Hurtle</surname><given-names>B</given-names></name><name><surname>Portz</surname><given-names>B</given-names></name><name><surname>Pyles</surname><given-names>NJ</given-names></name><name><surname>Guo</surname><given-names>L</given-names></name><name><surname>Calder</surname><given-names>CB</given-names></name><name><surname>Wills</surname><given-names>ZP</given-names></name><name><surname>Pandey</surname><given-names>UB</given-names></name><name><surname>Kofler</surname><given-names>JK</given-names></name><name><surname>Brodsky</surname><given-names>JL</given-names></name><name><surname>Thathiah</surname><given-names>A</given-names></name><name><surname>Shorter</surname><given-names>J</given-names></name><name><surname>Donnelly</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>RNA binding Antagonizes neurotoxic phase transitions of TDP-43</article-title><source>Neuron</source><volume>102</volume><fpage>321</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2019.01.048</pub-id><pub-id pub-id-type="pmid">30826182</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>May</surname><given-names>S</given-names></name><name><surname>Hornburg</surname><given-names>D</given-names></name><name><surname>Schludi</surname><given-names>MH</given-names></name><name><surname>Arzberger</surname><given-names>T</given-names></name><name><surname>Rentzsch</surname><given-names>K</given-names></name><name><surname>Schwenk</surname><given-names>BM</given-names></name><name><surname>Grässer</surname><given-names>FA</given-names></name><name><surname>Mori</surname><given-names>K</given-names></name><name><surname>Kremmer</surname><given-names>E</given-names></name><name><surname>Banzhaf-Strathmann</surname><given-names>J</given-names></name><name><surname>Mann</surname><given-names>M</given-names></name><name><surname>Meissner</surname><given-names>F</given-names></name><name><surname>Edbauer</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>C9Orf72 FTLD/ALS-associated Gly-Ala Dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration</article-title><source>Acta Neuropathologica</source><volume>128</volume><fpage>485</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1007/s00401-014-1329-4</pub-id><pub-id pub-id-type="pmid">25120191</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitra</surname><given-names>I</given-names></name><name><surname>Huang</surname><given-names>B</given-names></name><name><surname>Mousavi</surname><given-names>N</given-names></name><name><surname>Ma</surname><given-names>N</given-names></name><name><surname>Lamkin</surname><given-names>M</given-names></name><name><surname>Yanicky</surname><given-names>R</given-names></name><name><surname>Shleizer-Burko</surname><given-names>S</given-names></name><name><surname>Lohmueller</surname><given-names>KE</given-names></name><name><surname>Gymrek</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Patterns of de novo Tandem repeat mutations and their role in autism</article-title><source>Nature</source><volume>589</volume><fpage>246</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-03078-7</pub-id><pub-id pub-id-type="pmid">33442040</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizielinska</surname><given-names>S</given-names></name><name><surname>Grönke</surname><given-names>S</given-names></name><name><surname>Niccoli</surname><given-names>T</given-names></name><name><surname>Ridler</surname><given-names>CE</given-names></name><name><surname>Clayton</surname><given-names>EL</given-names></name><name><surname>Devoy</surname><given-names>A</given-names></name><name><surname>Moens</surname><given-names>T</given-names></name><name><surname>Norona</surname><given-names>FE</given-names></name><name><surname>Woollacott</surname><given-names>IOC</given-names></name><name><surname>Pietrzyk</surname><given-names>J</given-names></name><name><surname>Cleverley</surname><given-names>K</given-names></name><name><surname>Nicoll</surname><given-names>AJ</given-names></name><name><surname>Pickering-Brown</surname><given-names>S</given-names></name><name><surname>Dols</surname><given-names>J</given-names></name><name><surname>Cabecinha</surname><given-names>M</given-names></name><name><surname>Hendrich</surname><given-names>O</given-names></name><name><surname>Fratta</surname><given-names>P</given-names></name><name><surname>Fisher</surname><given-names>EMC</given-names></name><name><surname>Partridge</surname><given-names>L</given-names></name><name><surname>Isaacs</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>C9Orf72 repeat expansions cause neurodegeneration in <italic>Drosophila</italic> through arginine-rich proteins</article-title><source>Science</source><volume>345</volume><fpage>1192</fpage><lpage>1194</lpage><pub-id pub-id-type="doi">10.1126/science.1256800</pub-id><pub-id pub-id-type="pmid">25103406</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>K</given-names></name><name><surname>Arzberger</surname><given-names>T</given-names></name><name><surname>Grässer</surname><given-names>FA</given-names></name><name><surname>Gijselinck</surname><given-names>I</given-names></name><name><surname>May</surname><given-names>S</given-names></name><name><surname>Rentzsch</surname><given-names>K</given-names></name><name><surname>Weng</surname><given-names>SM</given-names></name><name><surname>Schludi</surname><given-names>MH</given-names></name><name><surname>van der Zee</surname><given-names>J</given-names></name><name><surname>Cruts</surname><given-names>M</given-names></name><name><surname>Van Broeckhoven</surname><given-names>C</given-names></name><name><surname>Kremmer</surname><given-names>E</given-names></name><name><surname>Kretzschmar</surname><given-names>HA</given-names></name><name><surname>Haass</surname><given-names>C</given-names></name><name><surname>Edbauer</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2013">2013a</year><article-title>Bidirectional transcripts of the expanded C9Orf72 Hexanucleotide repeat are translated into aggregating Dipeptide repeat proteins</article-title><source>Acta Neuropathologica</source><volume>126</volume><fpage>881</fpage><lpage>893</lpage><pub-id pub-id-type="doi">10.1007/s00401-013-1189-3</pub-id><pub-id pub-id-type="pmid">24132570</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>K</given-names></name><name><surname>Lammich</surname><given-names>S</given-names></name><name><surname>Mackenzie</surname><given-names>IRA</given-names></name><name><surname>Forné</surname><given-names>I</given-names></name><name><surname>Zilow</surname><given-names>S</given-names></name><name><surname>Kretzschmar</surname><given-names>H</given-names></name><name><surname>Edbauer</surname><given-names>D</given-names></name><name><surname>Janssens</surname><given-names>J</given-names></name><name><surname>Kleinberger</surname><given-names>G</given-names></name><name><surname>Cruts</surname><given-names>M</given-names></name><name><surname>Herms</surname><given-names>J</given-names></name><name><surname>Neumann</surname><given-names>M</given-names></name><name><surname>Van Broeckhoven</surname><given-names>C</given-names></name><name><surname>Arzberger</surname><given-names>T</given-names></name><name><surname>Haass</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2013">2013b</year><article-title>hnRNP A3 binds to GGGGCC repeats and is a constituent of P62-positive/Tdp43-negative inclusions in the hippocampus of patients with C9Orf72 mutations</article-title><source>Acta Neuropathologica</source><volume>125</volume><fpage>413</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1007/s00401-013-1088-7</pub-id><pub-id pub-id-type="pmid">23381195</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>K</given-names></name><name><surname>Weng</surname><given-names>SM</given-names></name><name><surname>Arzberger</surname><given-names>T</given-names></name><name><surname>May</surname><given-names>S</given-names></name><name><surname>Rentzsch</surname><given-names>K</given-names></name><name><surname>Kremmer</surname><given-names>E</given-names></name><name><surname>Schmid</surname><given-names>B</given-names></name><name><surname>Kretzschmar</surname><given-names>HA</given-names></name><name><surname>Cruts</surname><given-names>M</given-names></name><name><surname>Van Broeckhoven</surname><given-names>C</given-names></name><name><surname>Haass</surname><given-names>C</given-names></name><name><surname>Edbauer</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2013">2013c</year><article-title>The C9Orf72 GGGGCC repeat is translated into aggregating Dipeptide-repeat proteins in FTLD/ALS</article-title><source>Science</source><volume>339</volume><fpage>1335</fpage><lpage>1338</lpage><pub-id pub-id-type="doi">10.1126/science.1232927</pub-id><pub-id pub-id-type="pmid">23393093</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>K</given-names></name><name><surname>Gotoh</surname><given-names>S</given-names></name><name><surname>Yamashita</surname><given-names>T</given-names></name><name><surname>Uozumi</surname><given-names>R</given-names></name><name><surname>Kawabe</surname><given-names>Y</given-names></name><name><surname>Tagami</surname><given-names>S</given-names></name><name><surname>Kamp</surname><given-names>F</given-names></name><name><surname>Nuscher</surname><given-names>B</given-names></name><name><surname>Edbauer</surname><given-names>D</given-names></name><name><surname>Haass</surname><given-names>C</given-names></name><name><surname>Nagai</surname><given-names>Y</given-names></name><name><surname>Ikeda</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The Porphyrin Tmpyp4 inhibits elongation during the Noncanonical translation of the FTLD/ALS-associated GGGGCC repeat in the C9Orf72 gene</article-title><source>The Journal of Biological Chemistry</source><volume>297</volume><elocation-id>101120</elocation-id><pub-id pub-id-type="doi">10.1016/j.jbc.2021.101120</pub-id><pub-id pub-id-type="pmid">34450161</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nomura</surname><given-names>T</given-names></name><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Kaneko</surname><given-names>K</given-names></name><name><surname>Yamanaka</surname><given-names>K</given-names></name><name><surname>Nukina</surname><given-names>N</given-names></name><name><surname>Furukawa</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Intranuclear aggregation of mutant FUS/TLS as a molecular Pathomechanism of Amyotrophic lateral sclerosis</article-title><source>The Journal of Biological Chemistry</source><volume>289</volume><fpage>1192</fpage><lpage>1202</lpage><pub-id pub-id-type="doi">10.1074/jbc.M113.516492</pub-id><pub-id pub-id-type="pmid">24280224</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozdilek</surname><given-names>BA</given-names></name><name><surname>Thompson</surname><given-names>VF</given-names></name><name><surname>Ahmed</surname><given-names>NS</given-names></name><name><surname>White</surname><given-names>CI</given-names></name><name><surname>Batey</surname><given-names>RT</given-names></name><name><surname>Schwartz</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Intrinsically disordered RGG/RG domains mediate degenerate specificity in RNA binding</article-title><source>Nucleic Acids Research</source><volume>45</volume><fpage>7984</fpage><lpage>7996</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx460</pub-id><pub-id pub-id-type="pmid">28575444</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajkowitsch</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Stampfl</surname><given-names>S</given-names></name><name><surname>Semrad</surname><given-names>K</given-names></name><name><surname>Waldsich</surname><given-names>C</given-names></name><name><surname>Mayer</surname><given-names>O</given-names></name><name><surname>Jantsch</surname><given-names>MF</given-names></name><name><surname>Konrat</surname><given-names>R</given-names></name><name><surname>Bläsi</surname><given-names>U</given-names></name><name><surname>Schroeder</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>RNA chaperones, RNA annealers and RNA helicases</article-title><source>RNA Biology</source><volume>4</volume><fpage>118</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.4161/rna.4.3.5445</pub-id><pub-id pub-id-type="pmid">18347437</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname><given-names>K</given-names></name><name><surname>Zamiri</surname><given-names>B</given-names></name><name><surname>Stanley</surname><given-names>SYR</given-names></name><name><surname>Macgregor</surname><given-names>RB</given-names></name><name><surname>Pearson</surname><given-names>CE</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The disease-associated R(GGGGCC)N repeat from the C9Orf72 gene forms tract length-dependent Uni- and Multimolecular RNA G-Quadruplex structures</article-title><source>The Journal of Biological Chemistry</source><volume>288</volume><fpage>9860</fpage><lpage>9866</lpage><pub-id pub-id-type="doi">10.1074/jbc.C113.452532</pub-id><pub-id pub-id-type="pmid">23423380</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renton</surname><given-names>AE</given-names></name><name><surname>Majounie</surname><given-names>E</given-names></name><name><surname>Waite</surname><given-names>A</given-names></name><name><surname>Simón-Sánchez</surname><given-names>J</given-names></name><name><surname>Rollinson</surname><given-names>S</given-names></name><name><surname>Gibbs</surname><given-names>JR</given-names></name><name><surname>Schymick</surname><given-names>JC</given-names></name><name><surname>Laaksovirta</surname><given-names>H</given-names></name><name><surname>van Swieten</surname><given-names>JC</given-names></name><name><surname>Myllykangas</surname><given-names>L</given-names></name><name><surname>Kalimo</surname><given-names>H</given-names></name><name><surname>Paetau</surname><given-names>A</given-names></name><name><surname>Abramzon</surname><given-names>Y</given-names></name><name><surname>Remes</surname><given-names>AM</given-names></name><name><surname>Kaganovich</surname><given-names>A</given-names></name><name><surname>Scholz</surname><given-names>SW</given-names></name><name><surname>Duckworth</surname><given-names>J</given-names></name><name><surname>Ding</surname><given-names>J</given-names></name><name><surname>Harmer</surname><given-names>DW</given-names></name><name><surname>Hernandez</surname><given-names>DG</given-names></name><name><surname>Johnson</surname><given-names>JO</given-names></name><name><surname>Mok</surname><given-names>K</given-names></name><name><surname>Ryten</surname><given-names>M</given-names></name><name><surname>Trabzuni</surname><given-names>D</given-names></name><name><surname>Guerreiro</surname><given-names>RJ</given-names></name><name><surname>Orrell</surname><given-names>RW</given-names></name><name><surname>Neal</surname><given-names>J</given-names></name><name><surname>Murray</surname><given-names>A</given-names></name><name><surname>Pearson</surname><given-names>J</given-names></name><name><surname>Jansen</surname><given-names>IE</given-names></name><name><surname>Sondervan</surname><given-names>D</given-names></name><name><surname>Seelaar</surname><given-names>H</given-names></name><name><surname>Blake</surname><given-names>D</given-names></name><name><surname>Young</surname><given-names>K</given-names></name><name><surname>Halliwell</surname><given-names>N</given-names></name><name><surname>Callister</surname><given-names>JB</given-names></name><name><surname>Toulson</surname><given-names>G</given-names></name><name><surname>Richardson</surname><given-names>A</given-names></name><name><surname>Gerhard</surname><given-names>A</given-names></name><name><surname>Snowden</surname><given-names>J</given-names></name><name><surname>Mann</surname><given-names>D</given-names></name><name><surname>Neary</surname><given-names>D</given-names></name><name><surname>Nalls</surname><given-names>MA</given-names></name><name><surname>Peuralinna</surname><given-names>T</given-names></name><name><surname>Jansson</surname><given-names>L</given-names></name><name><surname>Isoviita</surname><given-names>VM</given-names></name><name><surname>Kaivorinne</surname><given-names>AL</given-names></name><name><surname>Hölttä-Vuori</surname><given-names>M</given-names></name><name><surname>Ikonen</surname><given-names>E</given-names></name><name><surname>Sulkava</surname><given-names>R</given-names></name><name><surname>Benatar</surname><given-names>M</given-names></name><name><surname>Wuu</surname><given-names>J</given-names></name><name><surname>Chiò</surname><given-names>A</given-names></name><name><surname>Restagno</surname><given-names>G</given-names></name><name><surname>Borghero</surname><given-names>G</given-names></name><name><surname>Sabatelli</surname><given-names>M</given-names></name><collab>ITALSGEN Consortium</collab><name><surname>Heckerman</surname><given-names>D</given-names></name><name><surname>Rogaeva</surname><given-names>E</given-names></name><name><surname>Zinman</surname><given-names>L</given-names></name><name><surname>Rothstein</surname><given-names>JD</given-names></name><name><surname>Sendtner</surname><given-names>M</given-names></name><name><surname>Drepper</surname><given-names>C</given-names></name><name><surname>Eichler</surname><given-names>EE</given-names></name><name><surname>Alkan</surname><given-names>C</given-names></name><name><surname>Abdullaev</surname><given-names>Z</given-names></name><name><surname>Pack</surname><given-names>SD</given-names></name><name><surname>Dutra</surname><given-names>A</given-names></name><name><surname>Pak</surname><given-names>E</given-names></name><name><surname>Hardy</surname><given-names>J</given-names></name><name><surname>Singleton</surname><given-names>A</given-names></name><name><surname>Williams</surname><given-names>NM</given-names></name><name><surname>Heutink</surname><given-names>P</given-names></name><name><surname>Pickering-Brown</surname><given-names>S</given-names></name><name><surname>Morris</surname><given-names>HR</given-names></name><name><surname>Tienari</surname><given-names>PJ</given-names></name><name><surname>Traynor</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A Hexanucleotide repeat expansion in C9Orf72 is the cause of Chromosome 9P21-linked ALS-FTD</article-title><source>Neuron</source><volume>72</volume><fpage>257</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.09.010</pub-id><pub-id pub-id-type="pmid">21944779</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudich</surname><given-names>P</given-names></name><name><surname>Snoznik</surname><given-names>C</given-names></name><name><surname>Watkins</surname><given-names>SC</given-names></name><name><surname>Monaghan</surname><given-names>J</given-names></name><name><surname>Pandey</surname><given-names>UB</given-names></name><name><surname>Lamitina</surname><given-names>ST</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Nuclear localized C9Orf72-associated arginine-containing Dipeptides exhibit age-dependent toxicity in <italic>C. elegans</italic></article-title><source>Human Molecular Genetics</source><volume>26</volume><fpage>4916</fpage><lpage>4928</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddx372</pub-id><pub-id pub-id-type="pmid">29036691</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saitoh</surname><given-names>Y</given-names></name><name><surname>Fujikake</surname><given-names>N</given-names></name><name><surname>Okamoto</surname><given-names>Y</given-names></name><name><surname>Popiel</surname><given-names>HA</given-names></name><name><surname>Hatanaka</surname><given-names>Y</given-names></name><name><surname>Ueyama</surname><given-names>M</given-names></name><name><surname>Suzuki</surname><given-names>M</given-names></name><name><surname>Gaumer</surname><given-names>S</given-names></name><name><surname>Murata</surname><given-names>M</given-names></name><name><surname>Wada</surname><given-names>K</given-names></name><name><surname>Nagai</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>P62 plays a protective role in the Autophagic degradation of Polyglutamine protein Oligomers in Polyglutamine disease model flies</article-title><source>The Journal of Biological Chemistry</source><volume>290</volume><fpage>1442</fpage><lpage>1453</lpage><pub-id pub-id-type="doi">10.1074/jbc.M114.590281</pub-id><pub-id pub-id-type="pmid">25480790</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>CA</given-names></name><name><surname>Rasband</surname><given-names>WS</given-names></name><name><surname>Eliceiri</surname><given-names>KW</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>NIH image to Imagej: 25 years of image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>671</fpage><lpage>675</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2089</pub-id><pub-id pub-id-type="pmid">22930834</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>S</given-names></name><name><surname>Staats</surname><given-names>KA</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Chang</surname><given-names>WH</given-names></name><name><surname>Hung</surname><given-names>ST</given-names></name><name><surname>Hendricks</surname><given-names>E</given-names></name><name><surname>Linares</surname><given-names>GR</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Son</surname><given-names>EY</given-names></name><name><surname>Wen</surname><given-names>X</given-names></name><name><surname>Kisler</surname><given-names>K</given-names></name><name><surname>Wilkinson</surname><given-names>B</given-names></name><name><surname>Menendez</surname><given-names>L</given-names></name><name><surname>Sugawara</surname><given-names>T</given-names></name><name><surname>Woolwine</surname><given-names>P</given-names></name><name><surname>Huang</surname><given-names>M</given-names></name><name><surname>Cowan</surname><given-names>MJ</given-names></name><name><surname>Ge</surname><given-names>B</given-names></name><name><surname>Koutsodendris</surname><given-names>N</given-names></name><name><surname>Sandor</surname><given-names>KP</given-names></name><name><surname>Komberg</surname><given-names>J</given-names></name><name><surname>Vangoor</surname><given-names>VR</given-names></name><name><surname>Senthilkumar</surname><given-names>K</given-names></name><name><surname>Hennes</surname><given-names>V</given-names></name><name><surname>Seah</surname><given-names>C</given-names></name><name><surname>Nelson</surname><given-names>AR</given-names></name><name><surname>Cheng</surname><given-names>TY</given-names></name><name><surname>Lee</surname><given-names>SJJ</given-names></name><name><surname>August</surname><given-names>PR</given-names></name><name><surname>Chen</surname><given-names>JA</given-names></name><name><surname>Wisniewski</surname><given-names>N</given-names></name><name><surname>Hanson-Smith</surname><given-names>V</given-names></name><name><surname>Belgard</surname><given-names>TG</given-names></name><name><surname>Zhang</surname><given-names>A</given-names></name><name><surname>Coba</surname><given-names>M</given-names></name><name><surname>Grunseich</surname><given-names>C</given-names></name><name><surname>Ward</surname><given-names>ME</given-names></name><name><surname>van den Berg</surname><given-names>LH</given-names></name><name><surname>Pasterkamp</surname><given-names>RJ</given-names></name><name><surname>Trotti</surname><given-names>D</given-names></name><name><surname>Zlokovic</surname><given-names>BV</given-names></name><name><surname>Ichida</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Haploinsufficiency leads to neurodegeneration in C9Orf72 ALS/FTD human induced motor neurons</article-title><source>Nature Medicine</source><volume>24</volume><fpage>313</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1038/nm.4490</pub-id><pub-id pub-id-type="pmid">29400714</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simone</surname><given-names>R</given-names></name><name><surname>Balendra</surname><given-names>R</given-names></name><name><surname>Moens</surname><given-names>TG</given-names></name><name><surname>Preza</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>G-Quadruplex-binding small molecules ameliorate C9Orf72 FTD/ALS pathology in vitro and in vivo</article-title><source>EMBO Molecular Medicine</source><volume>10</volume><fpage>22</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.15252/emmm.201707850</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sofola</surname><given-names>OA</given-names></name><name><surname>Jin</surname><given-names>P</given-names></name><name><surname>Qin</surname><given-names>Y</given-names></name><name><surname>Duan</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>de Haro</surname><given-names>M</given-names></name><name><surname>Nelson</surname><given-names>DL</given-names></name><name><surname>Botas</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>RNA-binding proteins hnRNP A2/B1 and Cugbp1 suppress fragile X CGG Premutation repeat-induced neurodegeneration in a <italic>Drosophila</italic> model of FXTAS</article-title><source>Neuron</source><volume>55</volume><fpage>565</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2007.07.021</pub-id><pub-id pub-id-type="pmid">17698010</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonobe</surname><given-names>Y</given-names></name><name><surname>Ghadge</surname><given-names>G</given-names></name><name><surname>Masaki</surname><given-names>K</given-names></name><name><surname>Sendoel</surname><given-names>A</given-names></name><name><surname>Fuchs</surname><given-names>E</given-names></name><name><surname>Roos</surname><given-names>RP</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Translation of Dipeptide repeat proteins from the C9Orf72 expanded repeat is associated with cellular stress</article-title><source>Neurobiology of Disease</source><volume>116</volume><fpage>155</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2018.05.009</pub-id><pub-id pub-id-type="pmid">29792928</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Gendron</surname><given-names>TF</given-names></name><name><surname>Bauer</surname><given-names>PO</given-names></name><name><surname>Chew</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>WY</given-names></name><name><surname>Fostvedt</surname><given-names>E</given-names></name><name><surname>Jansen-West</surname><given-names>K</given-names></name><name><surname>Belzil</surname><given-names>VV</given-names></name><name><surname>Desaro</surname><given-names>P</given-names></name><name><surname>Johnston</surname><given-names>A</given-names></name><name><surname>Overstreet</surname><given-names>K</given-names></name><name><surname>Oh</surname><given-names>SY</given-names></name><name><surname>Todd</surname><given-names>PK</given-names></name><name><surname>Berry</surname><given-names>JD</given-names></name><name><surname>Cudkowicz</surname><given-names>ME</given-names></name><name><surname>Boeve</surname><given-names>BF</given-names></name><name><surname>Dickson</surname><given-names>D</given-names></name><name><surname>Floeter</surname><given-names>MK</given-names></name><name><surname>Traynor</surname><given-names>BJ</given-names></name><name><surname>Morelli</surname><given-names>C</given-names></name><name><surname>Ratti</surname><given-names>A</given-names></name><name><surname>Silani</surname><given-names>V</given-names></name><name><surname>Rademakers</surname><given-names>R</given-names></name><name><surname>Brown</surname><given-names>RH</given-names></name><name><surname>Rothstein</surname><given-names>JD</given-names></name><name><surname>Boylan</surname><given-names>KB</given-names></name><name><surname>Petrucelli</surname><given-names>L</given-names></name><name><surname>Disney</surname><given-names>MD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Discovery of a biomarker and lead small molecules to target R(GGGGCC)-Associated defects in C9Ftd/ALS</article-title><source>Neuron</source><volume>84</volume><elocation-id>239</elocation-id><pub-id pub-id-type="doi">10.1016/j.neuron.2014.09.019</pub-id><pub-id pub-id-type="pmid">28898625</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabet</surname><given-names>R</given-names></name><name><surname>Schaeffer</surname><given-names>L</given-names></name><name><surname>Freyermuth</surname><given-names>F</given-names></name><name><surname>Jambeau</surname><given-names>M</given-names></name><name><surname>Workman</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>CZ</given-names></name><name><surname>Lin</surname><given-names>CC</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Jansen-West</surname><given-names>K</given-names></name><name><surname>Abou-Hamdan</surname><given-names>H</given-names></name><name><surname>Désaubry</surname><given-names>L</given-names></name><name><surname>Gendron</surname><given-names>T</given-names></name><name><surname>Petrucelli</surname><given-names>L</given-names></name><name><surname>Martin</surname><given-names>F</given-names></name><name><surname>Lagier-Tourenne</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>CUG initiation and Frameshifting enable production of Dipeptide repeat proteins from ALS/FTD C9Orf72 transcripts</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>152</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-02643-5</pub-id><pub-id pub-id-type="pmid">29323119</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taminato</surname><given-names>T</given-names></name><name><surname>Takeuchi</surname><given-names>T</given-names></name><name><surname>Ueyama</surname><given-names>M</given-names></name><name><surname>Mori</surname><given-names>K</given-names></name><name><surname>Ikeda</surname><given-names>M</given-names></name><name><surname>Mochizuki</surname><given-names>H</given-names></name><name><surname>Nagai</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Therapeutic reduction of GGGGCC repeat RNA levels by Hnrnpa3 suppresses neurodegeneration in Drosophila models of C9Orf72-linked ALS/FTD</article-title><source>Human Molecular Genetics</source><volume>32</volume><elocation-id>ddac298</elocation-id><pub-id pub-id-type="doi">10.1093/hmg/ddac298</pub-id><pub-id pub-id-type="pmid">36611007</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>H</given-names></name><name><surname>Schilling</surname><given-names>M</given-names></name><name><surname>Wirbelauer</surname><given-names>C</given-names></name><name><surname>Hess</surname><given-names>D</given-names></name><name><surname>Nagamine</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Facilitation of mRNA Deadenylation and decay by the Exosome-bound</article-title><source>Molecular Cell</source><volume>13</volume><fpage>101</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1016/s1097-2765(03)00481-7</pub-id><pub-id pub-id-type="pmid">14731398</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>H</given-names></name><name><surname>Almeida</surname><given-names>S</given-names></name><name><surname>Moore</surname><given-names>J</given-names></name><name><surname>Gendron</surname><given-names>TF</given-names></name><name><surname>Chalasani</surname><given-names>U</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Du</surname><given-names>X</given-names></name><name><surname>Nickerson</surname><given-names>JA</given-names></name><name><surname>Petrucelli</surname><given-names>L</given-names></name><name><surname>Weng</surname><given-names>Z</given-names></name><name><surname>Gao</surname><given-names>FB</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Differential toxicity of nuclear RNA foci versus Dipeptide repeat proteins in a <italic>Drosophila</italic> model of C9Orf72 FTD/ALS</article-title><source>Neuron</source><volume>87</volume><fpage>1207</fpage><lpage>1214</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2015.09.015</pub-id><pub-id pub-id-type="pmid">26402604</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trost</surname><given-names>B</given-names></name><name><surname>Engchuan</surname><given-names>W</given-names></name><name><surname>Nguyen</surname><given-names>CM</given-names></name><name><surname>Thiruvahindrapuram</surname><given-names>B</given-names></name><name><surname>Dolzhenko</surname><given-names>E</given-names></name><name><surname>Backstrom</surname><given-names>I</given-names></name><name><surname>Mirceta</surname><given-names>M</given-names></name><name><surname>Mojarad</surname><given-names>BA</given-names></name><name><surname>Yin</surname><given-names>Y</given-names></name><name><surname>Dov</surname><given-names>A</given-names></name><name><surname>Chandrakumar</surname><given-names>I</given-names></name><name><surname>Prasolava</surname><given-names>T</given-names></name><name><surname>Shum</surname><given-names>N</given-names></name><name><surname>Hamdan</surname><given-names>O</given-names></name><name><surname>Pellecchia</surname><given-names>G</given-names></name><name><surname>Howe</surname><given-names>JL</given-names></name><name><surname>Whitney</surname><given-names>J</given-names></name><name><surname>Klee</surname><given-names>EW</given-names></name><name><surname>Baheti</surname><given-names>S</given-names></name><name><surname>Amaral</surname><given-names>DG</given-names></name><name><surname>Anagnostou</surname><given-names>E</given-names></name><name><surname>Elsabbagh</surname><given-names>M</given-names></name><name><surname>Fernandez</surname><given-names>BA</given-names></name><name><surname>Hoang</surname><given-names>N</given-names></name><name><surname>Lewis</surname><given-names>MES</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Sjaarda</surname><given-names>C</given-names></name><name><surname>Smith</surname><given-names>IM</given-names></name><name><surname>Szatmari</surname><given-names>P</given-names></name><name><surname>Zwaigenbaum</surname><given-names>L</given-names></name><name><surname>Glazer</surname><given-names>D</given-names></name><name><surname>Hartley</surname><given-names>D</given-names></name><name><surname>Stewart</surname><given-names>AK</given-names></name><name><surname>Eberle</surname><given-names>MA</given-names></name><name><surname>Sato</surname><given-names>N</given-names></name><name><surname>Pearson</surname><given-names>CE</given-names></name><name><surname>Scherer</surname><given-names>SW</given-names></name><name><surname>Yuen</surname><given-names>RKC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Genome-wide detection of Tandem DNA repeats that are expanded in autism</article-title><source>Nature</source><volume>586</volume><fpage>80</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2579-z</pub-id><pub-id pub-id-type="pmid">32717741</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tseng</surname><given-names>YJ</given-names></name><name><surname>Sandwith</surname><given-names>SN</given-names></name><name><surname>Green</surname><given-names>KM</given-names></name><name><surname>Chambers</surname><given-names>AE</given-names></name><name><surname>Krans</surname><given-names>A</given-names></name><name><surname>Raimer</surname><given-names>HM</given-names></name><name><surname>Sharlow</surname><given-names>ME</given-names></name><name><surname>Reisinger</surname><given-names>MA</given-names></name><name><surname>Richardson</surname><given-names>AE</given-names></name><name><surname>Routh</surname><given-names>ED</given-names></name><name><surname>Smaldino</surname><given-names>MA</given-names></name><name><surname>Wang</surname><given-names>YH</given-names></name><name><surname>Vaughn</surname><given-names>JP</given-names></name><name><surname>Todd</surname><given-names>PK</given-names></name><name><surname>Smaldino</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The RNA helicase Dhx36-G4R1 modulates C9Orf72 GGGGCC hexanucleotide repeat-associated translation</article-title><source>The Journal of Biological Chemistry</source><volume>297</volume><elocation-id>100914</elocation-id><pub-id pub-id-type="doi">10.1016/j.jbc.2021.100914</pub-id><pub-id pub-id-type="pmid">34174288</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waite</surname><given-names>AJ</given-names></name><name><surname>Bäumer</surname><given-names>D</given-names></name><name><surname>East</surname><given-names>S</given-names></name><name><surname>Neal</surname><given-names>J</given-names></name><name><surname>Morris</surname><given-names>HR</given-names></name><name><surname>Ansorge</surname><given-names>O</given-names></name><name><surname>Blake</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Reduced C9Orf72 protein levels in frontal cortex of Amyotrophic lateral sclerosis and Frontotemporal degeneration brain with the C9Orf72 Hexanucleotide repeat expansion</article-title><source>Neurobiology of Aging</source><volume>35</volume><elocation-id>1779</elocation-id><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2014.01.016</pub-id><pub-id pub-id-type="pmid">24559645</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>JW</given-names></name><name><surname>Brent</surname><given-names>JR</given-names></name><name><surname>Tomlinson</surname><given-names>A</given-names></name><name><surname>Shneider</surname><given-names>NA</given-names></name><name><surname>McCabe</surname><given-names>BD</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The ALS-associated proteins FUS and TDP-43 function together to affect <italic>Drosophila</italic> locomotion and life span</article-title><source>The Journal of Clinical Investigation</source><volume>121</volume><fpage>4118</fpage><lpage>4126</lpage><pub-id pub-id-type="doi">10.1172/JCI57883</pub-id><pub-id pub-id-type="pmid">21881207</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>ZF</given-names></name><name><surname>Ursu</surname><given-names>A</given-names></name><name><surname>Childs-Disney</surname><given-names>JL</given-names></name><name><surname>Guertler</surname><given-names>R</given-names></name><name><surname>Yang</surname><given-names>WY</given-names></name><name><surname>Bernat</surname><given-names>V</given-names></name><name><surname>Rzuczek</surname><given-names>SG</given-names></name><name><surname>Fuerst</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>YJ</given-names></name><name><surname>Gendron</surname><given-names>TF</given-names></name><name><surname>Yildirim</surname><given-names>I</given-names></name><name><surname>Dwyer</surname><given-names>BG</given-names></name><name><surname>Rice</surname><given-names>JE</given-names></name><name><surname>Petrucelli</surname><given-names>L</given-names></name><name><surname>Disney</surname><given-names>MD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The hairpin form of R(G4C2)<sup>Exp</sup> in C9Als/FTD is repeat-associated non-ATG translated and a target for bioactive small molecules</article-title><source>Cell Chemical Biology</source><volume>26</volume><fpage>179</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2018.10.018</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>X</given-names></name><name><surname>Tan</surname><given-names>W</given-names></name><name><surname>Westergard</surname><given-names>T</given-names></name><name><surname>Krishnamurthy</surname><given-names>K</given-names></name><name><surname>Markandaiah</surname><given-names>SS</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>S</given-names></name><name><surname>Shneider</surname><given-names>NA</given-names></name><name><surname>Monaghan</surname><given-names>J</given-names></name><name><surname>Pandey</surname><given-names>UB</given-names></name><name><surname>Pasinelli</surname><given-names>P</given-names></name><name><surname>Ichida</surname><given-names>JK</given-names></name><name><surname>Trotti</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Antisense Proline-arginine RAN Dipeptides linked to C9Orf72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death</article-title><source>Neuron</source><volume>84</volume><fpage>1213</fpage><lpage>1225</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2014.12.010</pub-id><pub-id pub-id-type="pmid">25521377</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Poidevin</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Shu</surname><given-names>L</given-names></name><name><surname>Nelson</surname><given-names>DL</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Hales</surname><given-names>CM</given-names></name><name><surname>Gearing</surname><given-names>M</given-names></name><name><surname>Wingo</surname><given-names>TS</given-names></name><name><surname>Jin</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Expanded GGGGCC repeat RNA associated with Amyotrophic lateral sclerosis and Frontotemporal dementia causes neurodegeneration</article-title><source>PNAS</source><volume>110</volume><fpage>7778</fpage><lpage>7783</lpage><pub-id pub-id-type="doi">10.1073/pnas.1219643110</pub-id><pub-id pub-id-type="pmid">23553836</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>M</given-names></name><name><surname>Hirose</surname><given-names>F</given-names></name><name><surname>Inoue</surname><given-names>YH</given-names></name><name><surname>Shiraki</surname><given-names>M</given-names></name><name><surname>Hayashi</surname><given-names>Y</given-names></name><name><surname>Nishi</surname><given-names>Y</given-names></name><name><surname>Matsukage</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Ectopic expression of human P53 inhibits entry into S phase and induces apoptosis in the <italic>Drosophila</italic> eye Imaginal disc</article-title><source>Oncogene</source><volume>18</volume><fpage>6767</fpage><lpage>6775</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1203113</pub-id><pub-id pub-id-type="pmid">10597285</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>YJ</given-names></name><name><surname>Gendron</surname><given-names>TF</given-names></name><name><surname>Grima</surname><given-names>JC</given-names></name><name><surname>Sasaguri</surname><given-names>H</given-names></name><name><surname>Jansen-West</surname><given-names>K</given-names></name><name><surname>Xu</surname><given-names>YF</given-names></name><name><surname>Katzman</surname><given-names>RB</given-names></name><name><surname>Gass</surname><given-names>J</given-names></name><name><surname>Murray</surname><given-names>ME</given-names></name><name><surname>Shinohara</surname><given-names>M</given-names></name><name><surname>Lin</surname><given-names>WL</given-names></name><name><surname>Garrett</surname><given-names>A</given-names></name><name><surname>Stankowski</surname><given-names>JN</given-names></name><name><surname>Daughrity</surname><given-names>L</given-names></name><name><surname>Tong</surname><given-names>J</given-names></name><name><surname>Perkerson</surname><given-names>EA</given-names></name><name><surname>Yue</surname><given-names>M</given-names></name><name><surname>Chew</surname><given-names>J</given-names></name><name><surname>Castanedes-Casey</surname><given-names>M</given-names></name><name><surname>Kurti</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>ZS</given-names></name><name><surname>Liesinger</surname><given-names>AM</given-names></name><name><surname>Baker</surname><given-names>JD</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Lagier-Tourenne</surname><given-names>C</given-names></name><name><surname>Edbauer</surname><given-names>D</given-names></name><name><surname>Cleveland</surname><given-names>DW</given-names></name><name><surname>Rademakers</surname><given-names>R</given-names></name><name><surname>Boylan</surname><given-names>KB</given-names></name><name><surname>Bu</surname><given-names>G</given-names></name><name><surname>Link</surname><given-names>CD</given-names></name><name><surname>Dickey</surname><given-names>CA</given-names></name><name><surname>Rothstein</surname><given-names>JD</given-names></name><name><surname>Dickson</surname><given-names>DW</given-names></name><name><surname>Fryer</surname><given-names>JD</given-names></name><name><surname>Petrucelli</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>C9Orf72 Poly(GA) aggregates Sequester and impair Hr23 and Nucleocytoplasmic transport proteins</article-title><source>Nature Neuroscience</source><volume>19</volume><fpage>668</fpage><lpage>677</lpage><pub-id pub-id-type="doi">10.1038/nn.4272</pub-id><pub-id pub-id-type="pmid">26998601</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>YJ</given-names></name><name><surname>Gendron</surname><given-names>TF</given-names></name><name><surname>Ebbert</surname><given-names>MTW</given-names></name><name><surname>O’Raw</surname><given-names>AD</given-names></name><name><surname>Yue</surname><given-names>M</given-names></name><name><surname>Jansen-West</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Prudencio</surname><given-names>M</given-names></name><name><surname>Chew</surname><given-names>J</given-names></name><name><surname>Cook</surname><given-names>CN</given-names></name><name><surname>Daughrity</surname><given-names>LM</given-names></name><name><surname>Tong</surname><given-names>J</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Pickles</surname><given-names>SR</given-names></name><name><surname>Castanedes-Casey</surname><given-names>M</given-names></name><name><surname>Kurti</surname><given-names>A</given-names></name><name><surname>Rademakers</surname><given-names>R</given-names></name><name><surname>Oskarsson</surname><given-names>B</given-names></name><name><surname>Dickson</surname><given-names>DW</given-names></name><name><surname>Hu</surname><given-names>W</given-names></name><name><surname>Gitler</surname><given-names>AD</given-names></name><name><surname>Fryer</surname><given-names>JD</given-names></name><name><surname>Petrucelli</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Poly(GR) impairs protein translation and stress granule Dynamics in C9Orf72-associated Frontotemporal dementia and Amyotrophic lateral sclerosis</article-title><source>Nature Medicine</source><volume>24</volume><fpage>1136</fpage><lpage>1142</lpage><pub-id pub-id-type="doi">10.1038/s41591-018-0071-1</pub-id><pub-id pub-id-type="pmid">29942091</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Q</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Gendron</surname><given-names>TF</given-names></name><name><surname>McAlonis-Downes</surname><given-names>M</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Taylor</surname><given-names>A</given-names></name><name><surname>Diaz Garcia</surname><given-names>S</given-names></name><name><surname>Ghosh Dastidar</surname><given-names>S</given-names></name><name><surname>Rodriguez</surname><given-names>MJ</given-names></name><name><surname>King</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>La Spada</surname><given-names>AR</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Petrucelli</surname><given-names>L</given-names></name><name><surname>Ravits</surname><given-names>J</given-names></name><name><surname>Da Cruz</surname><given-names>S</given-names></name><name><surname>Lagier-Tourenne</surname><given-names>C</given-names></name><name><surname>Cleveland</surname><given-names>DW</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Reduced C9Orf72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9Orf72</article-title><source>Nature Neuroscience</source><volume>23</volume><fpage>615</fpage><lpage>624</lpage><pub-id pub-id-type="doi">10.1038/s41593-020-0619-5</pub-id><pub-id pub-id-type="pmid">32284607</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zu</surname><given-names>T</given-names></name><name><surname>Gibbens</surname><given-names>B</given-names></name><name><surname>Doty</surname><given-names>NS</given-names></name><name><surname>Gomes-Pereira</surname><given-names>M</given-names></name><name><surname>Huguet</surname><given-names>A</given-names></name><name><surname>Stone</surname><given-names>MD</given-names></name><name><surname>Margolis</surname><given-names>J</given-names></name><name><surname>Peterson</surname><given-names>M</given-names></name><name><surname>Markowski</surname><given-names>TW</given-names></name><name><surname>Ingram</surname><given-names>MAC</given-names></name><name><surname>Nan</surname><given-names>Z</given-names></name><name><surname>Forster</surname><given-names>C</given-names></name><name><surname>Low</surname><given-names>WC</given-names></name><name><surname>Schoser</surname><given-names>B</given-names></name><name><surname>Somia</surname><given-names>NV</given-names></name><name><surname>Clark</surname><given-names>HB</given-names></name><name><surname>Schmechel</surname><given-names>S</given-names></name><name><surname>Bitterman</surname><given-names>PB</given-names></name><name><surname>Gourdon</surname><given-names>G</given-names></name><name><surname>Swanson</surname><given-names>MS</given-names></name><name><surname>Moseley</surname><given-names>M</given-names></name><name><surname>Ranum</surname><given-names>LPW</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Non-ATG-initiated translation directed by Microsatellite expansions</article-title><source>PNAS</source><volume>108</volume><fpage>260</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1073/pnas.1013343108</pub-id><pub-id pub-id-type="pmid">21173221</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zu</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Bañez-Coronel</surname><given-names>M</given-names></name><name><surname>Reid</surname><given-names>T</given-names></name><name><surname>Pletnikova</surname><given-names>O</given-names></name><name><surname>Lewis</surname><given-names>J</given-names></name><name><surname>Miller</surname><given-names>TM</given-names></name><name><surname>Harms</surname><given-names>MB</given-names></name><name><surname>Falchook</surname><given-names>AE</given-names></name><name><surname>Subramony</surname><given-names>SH</given-names></name><name><surname>Ostrow</surname><given-names>LW</given-names></name><name><surname>Rothstein</surname><given-names>JD</given-names></name><name><surname>Troncoso</surname><given-names>JC</given-names></name><name><surname>Ranum</surname><given-names>LPW</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>RAN proteins and RNA foci from Antisense transcripts in C9Orf72 ALS and Frontotemporal dementia</article-title><source>PNAS</source><volume>110</volume><fpage>E4968</fpage><lpage>E4977</lpage><pub-id pub-id-type="doi">10.1073/pnas.1315438110</pub-id><pub-id pub-id-type="pmid">24248382</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zu</surname><given-names>T</given-names></name><name><surname>Cleary</surname><given-names>JD</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Bañez-Coronel</surname><given-names>M</given-names></name><name><surname>Bubenik</surname><given-names>JL</given-names></name><name><surname>Ayhan</surname><given-names>F</given-names></name><name><surname>Ashizawa</surname><given-names>T</given-names></name><name><surname>Xia</surname><given-names>G</given-names></name><name><surname>Clark</surname><given-names>HB</given-names></name><name><surname>Yachnis</surname><given-names>AT</given-names></name><name><surname>Swanson</surname><given-names>MS</given-names></name><name><surname>Ranum</surname><given-names>LPW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>RAN translation regulated by Muscleblind proteins in myotonic dystrophy type 2</article-title><source>Neuron</source><volume>95</volume><fpage>1292</fpage><lpage>1305</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.08.039</pub-id><pub-id pub-id-type="pmid">28910618</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.84338.3.sa0</article-id><title-group><article-title>eLife assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Eisen</surname><given-names>Michael B</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>University of California, Berkeley</institution><country>United States</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Convincing</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group></front-stub><body><p>This <bold>important</bold> study demonstrates that the human FUS protein, which is implicated in ALS and related conditions, interacts with RNAs containing GGGGCC repeats and can regulate their translation by altering three-dimensional structures caused by these repeats. The study is carefully executed and the data provide <bold>convincing</bold> evidence for its major claims. This work will likely be of interest to researchers studying RNA binding proteins, and to those working on ALS and related diseases.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.84338.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>This is a carefully performed and well documented study to indicate that the FUS protein interacts with the GGGGCC repeat sequence in <italic>Drosophila</italic> fly models, and the mechanism appears to include modulating the repeat structure and mitigating RAN translation. They suggest FUS, as well as a number of other G-quadruplex binding RNA proteins, are RNA chaperones, meaning they can alter the structure of the expanded repeat sequence to modulate its biological activities.Overall this is a nicely done study with nice quantitation.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.84338.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Fuijino et al provide interesting data describing the RNA-binding protein, FUS, for its ability to bind the RNA produced from the hexanucleotide repeat expansion of GGGGCC (G4C2). This binding correlates with reductions in RNA foci formation, the production of toxic dipeptides and concomitant reductions in toxic phenotypes seen in (G4C2)30+ expressing <italic>Drosophila</italic>. Both FUS and G4C2 repeats of &gt;25 are associated with ALS/FTD spectrum disorders. Thus, these data are important for increasing our understanding of potential interactions between multiple disease genes.</p></body></sub-article><sub-article article-type="referee-report" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.84338.3.sa3</article-id><title-group><article-title>Reviewer #3 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>In this manuscript Fujino and colleagues used C9-ALS/FTD fly models to demonstrate that FUS modulates the structure of (G4C2) repeat RNA as an RNA chaperone, and regulates RAN translation, resulting in the suppression of neurodegeneration in C9-ALS/FTD. They also confirmed that FUS preferentially binds to and modulates the G-quadruplex structure of (G4C2) repeat RNA, followed by the suppression of RAN translation. The potential significance of these findings is high, since C9ORF72 repeat expansion is the most common genetic cause of ALS/FTD, especially in Caucasian populations and the DPR proteins have been considered the major cause of the neurodegenerations.</p><p>1. While the effect of RBP as an RNA chaperone on (G4C2) repeat expansion is supposed to be dose-dependent according to (G4C2)n RNA expression, the first experiment of the screening for RBPs in C9-ALS/FTD flies lacks this concept. It is uncertain if the RBPs of the groups &quot;suppression (weak)&quot; and &quot;no effect&quot; were less or no ability of RNA chaperone or if the expression of the RBP was not sufficient, and if the RBPs of the group &quot;enhancement&quot; exacerbated the toxicity derived from (G4C2)89 RNA or the expression of the RBP was excessive. The optimal dose of any RBPs that bind to (G4C2) repeats may be able to neutralize the toxicity without the reduction of (G4C2)n RNA.</p><p>2. In relation to issue 1, the rescue effect of FUS on the fly expressing (G4C2)89 (FUS-4) in Figure 4-figure supplement 1 seems weaker than the other flies expressing both FUS and (G4C2)89 in Figure 1 and Figure 1-figure supplement 2. The expression level of both FUS protein and (G4C2)89 RNA in each line is important from the viewpoint of therapeutic strategy for C9-ALS/FTD.</p><p>3. While hallmarks of C9ORF72 are the presence of DPRs and the repeat-containing RNA foci, the loss of function of C9ORF72 is also considered to somehow contribute to neurodegeneration. It is unclear if FUS reduces not only the DPRs but also the protein expression of C9ORF72 itself.</p><p>4. In Figure 5E-F, it cannot be distinguished whether FUS binds to GGGGCC repeats or 5' flanking region. Same experiment should be done by using FUS-RRMmut to elucidate whether FUS binding is the major mechanism for this translational control. Authors should show that FUS binding to long GGGGCC repeats is important for RAN translation.</p><p>5. It is not possible to conclude, as the authors have, that G-quadruplex-targeting RBPs are generally important for RAN translation (Figure 6), without showing whether RBPs which do not affect to (G4C2)89 RNA levels lead to decreased DPR protein level or RNA foci.</p></body></sub-article><sub-article article-type="author-comment" id="sa4"><front-stub><article-id pub-id-type="doi">10.7554/eLife.84338.3.sa4</article-id><title-group><article-title>Author Response:</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Fujino</surname><given-names>Yuzo</given-names></name><role specific-use="author">Author</role><aff><institution>Kindai University Faculty of Medicine</institution><addr-line><named-content content-type="city">Osaka-Sayama</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Ueyama</surname><given-names>Morio</given-names></name><role specific-use="author">Author</role><aff><institution>Kindai University Faculty of Medicine</institution><addr-line><named-content content-type="city">Osaka-Sayama</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Ishiguro</surname><given-names>Taro</given-names></name><role specific-use="author">Author</role><aff><institution>National Center of Neurology and Psychiatry</institution><addr-line><named-content content-type="city">Kodaira</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Ozawa</surname><given-names>Daisaku</given-names></name><role specific-use="author">Author</role><aff><institution>Kindai University Faculty of Medicine</institution><addr-line><named-content content-type="city">Osaka-Sayama</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Ito</surname><given-names>Hayato</given-names></name><role specific-use="author">Author</role><aff><institution>Tokyo Institute of Technology</institution><addr-line><named-content content-type="city">Yokohama</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Sugiki</surname><given-names>Toshihiko</given-names></name><role specific-use="author">Author</role><aff><institution>Osaka University</institution><addr-line><named-content content-type="city">Osaka</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Murata</surname><given-names>Asako</given-names></name><role specific-use="author">Author</role><aff><institution>Osaka University</institution><addr-line><named-content content-type="city">Ibaraki</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Ishiguro</surname><given-names>Akira</given-names></name><role specific-use="author">Author</role><aff><institution>University of Hosei</institution><addr-line><named-content content-type="city">Koganei</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Gendron</surname><given-names>Tania</given-names></name><role specific-use="author">Author</role><aff><institution>Mayo Clinic</institution><addr-line><named-content content-type="city">Jacksonville</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Mori</surname><given-names>Kohji</given-names></name><role specific-use="author">Author</role><aff><institution>Osaka University Graduate School of Medicine</institution><addr-line><named-content content-type="city">Suita</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Tokuda</surname><given-names>Eiichi</given-names></name><role specific-use="author">Author</role><aff><institution>Keio University</institution><addr-line><named-content content-type="city">Yokohama</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Taminato</surname><given-names>Tomoya</given-names></name><role specific-use="author">Author</role><aff><institution>Kindai University Faculty of Medicine</institution><addr-line><named-content content-type="city">Osaka-Sayama</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Konno</surname><given-names>Takuya</given-names></name><role specific-use="author">Author</role><aff><institution>Niigata University</institution><addr-line><named-content content-type="city">Niigata</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Koyama</surname><given-names>Akihide</given-names></name><role specific-use="author">Author</role><aff><institution>Niigata University</institution><addr-line><named-content content-type="city">Niigata</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Kawabe</surname><given-names>Yuya</given-names></name><role specific-use="author">Author</role><aff><institution>Osaka University Graduate School of Medicine</institution><addr-line><named-content content-type="city">Suita</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Takeuchi</surname><given-names>Toshihide</given-names></name><role specific-use="author">Author</role><aff><institution>Kindai University Faculty of Medicine</institution><addr-line><named-content content-type="city">Osaka-Sayama</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Furukawa</surname><given-names>Yoshiaki</given-names></name><role specific-use="author">Author</role><aff><institution>Keio University</institution><addr-line><named-content content-type="city">Yokohama</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Fujiwara</surname><given-names>Toshimichi</given-names></name><role specific-use="author">Author</role><aff><institution>Osaka University</institution><addr-line><named-content content-type="city">Suita-shi</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Ikeda</surname><given-names>Manabu</given-names></name><role specific-use="author">Author</role><aff><institution>Osaka University Graduate School of Medicine</institution><addr-line><named-content content-type="city">Suita</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Mizuno</surname><given-names>Toshiki</given-names></name><role specific-use="author">Author</role><aff><institution>Kyoto Prefectural University of Medicine</institution><addr-line><named-content content-type="city">Kyoto</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Mochizuki</surname><given-names>Hideki</given-names></name><role specific-use="author">Author</role><aff><institution>Osaka University Graduate School of Medicine</institution><addr-line><named-content content-type="city">Osaka</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Mizusawa</surname><given-names>Hidehiro</given-names></name><role specific-use="author">Author</role><aff><institution>Tokyo Medical and Dental University</institution><addr-line><named-content content-type="city">Tokyo</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Wada</surname><given-names>Keiji</given-names></name><role specific-use="author">Author</role><aff><institution>National Center of Neurology and Psychiatry</institution><addr-line><named-content content-type="city">Kodaira</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Ishikawa</surname><given-names>Kinya</given-names></name><role specific-use="author">Author</role><aff><institution>Tokyo Medical and Dental University</institution><addr-line><named-content content-type="city">Tokyo</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Onodera</surname><given-names>Osamu</given-names></name><role specific-use="author">Author</role><aff><institution>Niigata University</institution><addr-line><named-content content-type="city">Niigata</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Nakatani</surname><given-names>Kazuhiko</given-names></name><role specific-use="author">Author</role><aff><institution>Osaka University</institution><addr-line><named-content content-type="city">Ibaraki</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Petrucelli</surname><given-names>Leonard</given-names></name><role specific-use="author">Author</role><aff><institution>Mayo Clinic</institution><addr-line><named-content content-type="city">Jacksonville</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Taguchi</surname><given-names>Hideki</given-names></name><role specific-use="author">Author</role><aff><institution>Tokyo Institute of Technology</institution><addr-line><named-content content-type="city">Yokohama</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Nagai</surname><given-names>Yoshitaka</given-names></name><role specific-use="author">Author</role><aff><institution>Kindai University Faculty of Medicine</institution><addr-line><named-content content-type="city">Osaka-Sayama</named-content></addr-line><country>Japan</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors' response to the original reviews.</p><p><bold>Reply to Public Reviews:</bold></p><disp-quote content-type="editor-comment"><p><bold>Reply to Reviewer #1:</bold></p><p>This is a carefully performed and well-documented study to indicate that the FUS protein interacts with the GGGGCC repeat sequence in <italic>Drosophila</italic> fly models, and the mechanism appears to include modulating the repeat structure and mitigating RAN translation. They suggest FUS, as well as a number of other G-quadruplex binding RNA proteins, are RNA chaperones, meaning they can alter the structure of the expanded repeat sequence to modulate its biological activities.</p></disp-quote><p><bold>Response:</bold> We would like to thank the reviewer for her/his time for evaluating our manuscript. We are very happy to see the reviewer for highly appreciating our manuscript.</p><disp-quote content-type="editor-comment"><p>1. Overall this is a nicely done study with nice quantitation. It remains somewhat unclear from the data and discussions in exactly what way the authors mean that FUS is an RNA chaperone: is FUS changing the structure of the repeat or does FUS binding prevent it from folding into alternative in vivo structure?</p></disp-quote><p><bold>Response:</bold> We appreciate the reviewer’s constructive comments. Indeed, we showed that FUS changes the higher-order structures of GGGGCC [G4C2] repeat RNA in vitro, and that FUS suppresses G4C2 RNA foci formation in vivo. According to the established definition of RNA chaperone, RNA chaperones are proteins changing the structures of misfolded RNAs without ATP use, resulting in the maintenance of proper RNAs folding (Rajkowitsich et al., 2007). Thus, we consider that FUS is classified into RNA chaperone. To clarify these interpretations, we revised the manuscript as follows.</p><p>(1) On page 10, line 215-219, the sentence “These results were in good agreement with our previous study on SCA31 showing the suppressive effects of FUS and other RBPs on RNA foci formation of UGGAA repeat RNA as RNA chaperones …” was changed to “These results were in good agreement with … RNA foci formation of UGGAA repeat RNA through altering RNA structures and preventing aggregation of misfolded repeat RNA as RNA chaperones …”.</p><p>(2) On page 17, line 363-366, the sentence “FUS directly binds to G4C2 repeat RNA and modulates its G-quadruplex structure, as evident by CD and NMR analyses (Figure 5), suggesting its functional role as an RNA chaperone.” was changed to “FUS directly binds to G4C2 repeat RNA and modulates its G-quadruplex structure as evident by CD and NMR analyses (Figure 5, Figure 5—figure supplement 2), and suppresses RNA foci formation in vivo (Figures 3A and 3B), suggesting its functional role as an RNA chaperone.”</p><disp-quote content-type="editor-comment"><p><bold>Reply to Reviewer #2:</bold></p><p>Fuijino et al. provide interesting data describing the RNA-binding protein, FUS, for its ability to bind the RNA produced from the hexanucleotide repeat expansion of GGGGCC (G4C2). This binding correlates with reductions in the production of toxic dipeptides and reductions in toxic phenotypes seen in (G4C2)30+ expressing <italic>Drosophila</italic>. Both FUS and G4C2 repeats of &gt;25 are associated with ALS/FTD spectrum disorders. Thus, these data are important for increasing our understanding of potential interactions between multiple disease genes. However, further validation of some aspects of the provided data is needed, especially the expression data.</p></disp-quote><p><bold>Response:</bold> We would like to thank the reviewer for her/his time for evaluating our manuscript and also for her/his important comments that helped to strengthen our manuscript.</p><disp-quote content-type="editor-comment"><p>Some points to consider when reading the work:</p><p>1. The broadly expressed GMR-GAL4 driver leads to variable tissue loss in different genotypes, potentially confounding downstream analyses dependent on viable tissue/mRNA levels.</p></disp-quote><p><bold>Response:</bold> We thank the reviewer for this constructive comment. In the RT-qPCR experiments (Figures 1E, 3C, 4G, 6D and Figure 1—figure supplement 1C), the amounts of G4C2 repeat transcripts were normalized to those of <italic>gal4</italic> transcripts expressed in the same tissue, to avoid potential confounding derived from the difference in tissue viability between genotypes, as the reviewer pointed out. To clarify this process, we have made the following change to the revised manuscript.</p><p>(1) On page 30, line 548-550, the sentence “The amounts of G4C2 repeat transcripts were normalized to those of <italic>gal4</italic> transcripts in the same sample” was changed to “The amounts of G4C2 repeat transcripts were normalized to those of <italic>gal4</italic> transcripts expressed in the same tissue to avoid potential confounding derived from the difference in tissue viability between genotypes”.</p><disp-quote content-type="editor-comment"><p>2. The relationship between FUS and foci formation is unclear and should be interpreted carefully.</p></disp-quote><p><bold>Response:</bold> We appreciate the reviewer’s important comment. We apologize for the lack of clarity. We showed the relationship between FUS and RNA foci formation in our C9-ALS/FTD fly, that is, FUS suppresses RNA foci formation (Figures 3A and 3B), and knockdown of endogenous <italic>caz</italic>, a <italic>Drosophila</italic> homologue of <italic>FUS</italic>, enhanced it conversely (Figures 4E and 4F). We consider that FUS suppresses RNA foci formation through altering RNA structures and preventing aggregation of misfolded G4C2 repeat RNA as an RNA chaperone. To clarify these interpretations, we revised the manuscript as follows.</p><p>(1) On page 10, line 215-219, the sentence “These results were in good agreement with our previous study on SCA31 showing the suppressive effects of FUS and other RBPs on RNA foci formation of UGGAA repeat RNA as RNA chaperones …” was changed to “These results were in good agreement with … RNA foci formation of UGGAA repeat RNA through altering RNA structures and preventing aggregation of misfolded repeat RNA as RNA chaperones …”.</p><p>(2) On page 17, line 363-366, the sentence “FUS directly binds to G4C2 repeat RNA and modulates its G-quadruplex structure, as evident by CD and NMR analyses (Figure 5), suggesting its functional role as an RNA chaperone.” was changed to “FUS directly binds to G4C2 repeat RNA and modulates its G-quadruplex structure as evident by CD and NMR analyses (Figure 5, Figure 5—figure supplement 2), and suppresses RNA foci formation in vivo (Figures 3A and 3B), suggesting its functional role as an RNA chaperone.”</p><disp-quote content-type="editor-comment"><p><bold>Reply to Reviewer #3:</bold></p><p>In this manuscript Fujino and colleagues used C9-ALS/FTD fly models to demonstrate that FUS modulates the structure of (G4C2) repeat RNA as an RNA chaperone, and regulates RAN translation, resulting in the suppression of neurodegeneration in C9-ALS/FTD. They also confirmed that FUS preferentially binds to and modulates the G-quadruplex structure of (G4C2) repeat RNA, followed by the suppression of RAN translation. The potential significance of these findings is high since C9ORF72 repeat expansion is the most common genetic cause of ALS/FTD, especially in Caucasian populations and the DPR proteins have been considered the major cause of the neurodegenerations.</p></disp-quote><p><bold>Response:</bold> We would like to thank the reviewer for her/his time for evaluating our manuscript. We are grateful to the reviewer for the insightful comments, which were very helpful for us to improve the manuscript.</p><disp-quote content-type="editor-comment"><p>1. While the effect of RBP as an RNA chaperone on (G4C2) repeat expansion is supposed to be dose-dependent according to (G4C2)n RNA expression, the first experiment of the screening for RBPs in C9-ALS/FTD flies lacks this concept. It is uncertain if the RBPs of the groups &quot;suppression (weak)&quot; and &quot;no effect&quot; were less or no ability of RNA chaperone or if the expression of the RBP was not sufficient, and if the RBPs of the group &quot;enhancement&quot; exacerbated the toxicity derived from (G4C2)89 RNA or the expression of the RBP was excessive. The optimal dose of any RBPs that bind to (G4C2) repeats may be able to neutralize the toxicity without the reduction of (G4C2)n RNA.</p></disp-quote><p><bold>Response:</bold> We appreciate the reviewer’s constructive comments. We employed the site-directed transgenesis for the establishment of RBP fly lines, to ensure the equivalent expression levels of the inserted transgenes. We also evaluated the toxic effects of overexpressed RBPs themselves by crossbreeding with control <italic>EGFP</italic> flies, showing in Figure 1A. To clarify them, we have made the following changes to the revised manuscript.</p><p>(1) On page 8, line 166-168, the sentence “The variation in the effects of these G4C2 repeat-binding RBPs on G4C2 repeat-induced toxicity may be due to their different binding affinities to G4C2 repeat RNA, and their different roles in RNA metabolism.” was changed to “The variation in the effects of these G4C2 repeat-binding RBPs on G4C2 repeat-induced toxicity may be due to their different binding affinities to G4C2 repeat RNA, and the different toxicity of overexpressed RBPs themselves.”.</p><p>(2) On page 29, line 519-522, the sentence “By employing site-specific transgenesis using the pUASTattB vector, each transgene was inserted into the same locus of the genome, and was expected to be expressed at the equivalent levels.” was added.</p><disp-quote content-type="editor-comment"><p>2. In relation to issue 1, the rescue effect of FUS on the fly expressing (G4C2)89 (FUS-4) in Figure 4-figure supplement 1 seems weaker than the other flies expressing both FUS and (G4C2)89 in Figure 1 and Figure 1-figure supplement 2. The expression level of both FUS protein and (G4C2)89 RNA in each line is important from the viewpoint of therapeutic strategy for C9-ALS/FTD.</p></disp-quote><p><bold>Response:</bold> We appreciate the reviewer’s important comment. The <italic>FUS-4</italic> transgene is expected to be expressed at the equivalent level to the <italic>FUS-3</italic> transgene, since they are inserted into the same locus of the genome by the site-directed transgenesis. Thus, we suppose that the weaker suppressive effect of <italic>FUS-4</italic> coexpression on G4C2 repeat-induced eye degeneration can be attributed to the C-terminal FLAG tag that is fused to FUS protein expressed in <italic>FUS-4</italic> fly line. Since the <italic>caz</italic> fly expresses caz protein also fused to FLAG tag at the C-terminus, we used this <italic>FUS-4</italic> fly line to directly compare the effect of caz on G4C2 repeat-induced toxicity to that of FUS.</p><disp-quote content-type="editor-comment"><p>3. While hallmarks of C9ORF72 are the presence of DPRs and the repeat-containing RNA foci, the loss of function of C9ORF72 is also considered to somehow contribute to neurodegeneration. It is unclear if FUS reduces not only the DPRs but also the protein expression of C9ORF72 itself.</p></disp-quote><p><bold>Response:</bold> We thank the reviewer for this comment. We agree that not only DPRs, but also toxic repeat RNA and the loss-of-function of C9ORF72 jointly contribute to the pathomechanisms of C9-ALS/FTD. Since <italic>Drosophila</italic> has no homolog corresponding to the human <italic>C9orf72</italic> gene, the effect of FUS on <italic>C9orf72</italic> expression cannot be assessed. Our fly models are useful for evaluating gain-of-toxic pathomechanisms such as RNA foci formation and RAN translation, and the association between FUS and loss-of function of C9ORF72 is beyond the scope of this study.</p><disp-quote content-type="editor-comment"><p>4. In Figure 5E-F, it cannot be distinguished whether FUS binds to GGGGCC repeats or the 5' flanking region. The same experiment should be done by using FUS-RRMmut to elucidate whether FUS binding is the major mechanism for this translational control. Authors should show that FUS binding to long GGGGCC repeats is important for RAN translation.</p></disp-quote><p><bold>Response:</bold> We would like to thank the reviewer for these insightful comments. Following the reviewer’s suggestion, we perform in vitro translation assay again using FUS-RRMmut, which loses the binding ability to G4C2 repeat RNA as evident by the filter binding assay (Figure 5A), instead of BSA. The results are shown in the figures of Western blot analysis below. The addition of FUS to the translation system suppressed the expression levels of GA-Myc efficiently, whereas that of FUS-RRMmut did not. FUS decreased the expression level of GA-Myc at as low as 10nM, and nearly eliminated RAN translation activity at 100nM. At 400nM, FUS-RRMmut weakly suppressed the GA-Myc expression levels probably because of the residual RNA-binding activity. These results suggest that FUS suppresses RAN translation in vitro through direct interactions with G4C2 repeat RNA.</p><p>Unfortunately, RAN translation from short G4C2 repeat RNA was not investigated in our translation system, although the previous study reported the low efficacy of RAN translation from short G4C2 repeat RNA (Green et al., 2017).</p><p><bold>Author response image 1.</bold></p><p>(A) Western blot analysis of the GA-Myc protein in the samples from in vitro translation.</p><p>(B) Quantification of the GA-Myc protein levels.</p><p>We have made the following changes to the revised manuscript.</p><p>(1) Figure 5F was replaced to new Figures 5F and 5G.</p><p>(2) On page 14-15, line 326-330, the sentence “Notably, the addition of FUS to this system decreased the expression level of GA-Myc in a dose-dependent manner, whereas the addition of the control bovine serum albumin (BSA) did not (Figure 5F).” was changed to “Notably, upon the addition to this translation system, FUS suppressed RAN translation efficiently, whereas FUS-RRMmut did not. FUS decreased the expression levels of GA-Myc at as low as 10nM, and nearly eliminated RAN translation activity at 100nM. At 400nM, FUS-RRMmut weakly suppressed the GA-Myc expression levels probably because of the residual RNA-binding activity (Figure 5F and 5G).”.</p><p>(3) On page 15, line 330-332, the sentence “Taken together, these results indicate that FUS suppresses RAN translation from G4C2 repeat RNA in vitro as an RNA chaperone.” was changed to “Taken together, these results indicate that FUS suppresses RAN translation in vitro through direct interactions with G4C2 repeat RNA as an RNA chaperone.”.</p><p>(4) On page 37, line 720-723, the sentence “For preparation of the FUS protein, the human <italic>FUS</italic> (WT) gene flanked at the 5¢ end with an _Nde_I recognition site and at the 3¢ end with a _Xho_I recognition site was amplified by PCR from pUAST-<italic>FUS</italic>.” was changed to “For preparation of the FUS proteins, the human <italic>FUS</italic> (WT) and <italic>FUS-RRMmut</italic> genes flanked at the 5¢ end with an _Nde_I recognition site and at the 3¢ end with a _Xho_I recognition site was amplified by PCR from pUAST-<italic>FUS</italic> and pUAST- <italic>FUS-RRMmut</italic>, respectively.”.</p><p>(5) On page 41, line 816-819, the sentence “FUS or BSA at each concentration (10, 100, and 1,000 nM) was added for translation in the lysate.” was changed to “FUS or FUS-RRMmut at each concentration (10, 100, 200, 400, and 1,000 nM) was preincubated with mRNA for 10 min to facilitate the interaction between FUS protein and G4C2 repeat RNA, and added for translation in the lysate.”.</p><disp-quote content-type="editor-comment"><p>5. It is not possible to conclude, as the authors have, that G-quadruplex-targeting RBPs are generally important for RAN translation (Figure 6), without showing whether RBPs that do not affect (G4C2)89 RNA levels lead to decreased DPR protein level or RNA foci.</p></disp-quote><p><bold>Response:</bold> We appreciate the reviewer’s critical comment. Following the suggestion by the reviewer, we evaluate the effect of these G-quadruplex-targeting RBPs on RAN translation. We additionally performed immunohistochemistry of the eye imaginal discs of fly larvae expressing (<italic>G4C2</italic>)89 and these G-quadruplex-targeting RBPs. As shown in the figures of immunohistochemistry below, we found that coexpression of <italic>EWSR1</italic>, <italic>DDX3X</italic>, <italic>DDX5</italic>, and <italic>DDX17</italic> significantly decreased the number of poly(GA) aggregates. The results suggest that these G-quadruplex-targeting RBPs regulate RAN translation as well as FUS.</p><p><bold>Author response image 2.</bold></p><p>(A) Immunohistochemistry of poly(GA) in the eye imaginal discs of fly larvae expressing (<italic>G4C2</italic>)89 and the indicated G-quadruplex-targeting RBPs.</p><p>(B) Quantification of the number of poly(GA) aggregates.</p><p>We have made the following changes to the revised manuscript.</p><p>(1) Figures 6E and 6F were added.</p><p>(2) On page 6-7, line 135-137, the sentence “In addition, other G-quadruplex-targeting RBPs also suppressed G4C2 repeat-induced toxicity in our C9-ALS/FTD flies.” was changed to “In addition, other G-quadruplex-targeting RBPs also suppressed RAN translation and G4C2 repeat-induced toxicity in our C9-ALS/FTD flies.”.</p><p>(3) On page 15, line 344-346, the sentence “As expected, these RBPs also decreased the number of poly(GA) aggregates in the eye imaginal discs (Figures 6E and 6F).” was added.</p><p>(4) On page 15, line 346-347, the sentence “Their effects on G4C2 repeat-induced toxicity and repeat RNA expression were consistent with those of FUS.” was changed to “Their effects on G4C2 repeat-induced toxicity, repeat RNA expression, and RAN translation were consistent with those of FUS.”</p><p>(5) On page 16, line 355-357, the sentence “Thus, some G-quadruplex-targeting RBPs regulate G4C2 repeat-induced toxicity by binding to and possibly by modulating the G-quadruplex structure of G4C2 repeat RNA.” was changed to “Thus, some G-quadruplex-targeting RBPs regulate RAN translation and G4C2 repeat-induced toxicity by binding to and possibly by modulating the G-quadruplex structure of G4C2 repeat RNA.”</p><p>(6) On page 19, line 417-421, the sentence “We further found that G-quadruplex-targeting RNA helicases, including DDX3X, DDX5, and DDX17, which are known to bind to G4C2 repeat RNA (Cooper-Knock et al., 2014; Haeusler et al., 2014; Mori et al., 2013a; Xu et al., 2013), also alleviate G4C2 repeat-induced toxicity without altering the expression levels of G4C2 repeat RNA in our <italic>Drosophila</italic> models.” was changed to “We further found that G-quadruplex-targeting RNA helicases, … ,also suppress RAN translation and G4C2 repeat-induced toxicity without altering the expression levels of G4C2 repeat RNA in our <italic>Drosophila</italic> models.”.</p><disp-quote content-type="editor-comment"><p><bold>Reply to Recommendations For The Authors:</bold></p><p>1. It is not clear from the start that the flies they generated with the repeat have an artificial vs human intronic sequence ahead of the repeat. It would be nice if they presented somewhere the entire sequence of the insert. The reason being that it seems they also tested flies with the human intronic sequence, and the effect may not be as strong (line 234). In any case, in the future, with a new understanding of RAN translation, it would be nice to compare different transgenes, and so as much transparency as possible would be helpful regarding sequences. Can they include these data?</p></disp-quote><p><bold>Response:</bold> We thank the editors and reviewers for this comment. We apologize for the lack of clarity. We used artificially synthesized G4C2 repeat sequences when generating constructs for (<italic>G4C2</italic>)n transgenic flies, so these constructs do not contain human intronic sequence ahead of the G4C2 repeat in the <italic>C9orf72</italic> gene, as explained in the Materials and Methods section. To clarify the difference between our C9-ALS/FTD fly models and LDS-(<italic>G4C2</italic>)44GR-GFP fly model (Goodman et al., 2019), we have made the following change to the revised manuscript.</p><p>(1) Schema of the LDS-(<italic>G4C2</italic>)44GR-GFP construct was presented in Figure 3—figure supplement 1.</p><p>Furthermore, to maintain transparency of the study, we have provided the entire sequence of the insert as the following source file.</p><p>(2) The artificial sequences inserted in the pUAST vector for generation of the (<italic>G4C2</italic>)n flies were presented in Figure 1—figure supplement 1—source data 1.</p><disp-quote content-type="editor-comment"><p>2. It is really nice how they quantitated everything and showed individual data points.</p></disp-quote><p><bold>Response:</bold> We thank the editors and reviewers for appreciating our data analysis method. All individual data points and statistical analyses are summarized in source data files.</p><disp-quote content-type="editor-comment"><p>3. So when they call FUS an RNA chaperone, are they simply meaning it is changing the structure of the repeat, or could it just be interacting with the repeat to coat the repeat and prevent it from folding into whatever in vivo structures? Can they speculate on why some RNA chaperones lead to presumed decay of the repeat and others do not? Can they discuss these points in the discussion? Detailed mechanistic understanding of RNA chaperones that ultimately promote decay of the repeat might be of highly significant therapeutic benefit.</p></disp-quote><p><bold>Response:</bold> We appreciate these critical comments. Indeed, we showed that FUS changes the higher-order structures of G4C2 repeat RNA in vitro, and that FUS suppresses G4C2 RNA foci formation. According to the established definition of RNA chaperone, RNA chaperones are proteins changing the structures of misfolded RNAs without ATP use, resulting in the maintenance of proper RNAs folding (Rajkowitsich et al., 2007). Thus, we consider that FUS is classified into RNA chaperone. To clarify these interpretations, we revised the manuscript as follows.</p><p>(1) On page 10, line 215-219, the sentence “These results were in good agreement with our previous study on SCA31 showing the suppressive effects of FUS and other RBPs on RNA foci formation of UGGAA repeat RNA as RNA chaperones …” was changed to “These results were in good agreement with … RNA foci formation of UGGAA repeat RNA through altering RNA structures and preventing aggregation of misfolded repeat RNA as RNA chaperones …”.</p><p>(2) On page 17, line 363-366, the sentence “FUS directly binds to G4C2 repeat RNA and modulates its G-quadruplex structure, as evident by CD and NMR analyses (Figure 5), suggesting its functional role as an RNA chaperone.” was changed to “FUS directly binds to G4C2 repeat RNA and modulates its G-quadruplex structure as evident by CD and NMR analyses (Figure 5, Figure 5—figure supplement 2), and suppresses RNA foci formation in vivo (Figures 3A and 3B), suggesting its functional role as an RNA chaperone.”</p><p>Besides these RNA chaperones, we observed the expression of IGF2BP1, hnRNPA2B1, DHX9, and DHX36 decreased G4C2 repeat RNA expression levels. In addition, we recently reported that hnRNPA3 reduces G4C2 repeat RNA expression levels, leading to the suppression of neurodegeneration in C9-ALS/FTD fly models (Taminato et al., 2023). We speculate these RBPs could be involved in RNA decay pathways as components of the P-body or interactors with the RNA deadenylation machinery (Tran et al., 2004; Katahira et al., 2008; Geissler et al., 2016; Hubstenberger et al., 2017), possibly contributing to the reduced expression levels of G4C2 repeat RNA. To clarify these interpretations, we revised the manuscript as follows.</p><p>(3) On page 18, line 392-398, the sentences “Similarly, we recently reported that hnRNPA3 reduces G4C2 repeat RNA expression levels, leading to the suppression of neurodegeneration in C9-ALS/FTD fly models (Taminato et al., 2023). Interestingly, these RBPs have been reported to be involved in RNA decay pathways as components of the P-body or interactors with the RNA deadenylation machinery (Tran et al., 2004; Katahira et al., 2008; Geissler et al., 2016; Hubstenberger et al., 2017), possibly contributing to the reduced expression levels of G4C2 repeat RNA.” was added.</p><disp-quote content-type="editor-comment"><p>4. What is the level of the G4C2 repeat when they knock down caz? Is it possible that knockdown impacts the expression level of the repeat? Can they show this (or did they and I miss it)?</p></disp-quote><p><bold>Response:</bold> We thank the editors and reviewers for this comment. The expression levels of G4C2 repeat RNA in (<italic>G4C2</italic>)89 flies were not altered by the knockdown of <italic>caz</italic>, as shown in Figure 4G.</p><disp-quote content-type="editor-comment"><p>5. A puzzling point is that FUS is supposed to be nuclear, so where is FUS in the brain in their lines? They suggest it modulates RAN translation, and presumably, that is in the cytoplasm. Is FUS when overexpressed now in part in the cytoplasm? Is the repeat dragging it into the cytoplasm? Can they address this in the discussion? If FUS is never found in vivo in the cytoplasm, then it raises the point that the impact they find of FUS on RAN translation might not reflect an in vivo situation with normal levels of FUS.</p></disp-quote><p><bold>Response:</bold> We appreciate these important comments. We agree with the editors and reviewers that FUS is mainly localized in the nucleus. However, FUS is known as a nucleocytoplasmic shuttling RBP that can transport RNA into the cytoplasm. Indeed, FUS is reported to facilitate transport of actin-stabilizing protein mRNAs to function in the cytoplasm (Fujii et al., 2005). Thus, we consider that FUS binds to G4C2 repeat RNA in the cytoplasm and suppresses RAN translation in this study.</p><disp-quote content-type="editor-comment"><p>6. When they are using 2 copies of the driver and repeat, are they also using 2 copies of FUS? These are quite high levels of transgenes.</p></disp-quote><p><bold>Response:</bold> We thank the editors and reviewers for this comment. We used only 1 copy of <italic>FUS</italic> when using 2 copies of <italic>GMR-Gal4</italic> driver. Full genotypes of the fly lines used in all experiments are described in Supplementary file 1.</p><disp-quote content-type="editor-comment"><p>7. In Figure5-S1, FUS colocalizing with (G4C2)RNA is not clear. High-magnification images are recommended.</p></disp-quote><p><bold>Response:</bold> We appreciate this constructive comment on the figure. Following the suggestion, high-magnification images are added in Figure 5—figure supplement 1.</p><disp-quote content-type="editor-comment"><p>8. I also suggest that the last sentence of the Discussion be revised as follows: Thus, our findings contribute not only to the elucidation of C9-ALS/FTD, but also to the elucidation of the repeat-associated pathogenic mechanisms underlying a broader range of neurodegenerative and neuropsychiatric disorders than previously thought, and it will advance the development of potential therapies for these diseases.</p></disp-quote><p><bold>Response:</bold> We appreciate this recommendation. We have made the following change based on the suggested sentence.</p><p>(1) On page 20-21, line 455-459, “Thus, our findings contribute not only towards the elucidation of repeat-associated pathogenic mechanisms underlying a wider range of neuropsychiatric diseases than previously thought, but also towards the development of potential therapies for these diseases.” was changed to “Thus, our findings contribute to the elucidation of the repeat-associated pathogenic mechanisms underlying not only C9-ALS/FTD, but also a broader range of neuromuscular and neuropsychiatric diseases than previously thought, and will advance the development of potential therapies for these diseases.”.</p><p><bold>Authors’ comment on previous eLife assessment:</bold></p><p>We thank the editors and reviewers for appreciating our study. We mainly evaluated the function of human FUS protein on RAN translation and G4C2 repeat-induced toxicity using <italic>Drosophila</italic> expressing human <italic>FUS in vivo</italic>, and the recombinant human FUS protein <italic>in vitro</italic>. To validate that FUS functions as an endogenous regulator of RAN translation, we additionally evaluated the function of <italic>Drosophila</italic> caz protein as well. We are afraid that the first sentence of the eLife assessment, that is, “This important study demonstrates that the Drosophila FUS protein, the human homolog of which is implicated in amyotrophic lateral sclerosis (ALS) and related conditions, …” is somewhat misleading. We would be happy if you modify this sentence like “This important study demonstrates that the human FUS protein, which is implicated in amyotrophic lateral sclerosis (ALS) and related conditions, …”.</p></body></sub-article></article>